<DOC>
<DOCNO>10022389_0.141</DOCNO>
<TEXT>
      15-Hydroxyprostaglandin Dehydrogenase: Cinderella Meets Prince Serendip          John W. Funder  
</TEXT>
</DOC>


<DOC>
<DOCNO>10022389_144.85</DOCNO>
<TEXT>
    Baker Medical Research Institute  Melbourne, Victoria, Australia 8008   
</TEXT>
</DOC>


<DOC>
<DOCNO>10022389_232.223</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: John W. Funder, Baker Medical Research Institute, Monash University, P.O. Box 6492, St. Kilda Road Central, Melbourne, Victoria, Australia 8008.
</TEXT>
</DOC>

<DOC>
<DOCNO>10022391_0.162</DOCNO>
<TEXT>
      Treatment of Resistance to Thyroid Hormone&#151;Primum Non Nocere          Roy E. Weiss and   Samuel Refetoff  
</TEXT>
</DOC>



<DOC>
<DOCNO>10022391_250.510</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Roy E. Weiss, M.D., PhD, Thyroid Study Unit MC 3090, Department of Medicine, University of Chicago, 5841 S. Maryland Ave, Chicago, IL 60637.  E-mail:  rweiss{at}medicine.bsd.uchicago.edurweiss@medicine.bsd.uchicago.edu.'//-->
</TEXT>
</DOC>



<DOC>
<DOCNO>10022461_0.160</DOCNO>
<TEXT>
      Proopiomelanocortin Products and Human Early-Onset Obesity          Robert S. Jackson and   Stephen O&#146;Rahilly  
</TEXT>
</DOC>


<DOC>
<DOCNO>10022461_163.79</DOCNO>
<TEXT>
    Addenbrooke&#146;s Hospital,  Cambridge, CB2 2QQ, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>10022461_245.61</DOCNO>
<TEXT>
    Caroline Brain and   Stephen S. Nussey  
</TEXT>
</DOC>

<DOC>
<DOCNO>10022466_0.242</DOCNO>
<TEXT>
      About the Use and Misuse of an ACTH 1-39 Radioimmunoassay to Measure ACTH 1-24          M. Grino,   P. Darmon,   F. Dadoun,   C. Frachebois,   J.-G. Velut,   S. Boullu,   A. Dutour and   C. Oliver  
</TEXT>
</DOC>


<DOC>
<DOCNO>10022466_245.331</DOCNO>
<TEXT>
    Laboratoire de Neuroendocrinologie Exp&eacute;rimentale, INSERM  U 501 (M.G., F.D., C.F., J.-G.V., S.B., A.D., C.O.)  Laboratoire de Biochimie (M.G.)  Service d&#146;Endocrinologie, Maladies M&eacute;taboliques et de la  Nutrition (P.D., F.D., C.F., S.B., A.D., C.O.)  H&ocirc;pital Nord, Marseille Cedex 20, France   
</TEXT>
</DOC>


<DOC>
<DOCNO>10022466_579.2523</DOCNO>
<TEXT>
          In a recent paper Mayenknecht et al. (1) have shown that the  diagnostic sensitivities of the low (LDT) and high (HDT) dose  tetracosactin (ACTH 1-24) stimulation tests are almost identical. Their  conclusions are supported in part by the measurements of plasma  immunoreactive tetracosactin, which show that "In the HDT, plasma  tetracosactin rose to more than 60,000 pg/mL shortly after injection.  In the LDT, it rose to 1900 pg/mL." Based on these results and on the  observation that the response of the normal human adrenal to an  increment in plasma corticotropin to 70&#150;80 pg/mL is almost maximal  (2), the authors assumed that the LDT cannot be more sensitive than the  HDT. However, we feel that these tetracosactin measurements were  largely overestimated. Indeed, assuming a distribution space of 10 L,  injection of 1 &#181;g (i.e. the dose used in the LDT) or 250  &#181;g (i.e. the dose used in the HDT) tetracosactin would  give maximal plasma concentration of 100 and 25,000 pg/mL,  respectively. This discrepancy is most probably related to the  methodology used to measure plasma tetracosactin. Indeed, the authors  have used a radioimmunoassay (distributed by CIS) designed to measure  ACTH 1-39. They specify that the antiserum used in the assay recognizes  the N-terminal sequence of ACTH. However, this does not necessarily  imply that it recognizes equally ACTH 1-24 and ACTH 1-39. Our findings  indicate that the antiserum used in this radioimmunoassay crossreacts  about 5 times more (on a mass basis) with ACTH 1-24 than with ACTH  1-39. In addition, standard curves obtained with ACTH 1-24 or ACTH 1-39  are not strictly parallel [this can be explained by the fact that the  antiserum may contain several species of anti-ACTH immunoglobulins  having different affinity for ACTH 1-24 or ACTH 1-39]. As a  consequence, plasma tetracosactin levels measured using the CIS  antiserum and plotted against a standard curve generated with ACTH 1-39  will be overestimated by at least 5 times (see Fig. 1). 
</TEXT>
</DOC>



<DOC>
<DOCNO>10084557_0.170</DOCNO>
<TEXT>
      Shortcomings in the Low-Dose (1 &#181;g) ACTH Test for the Diagnosis of ACTH Deficiency States          David H. P. Streeten  
</TEXT>
</DOC>


<DOC>
<DOCNO>10084557_173.100</DOCNO>
<TEXT>
    Professor Emeritus of Medicine  SUNY Health Science Center  Syracuse, New York 13210   
</TEXT>
</DOC>


<DOC>
<DOCNO>10084557_276.205</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: David H. P. Streeten, Dept. of Medicine, SUNY Health Science Center, 750 E. Adams St., Room CWB-322, Syracuse, New York 13210.
</TEXT>
</DOC>

<DOC>
<DOCNO>10199747_0.173</DOCNO>
<TEXT>
      Type 2 Diabetes Mellitus: Update on Diagnosis, Pathophysiology, and Treatment          Richard J. Mahler and   Michael L. Adler  
</TEXT>
</DOC>


<DOC>
<DOCNO>10199747_176.129</DOCNO>
<TEXT>
    Division of Diabetes, Endocrinology, and Metabolism, Cornell  University Medical College, New York, New York 10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>10199747_308.242</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Richard J. Mahler, Division of Diabetes, Endocrinology, and Metabolism, Cornell University Medical College, 220 East 69th Street, New York, New York 10021.
</TEXT>
</DOC>




<DOC>
<DOCNO>10199803_0.214</DOCNO>
<TEXT>
      Uneventful Pregnancy in an Acromegalic Patient Treated with Slow-Release Lanreotide: A Case Report          Ernesto de Menis,   Domenico Billeci and   Elisabetta Marton  
</TEXT>
</DOC>


<DOC>
<DOCNO>10199803_217.97</DOCNO>
<TEXT>
    Ospedale Regionale  Treviso 31100, Italy  Gualberto Gussoni  Milano, 20156, Italy   
</TEXT>
</DOC>


<DOC>
<DOCNO>10199803_317.637</DOCNO>
<TEXT>
          Until recently, pregnancy was considered an  unfrequent event in acromegalic females. With the advent of advanced  surgical and medical management more affected women will probably get  pregnant, as reviewed in the recent paper by Herman-Bonert et  al. (1). Now that somatostatin analogues are the drugs of choice  in acromegaly, the safety of their use in pregnancy is becoming of  concern. We report the first case of an acromegalic patient who became  pregnant while being treated with slow-release lanreotide. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10323368_0.186</DOCNO>
<TEXT>
      Neonatal Screening for 21-Hydroxylase Deficient Congenital Adrenal Hyperplasia&#151;The Role of CYP21 Analysis          Allen W. Root  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323368_189.115</DOCNO>
<TEXT>
    University of South Florida, Tampa and  All Children&#146;s Hospital  St. Petersburg, Florida 33701   
</TEXT>
</DOC>


<DOC>
<DOCNO>10323368_307.253</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to Allen W. Root, M.D., Division of Pediatric Endocrinology, Diabetes and Metabolism, All Children&#146;s Hospital, 801 6th Street South, Box 6900, St. Petersburg, Florida 33701.
</TEXT>
</DOC>

<DOC>
<DOCNO>10323370_0.307</DOCNO>
<TEXT>
      Administration of Metformin to a Diabetic Woman with Extreme Hyperandrogenemia of Nontumoral Origin: Management of Infertility and Prevention of Inadvertent Masculinization of a Female Fetus          Nicholas J. Sarlis,   Stacie J. Weil and   Lawrence M. Nelson  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323370_310.307</DOCNO>
<TEXT>
    Developmental Endocrinology Branch (S.J.W., L.M.N.), National  Institute of Child Health and Human Development; and Molecular and  Cellular Endocrinology Branch (N.J.S.), National Institute of Diabetes,  Digestive, and Kidney Diseases, National Institutes of Health,  Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323370_620.588</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Nicholas J. Sarlis, Molecular and Cellular Endocrinology Branch/National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Building 10, Room 8D12C, 10 Center Drive-MSC 1758, Bethesda, Maryland 20892-1758.  E-mail:  njsarlis{at}box-n.nih.govnjsarlis@box-n.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10323408_0.200</DOCNO>
<TEXT>
      Adrenocorticotropin (ACTH)- and Non-ACTH-Mediated Regulation of the Adrenal Cortex: Neural and Immune Inputs          S. R. Bornstein and   G. P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323408_203.166</DOCNO>
<TEXT>
    Developmental Endocrinology Branch, National Institute of Child  Health and Human Development, National Institutes of Health, Bethesda,  Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323408_372.267</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Stefan R. Bornstein, M.D., National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N242, 10 Center Drive, Bethesda, Maryland 20892.
</TEXT>
</DOC>

<DOC>
<DOCNO>10323413_0.247</DOCNO>
<TEXT>
      Treatment of Hemangiopericytoma-Induced Hypoglycemia with Growth Hormone and Corticosteroids          Damiano Gullo,   Laura Sciacca,   Giuseppina Parrinello,   Letizia Tomaselli and   Riccardo Vigneri  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323413_250.96</DOCNO>
<TEXT>
    Cattedra di Endocrinologia  Universit&agrave; di Catania  I-95123 Catania, Italy   
</TEXT>
</DOC>


<DOC>
<DOCNO>10323413_349.2689</DOCNO>
<TEXT>
          A 56-yr-old man was admitted to our department because of  recurrent and severe hypoglycemia. Ten years previously the patient had  undergone surgery for an intraabdominal hemangiopericytoma, a  mesenchymal tumor. An ileocolectomy with colostomy was performed about  twenty months later because of local recurrence of the tumor. He was  apparently well thereafter until 2 years before the admission to our  department, when he was treated with chemotherapy and radiotherapy  because of a small mass in the pelvis evidenced at a computed  tomography scan. Two months before admission to our department, he was  brought to the emergency room in a state of unconsciousness and with a  plasma glucose level of 20 mg/dL (1.1 mM). He was given  20% dextrose iv, and he promptly recovered. The hypoglycemic episodes  recurred and became more frequent. Upon admission to our department the  patient was first treated with 50% dextrose infusion through a  subclavian vein. Nevertheless episodes of hypoglycemia persisted,  especially at night, when fasting was longer than 4&#150;5 hr. Increased  meal frequency with complex carbohydrates administration plus  continuous dextrose infusion were no longer able to control  hypoglycemia. The patient had normal-to-low plasma insulin levels and  very high levels of insulin-like growth factor (IGF)-II, especially in  the isoform 10&#150;17 kDa, around 80% of total measured IGF-II (Fig. 1and Table 1  ). The diagnosis of nonislet cell tumor hypoglycemia (NICTH) was  proposed. Evaluation of liver showed metastatic lesions, but because of  the size, a palliative surgical attempt was not advised. Therapy with  both prednisone (15 mg/day per os) and, after informed consent,  biosynthetic GH (2 U/day sc) at bedtime was soon started. Dextrose  infusion was gradually reduced and eventually suspended 4 days after  beginning continued hormone treatment. No further episode of  hypoglycemia occurred in the following 3 days, and he was discharged  from the hospital in apparent good condition with instructions for  blood glucose self monitoring and glucagon use in the case of severe  hypoglycemia. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10323415_0.207</DOCNO>
<TEXT>
      Comment on Association between Insulin-Like Growth Factor-I (IGF-I) and Bone Mineral Density: Further Evidence Linking IGF-I to Breast Cancer Risk          He Yu  
</TEXT>
</DOC>


<DOC>
<DOCNO>10323415_210.120</DOCNO>
<TEXT>
    Feist-Weiller Cancer Center  Louisiana State University Medical Center  Shreveport, Louisiana 71130-3932   
</TEXT>
</DOC>


<DOC>
<DOCNO>10323415_333.878</DOCNO>
<TEXT>
          The study by Langlois et al. (1) demonstrated an intriguing  association between insulin-like growth factor I (IGF-I) and bone  mineral density (BMD) in older women. Serum IGF-I levels were  positively associated with BMD in all five bone sites, and the  association remained statistically significant after potentially  confounding factors were adjusted in the analysis, including age, body  mass index (BMI), mobility limitation, smoking, and estrogen use. This  finding not only suggests the impact of IGF-I on the balance between  bone resorption and formation, but also provides evidence to the  involvement of IGF-I in breast cancer risk. Both BMD and IGF-I are  found to be associated with the risk of the disease. 
</TEXT>
</DOC>



<DOC>
<DOCNO>10372662_0.101</DOCNO>
<TEXT>
      Stress and the Reproductive Cycle          Michel Ferin  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372662_104.179</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology and the Center for  Reproductive Sciences, Columbia University College of Physicians and  Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372662_286.264</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Michel Ferin, Department of Obstetrics and Gynecology and the Center for Reproductive Sciences, Columbia University College of Physicians and Surgeons, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372663_0.176</DOCNO>
<TEXT>
      Amenorrheic Bone Loss1          Karen K. Miller and   Anne Klibanski  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372663_179.174</DOCNO>
<TEXT>
    Neuroendocrine Unit, Department of Medicine, Clinical Research  Center, Massachusetts General Hospital and Harvard Medical School,  Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372663_356.218</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Anne Klibanski, M.D., Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457B, Boston, Massachusetts 02114.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372664_0.271</DOCNO>
<TEXT>
      Role of Gonadal Steroids in the Sexual Dimorphisms in Body Composition and Circulating Concentrations of Leptin1          Michael Rosenbaum and   Rudolph L. Leibel  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372664_274.130</DOCNO>
<TEXT>
    Department of Pediatrics, Division of Molecular Genetics, New York  Presbyterian Hospital, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372664_407.450</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael Rosenbaum, M.D., Russ Berrie Research Building, 1150 St. Nicholas Avenue, 6th Floor, New York, New York 10032.  E-mail:  mr475{at}columbia.edumr475@columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10372665_0.161</DOCNO>
<TEXT>
      The Molecular and Neuroanatomical Basis for Estrogen Effects in the Central Nervous System          Bruce S. McEwen  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372665_164.134</DOCNO>
<TEXT>
    Harold and Margaret Milliken Hatch Laboratory of  Neuroendocrinology, Rockefeller University, New York, New York  10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372665_301.502</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Bruce S. McEwen, Laboratory of Neuroendocrinology, Rockefeller University, 1230 York Avenue, New York, New York 10021.  E-mail:mcewen{at}rockvax.rockefeller.eduE-mail:mcewen@rockvax.rockefeller.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10372666_0.93</DOCNO>
<TEXT>
      Where Are We Going?          Nanette F. Santoro  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372666_96.134</DOCNO>
<TEXT>
    Department of Obstetrics, Gynecology and Women's Health, Albert  Einstein College of Medicine, New York, New York 10461  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372666_233.1222</DOCNO>
<TEXT>
                  &nbsp;&nbsp;  Introduction      Top  Introduction  References    &nbsp;    THIS issue of JCEM again addresses the topic of hormone  replacement therapy (HRT) for postmenopausal women. Much has happened  since this item was last brought up in 1996, and much remains to be  known. Despite our lack of definitive data in key areas, patients  continue to require care, and we must help them to make informed  choices. 
</TEXT>
</DOC>



<DOC>
<DOCNO>10372671_0.188</DOCNO>
<TEXT>
      Adolescent Nutrition in the Prevention of Postmenopausal Osteoporosis          Connie M. Weaver,   Munro Peacock and   C. Conrad Johnston, Jr.  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372671_191.172</DOCNO>
<TEXT>
    Department of Foods and Nutrition, Purdue University, West  Lafayette, Indiana 47907; and Indiana University School of Medicine,  Indianapolis, Indiana 46223  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372671_366.478</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Connie M. Weaver, Ph.D., Department of Foods and Nutrition, Purdue University, 1264 Stone Hall, West Lafayette, Indiana 47907-1264.  E-mail:  weavercm{at}cfs.purdue.eduweavercm@cfs.purdue.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10372672_0.152</DOCNO>
<TEXT>
      What Causes Low Rates of Child-Bearing in Congenital Adrenal Hyperplasia?          H. F. L. Meyer-Bahlburg  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372672_155.143</DOCNO>
<TEXT>
    New York State Psychiatric Institute, Unit 15, and Department of  Psychiatry, Columbia University, New York, New York 10032-2695  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372672_301.189</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. H. F. L. Meyer-Bahlburg, New York State Psychiatric Institute, Unit 15, New York, New York 10032-2695.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372673_0.201</DOCNO>
<TEXT>
      Hormones and Heart Disease in Women: Heart and Estrogen/Progestin Replacement Study in Perspective          Elizabeth Barrett-Connor and   Cynthia Stuenkel  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372673_204.130</DOCNO>
<TEXT>
    Department of Family and Preventive Medicine, University of  California, San Diego, La Jolla, California 92093-0607  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372673_337.497</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Elizabeth Barrett-Connor, M.D., Division of Epidemiology 0607, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0607.  E-mail: ebarrettconnor{at}ucsd.eduebarrettconnor@ucsd.edu.'//-->
</TEXT>
</DOC>



<DOC>
<DOCNO>10372675_0.222</DOCNO>
<TEXT>
      Hypertension in Pregnancy: A Potential Window into Long-Term Cardiovascular Risk in Women          Ellen W. Seely1  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372675_225.163</DOCNO>
<TEXT>
    Endocrine-Hypertension Division, Department of Medicine, Brigham  and Women&#146;s Hospital and Harvard Medical School, Boston, Massachusetts  02115  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372675_391.516</DOCNO>
<TEXT>
     Address correspondence and reprint requests to: Ellen W. Seely, M.D., Endocrine-Hypertension Division, Brigham and Women&#146;s Hospital, 221 Longwood Avenue, Boston, Massachusetts 02115.  E-mail:  EWSEELY{at}BICS.BWH.HARVARD.EDUEWSEELY", d = "BICS.BWH.HARVARD.EDU"; document.getElementById("em0").innerHTML = 'EWSEELY@BICS.BWH.HARVARD.EDU'//-->
</TEXT>
</DOC>



<DOC>
<DOCNO>10372677_0.216</DOCNO>
<TEXT>
      Bone Densitometry: The Best Way to Detect Osteoporosis and to Monitor Therapy          Paul D. Miller,   Carol Zapalowski,   Carolina A. M. Kulak and   John P. Bilezikian  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372677_219.368</DOCNO>
<TEXT>
    Colorado Center for Bone Research (P.D.M., C.Z.), Lakewood,  Colorado 80227; the Departments of Medicine (C.A.M.K., J.P.B.)  and Pharmacology (J.P.B.), Columbia University College of Physicians  and Surgeons, New York, New York 10032; and the Department of  Endocrinology, Federal University of Parana, Hospital de Clinicas  (C.A.M.K.), Curitiba, Brazil  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372677_590.237</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John P. Bilezikian, M.D., Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372678_0.195</DOCNO>
<TEXT>
      Does Estrogen Adequately Protect Postmenopausal Women Against Osteoporosis: An Iconoclastic Perspective          Eric S. Orwoll and   Heidi D. Nelson  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372678_198.95</DOCNO>
<TEXT>
    Oregon Health Sciences University, Portland VA Medical Center,  Portland, Oregon  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372678_296.208</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Eric S. Orwoll, Bone and Mineral Unit, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park, Portland, Oregon 97201.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372679_0.186</DOCNO>
<TEXT>
      Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy          Richard J. Santen and   Gina R. Petroni  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372679_189.151</DOCNO>
<TEXT>
    Departments of Medicine and Health Evaluation Sciences, University  of Virginia Health Sciences Center, Charlottesville, Virginia  22908  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372679_343.1361</DOCNO>
<TEXT>
          Estrogen deficiency causes vasomotor instability  and urogenital atrophy in a large fraction of menopausal women. Short  term use of estrogen replacement therapy (ERT) can effectively relieve  symptoms related to these conditions (1, 2). ERT may also relieve  neurocognitive symptoms of mood changes, irritability, and depression  resulting from acute estrogen deprivation (3). When given long term,  estrogens prevent the development of osteopenia, osteoporosis, and bony  fractures (4, 5) and may be effective for primary prevention and  reduction of mortality from cardiovascular disease (6, 7).  Observational studies suggest that the incidence of colon cancer and  Alzheimer&#146;s disease may be reduced by hormone replacement therapy  (8, 9, 10, 11, 12). The Nurses Health Study, a large prospective cohort study,  reported that all causes of mortality among nurses who use  postmenopausal hormones are lower than those among nonusers (13). 
</TEXT>
</DOC>

<DOC>
<DOCNO>10372680_0.152</DOCNO>
<TEXT>
      Testing for Hereditary Cancer Risk: Pandora or Prometheus?          Thomas S. Frank and   Mark H. Skolnick  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372680_155.70</DOCNO>
<TEXT>
    Myriad Genetic Laboratories, Salt Lake City, Utah 84108  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372680_228.183</DOCNO>
<TEXT>
     Address correspondence and reprint requests to: Dr. Thomas S. Frank, Medical Director, Myriad Genetic Laboratories, 320 Wakara Way, Salt Lake City, UT 84108.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372682_0.199</DOCNO>
<TEXT>
      Health Issues for Women Athletes: Exercise- Induced Amenorrhea1          Michelle P. Warren  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372682_202.151</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology and Medicine, Columbia  University College of Physicians and Surgeons, New York, New York  10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372682_356.497</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Michelle P. Warren, M.D., Columbia University, Department of Obstetrics/Gynecology, 622 West 168th Street, PH 16&#150;20, New York, New York 10032.  E-mail:  mpw1{at}columbia.edumpw1", d = "columbia.edu"; document.getElementById("em0").innerHTML = 'mpw1@columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10372683_0.215</DOCNO>
<TEXT>
      Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women          Enrico Carmina and   Rogerio A. Lobo  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372683_218.142</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology, Columbia University  College of Physicians and Surgeons, New York, New York 10032-3784  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372683_363.255</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Rogerio A. Lobo, M.D., Department of Obstetrics &amp; Gynecology, Columbia University College of Physicians &amp; Surgeons, 630 West 168th Street, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372684_0.121</DOCNO>
<TEXT>
      The Individualized Approach to Menopause Management          Brian W. Walsh  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372684_124.119</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology, Brigham and Women&#146;s  Hospital, Boston, Massachusetts 02115  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372684_246.487</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Brian W. Walsh, Department of Obstetrics and Gynecology, Brigham and Women&#146;s Hospital, 75 Francis Street, Boston, Massachusetts 02115.  E-mail:  bwwalsh{at}bics.bwh.harvard.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10372686_0.302</DOCNO>
<TEXT>
      The Reproductive Endocrine Associates of the Massachusetts General Hospital: Fifteen Years of Integrated Clinical Practice and Investigation          Stephanie B. Seminara,   Janet E. Hall,   Ann E. Taylor,   William F. Crowley, Jr. and   Kathryn A. Martin  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372686_305.128</DOCNO>
<TEXT>
    Reproductive Endocrine Unit, Department of Medicine, Massachusetts  General Hospital, Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372686_436.225</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Stephanie B. Seminara, Reproductive Endocrine Unit, BHX 505, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114.
</TEXT>
</DOC>

<DOC>
<DOCNO>10372743_0.258</DOCNO>
<TEXT>
      Changes in Plasma Concentrations of Leptin and Body Fat Composition during Weight Restoration in Anorexia Nervosa          John F. Morgan,   Jim Bolton,   Philip M. Sedgwick,   Sanjeev Patel and   J. Hubert Lacey  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372743_261.184</DOCNO>
<TEXT>
    St. George&#146;s Hospital Medical School  London SW17 0RE, United Kingdom  Gerard S. Conway  Department of Medicine, University College  London SW1 8AA, United Kingdom   
</TEXT>
</DOC>


<DOC>
<DOCNO>10372743_448.1224</DOCNO>
<TEXT>
          Recently, Eckert et al. (1) presented longitudinal data  confirming previous cross-sectional reports (2, 3) that leptin  concentrations in female anorectics were significantly lower than  normal weight controls, increased significantly on refeeding, and  correlated linearly with body mass index. They also suggested an  uncoupling of leptin and adiposity at lowest body weights. However,  they acknowledged that "a major limitation of this study is the lack  of data on percent body fat," as body mass index does not necessarily  correlate with percent body fat. Similarly the cross-sectional reports  (2, 3) estimated percent body fat using bioimpedance. The latter  assumes uniform hydration, which may not be true in refeeding  anorectics (4). To our knowledge, no previous study has longitudinally  correlated leptin against total body fat during weight restoration in  anorexia nervosa, except by such crude means of body fat  estimation. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10372746_0.190</DOCNO>
<TEXT>
      Comment&#151;Do Glucocorticoids Mediate the Hypoglycemia-Induced Rise in Insulin-Like Growth Factor Binding Protein-1?          Robert C. Baxter  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372746_193.114</DOCNO>
<TEXT>
    Kolling Institute of Medical Research  Royal North Shore Hospital  St Leonards, NSW 2065, Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372746_310.695</DOCNO>
<TEXT>
          Insulin-like growth factor binding protein-1 (IGFBP-1) is distinct among  the members of the IGFBP family in being acutely regulated by metabolic  stimuli (1). Studies with cultured human liver explants suggest that  the major regulatory influences on IGFBP-1 production are insulin,  which is inhibitory, and hepatic substrate deprivation, which is  stimulatory, acting through a cyclic AMP-dependent mechanism (2, 3).  Dexamethasone is also markedly inhibitory to IGFBP-1 production by  human liver in explant culture (2). 
</TEXT>
</DOC>

<DOC>
<DOCNO>10372749_0.171</DOCNO>
<TEXT>
      TSH Receptor Mutation Database          Istvan T. Nebel, Dipl.-Inf.,,   Barbara Tr&uuml;ltsch, M.D., and   Ralf Paschke, M.D.  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372749_174.63</DOCNO>
<TEXT>
    University of Leipzig  %D-04103 Leipzig, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>10372749_240.407</DOCNO>
<TEXT>
          The increasing number of TSH receptor mutations has stimulated us to  establish a TSH receptor mutation database that is accessible via the  internet (http://www.uni-leipzig.de/innere/TSH). This  database describes all published activating and inactivating TSH  receptor germline mutations. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10404788_0.107</DOCNO>
<TEXT>
      Is Leptin a Secretion of the Brain?          Seymour Reichlin  
</TEXT>
</DOC>


<DOC>
<DOCNO>10404788_110.87</DOCNO>
<TEXT>
    The University of Arizona Health Sciences Center  Tucson, Arizona 85724   
</TEXT>
</DOC>


<DOC>
<DOCNO>10404788_200.255</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Seymour Reichlin, Department of Medicine, The University of Arizona Health Sciences Center, 1501 N. Campbell Avenue, P.O. Box 25099, AHSC Room 7338, Tucson, Arizona 85724-5099.
</TEXT>
</DOC>



<DOC>
<DOCNO>10443644_0.150</DOCNO>
<TEXT>
      Dying (Apoptosing?) for a Consensus on the Fas Death Pathway in the Thyroid          James R. Baker, Jr.  
</TEXT>
</DOC>


<DOC>
<DOCNO>10443644_153.126</DOCNO>
<TEXT>
    Director, Center for Biologic Nanotechnology  University of Michigan Medical School  Ann Arbor, Michigan 48109   
</TEXT>
</DOC>


<DOC>
<DOCNO>10443644_282.409</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: James R. Baker, Jr, M.D., 9220 MSRBIII; Ann Arbor, Michigan 48109-0648.  E-mail:  jbakerjr{at}umich.edujbakerjr@umich.edu;'//--> Internet:
</TEXT>
</DOC>




<DOC>
<DOCNO>10487655_0.161</DOCNO>
<TEXT>
      CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells          Stephen J. Marx  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487655_164.142</DOCNO>
<TEXT>
    Genetics and Endocrinology Section, National Institute of Diabetes  and Digestive and Kidney Diseases, Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487655_309.462</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Stephen J. Marx, M.D., Bld 10, Room 9C-101, National Institutes of Health, Bethesda, Maryland 20892-1802;  E-mail: StephenM{at}INTRA.NIDDK.NIH.GOVStephenM@INTRA.NIDDK.NIH.GOV.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10487681_0.238</DOCNO>
<TEXT>
      Hormonal and Volumetric Long Term Control of a Growth Hormone-Releasing Hormone-Producing Carcinoid Tumor          A. Van den Bruel,   J. Fevery,   J. Van Dorpe,   L. Hofland and   R. Bouillon  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487681_241.365</DOCNO>
<TEXT>
    Laboratory and Clinic of Experimental Medicine and Endocrinology  (A.V.d.B., R.B.), the Department of Internal Medicine, Hepatology  (J.F.), and the Department of Pathology (J.V.D.), Universitaire  Ziekenhuizen, Gasthuisberg, B-3000 Leuven, Belgium; and the Department  of Internal Medicine III, Erasmus University (L.H.), Rotterdam, The  Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487681_609.521</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. R. Bouillon, Laboratory for Experimental Medicine and Endocrinology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.  E-mail: roger.bouillon{at}med.kuleuven.ac.beroger.bouillon@med.kuleuven.ac.be.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10487718_0.207</DOCNO>
<TEXT>
      Comment on Primary Localization of an Ectopic ACTH-Producing Bronchial Carcinoid Tumor by Indium111 Pentetreotide Scintigraphy          Martin Reincke  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487718_210.65</DOCNO>
<TEXT>
    University Hospital of Freiburg  Freiburg, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487718_278.77</DOCNO>
<TEXT>
    Bruno Allolio,   Wiebke Arlt and   Carsten K&ouml;rber  
</TEXT>
</DOC>

<DOC>
<DOCNO>10487719_0.222</DOCNO>
<TEXT>
      Relative Eosinophilia (Thorn Test) as a Bioassay to Judge the Clinical Relevance of Cortisol Values during Severe Stress          Albertus Beishuizen and   Istv&aacute;n Vermes  
</TEXT>
</DOC>


<DOC>
<DOCNO>10487719_225.147</DOCNO>
<TEXT>
    Departments of Internal Medicine and Clinical Chemistry  Medical Spectrum Twente, Hospital Group  Enschede, the Netherlands 7500 KA   
</TEXT>
</DOC>


<DOC>
<DOCNO>10487719_375.1107</DOCNO>
<TEXT>
          We read with interest the recent editorial by  D. H. P. Streeten (1) in JCEM. In his discussion of the  paper by Abdu et al. (2), Streeten indicated that the low  dose ACTH test cannot conclusively exclude the presence of mild or  incomplete deficiencies in the functional capacity of the  hypothalamic-pituitary-adrenal (HPA) system. He addressed the  impairment of ACTH response to severe stress (3) and the lack of  reliable testing of the HPA axis during prolonged stress conditions. In  contrast to the mostly increased cortisol levels during severe stress  (4), we reported discrepant low ACTH levels in severely ill trauma and  septic patients (5). Streeten states that we still have to rely on  clinical judgement to determine the adequacy of the measured cortisol  levels in patients under stressful conditions, as in intensive care  units. 
</TEXT>
</DOC>



<DOC>
<DOCNO>10522972_0.269</DOCNO>
<TEXT>
      Cardiovascular Actions of Estrogens in Men          Krishnankutty Sudhir1 and   Paul A. Komesaroff2  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522972_272.149</DOCNO>
<TEXT>
    Hormones and Vasculature Laboratory, Baker Medical Research  Institute, Commercial Road, Prahran, Melbourne, Victoria 3181,  Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522972_424.485</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. K. Sudhir, Alfred Heart Centre, 3rd Floor, Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria 3181, Australia;  E-mail:  Krishna.sudhir{at}baker,edu.auKrishna.sudhir@baker,edu.au.'//-->
</TEXT>
</DOC>



<DOC>
<DOCNO>10522974_0.168</DOCNO>
<TEXT>
      Anabolic Interventions for Aging-Associated Sarcopenia          Rachelle Bross,   Marjan Javanbakht and   Shalender Bhasin  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522974_171.161</DOCNO>
<TEXT>
    Division of Endocrinology, Metabolism, and Molecular Medicine,  Charles R. Drew University of Medicine and Science, Los Angeles,  California 90049  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522974_335.578</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Shalender Bhasin, M.D., Division of Endocrinology, Metabolism and Molecular Medicine, Charles R. Drew University of Medicine and Science, University of California at Los Angeles School of Medicine, 1621 East 120th Street, Los Angeles, California 90059.  E-mail:  sbhasin{at}ucla.edusbhasin@ucla.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10522975_0.156</DOCNO>
<TEXT>
      Osteoporosis in Men1          John P. Bilezikian  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522975_159.138</DOCNO>
<TEXT>
    Departments of Medicine and Pharmacology, Columbia University  College of Physicians and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522975_300.536</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John P. Bilezikian, M.D., Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.  E-mail: bilezik{at}medicine1.cpmc.columbia.edubilezik@medicine1.cpmc.columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10522976_0.237</DOCNO>
<TEXT>
      Male Pseudohermaphroditism Caused by Mutations of the Human Androgen Receptor1          Michael J. McPhaul and   James E. Griffin  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522976_240.121</DOCNO>
<TEXT>
    Department of Internal Medicine University of Texas Southwestern  Medical Center, Dallas, Texas 75235-8857  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522976_364.234</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: M.J. McPhaul, M.D., Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235-8857.
</TEXT>
</DOC>

<DOC>
<DOCNO>10522977_0.220</DOCNO>
<TEXT>
      Infertility in Men: Recent Advances and Continuing Controversies1          D. M. de Kretser and   H. W. G. Baker  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522977_223.206</DOCNO>
<TEXT>
    Institute of Reproduction and Development (D.M.K.), Monash  University, Clayton; Department of Obstetrics and Gynaecology  (H.W.G.B.), University of Melbourne, Parkville, Victoria,  Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522977_432.521</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Professor D.M. de Kretser, Institute of Reproduction and Development, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia;  E-mail:  David.de.Kretser{at}med.monash.edu.auDavid.de.Kretser@med.monash.edu.au.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10522978_0.89</DOCNO>
<TEXT>
      Hypertension in Men          Phyllis August  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522978_92.102</DOCNO>
<TEXT>
    Joan and Sanford Weill Medical College of Cornell University, New  York, New York 10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522978_197.258</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Phyllis August, M.D., Division of Hypertension, New York Presbyterian Hospital, Weill Medical College of Cornell University, 520 East 70th Street, Room ST-420, New York, New York.
</TEXT>
</DOC>

<DOC>
<DOCNO>10522979_0.170</DOCNO>
<TEXT>
      Gender Assignment and Reassignment in 46,XY Pseudohermaphroditism and Related Conditions          Heino F. L. Meyer-Bahlburg  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522979_173.135</DOCNO>
<TEXT>
    New York State Psychiatric Institute, Unit 15, and Dept.  Psychiatry, Columbia University, New York, New York 10032-2695  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522979_311.283</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Heino F. L. Meyer-Bahlburg, Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, Unit 15, 1051 Riverside Drive, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>10522980_0.188</DOCNO>
<TEXT>
      Selective Androgen Receptor Modulators (SARMs): A Novel Approach to Androgen Therapy for the New Millennium          Andr&eacute;s Negro-Vilar  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522980_191.74</DOCNO>
<TEXT>
    Ligand Pharmaceuticals, Inc., San Diego,  California  92121  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522980_268.446</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Andr&eacute;s Negro-Vilar, Ligand Pharmaceuticals, 10275 Science Center Drive, San Diego, California 92121.  E-mail: anegrovilar{at}ligand.comanegrovilar@ligand.com.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10522981_0.216</DOCNO>
<TEXT>
      Hormonal Signaling in Prostatic Hyperplasia and Neoplasia1          Marco Marcelli and   Glenn R. Cunningham  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522981_219.152</DOCNO>
<TEXT>
    Department of Medicine, Division of Endocrinology, Veterans Affairs  Medical Center and Baylor College of Medicine, Houston, Texas  77030  
</TEXT>
</DOC>


<DOC>
<DOCNO>10522981_374.230</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Glenn R. Cunningham, Department of Medicine, Division of Endocrinology, Veterans Affairs Medical Center, 2002 Holcombe Boulevard, Houston, Texas 77030.
</TEXT>
</DOC>

<DOC>
<DOCNO>10523002_0.405</DOCNO>
<TEXT>
      A Possible Role of Immunoglobulin E in Patients with Hyperthyroid Graves&#146; Disease          Akira Sato,   Yoshihiro Takemura,   Takashi Yamada,   Hiromi Ohtsuka,   Hideki Sakai,   Yasuhiro Miyahara,   Toru Aizawa,   Akira Terao,   Soshin Onuma,   Kazuhiro Junen,   Akira Kanamori,   Yutaka Nakamura,   Eizaburo Tejima,   Yoshiharu Ito and   Keiichi Kamijo  
</TEXT>
</DOC>


<DOC>
<DOCNO>10523002_408.437</DOCNO>
<TEXT>
    Department of Medicine (A.S., Y.T.), Dokkyo Koshigaya Hospital,  Dokkyo University School of Medicine, Koshigaya, Saitama 343-8555,  Japan; Department of Medicine (T.Y., H.O., H.S., Y.M., A.T., S.O.,  K.J., A.K., Y.N., E.T., Y.I., K.K.), Kashiwa City Hospital, Kashiwa,  Chiba 277, Japan; Department of Gerontology (T.A.), Endocrinology and  Metabolism, Shinshu University School of Medicine, Matsumoto, Nagano  390, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>10523002_848.221</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Akira Sato, M.D., Department of Medicine, Dokkyo Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya, Saitama 343-8555, Japan.
</TEXT>
</DOC>

<DOC>
<DOCNO>10523005_0.460</DOCNO>
<TEXT>
      A Soluble PC-1 Circulates in Human Plasma: Relationship with Insulin Resistance and Associated Abnormalities1          Lucia Frittitta,   Stefania Camastra,   Roberto Baratta,   Benedetta V. Costanzo,   Monica D&#146;Adamo,   Salvatore Graci,   Daniela Spampinato,   Betty A. Maddux,   Riccardo Vigneri,   Eleuterio Ferrannini and   Vincenzo Trischitta  
</TEXT>
</DOC>


<DOC>
<DOCNO>10523005_463.748</DOCNO>
<TEXT>
    Istituto di Medicina Interna, Malattie Endocrine e Metaboliche,  Universit&agrave; di Catania, Ospedale Garibaldi (L.F., R.B., B.C.,  S.G., D.S., R.V., V.T.), 95123 Catania; Consiglionazionale della  Ricerca, Institute of Clinical Physiology and Department of  Internal Medicine, University of Pisa (S.C., E.F.), 56100 Pisa;  Divisione ed Unita di Ricerca di Endocrinologia, Istituto Scientifico  Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo (V.T.),  71013 Foggia; and Divisione di Endocrinologia 1,  Universit&agrave; La Sapienza (M.D.), 00100 Rome, Italy; and the  Diabetes Research Laboratory, Mount Zion Hospital, University of  California&#150;San Francisco (M.D., B.A.M.), San Francisco,  California 94143-1616  
</TEXT>
</DOC>


<DOC>
<DOCNO>10523005_1214.452</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Lucia Frittitta, M.D., Endocrinologia, Ospedale Garibaldi, P.zza S. M. di Ges&ugrave;, 95123 Catania, Italy.  E-mail:  segmeint{at}mbox.unict.itsegmeint@mbox.unict.it.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10523041_0.223</DOCNO>
<TEXT>
      Comment on Analysis of Mutations in Genes of the Follicle-Stimulating Hormone Receptor in Ovarian Granulosa Cell Tumors          Sonay Hussein,   Simon Chu and   Peter J. Fuller  
</TEXT>
</DOC>


<DOC>
<DOCNO>10523041_226.90</DOCNO>
<TEXT>
    Prince Henry&#146;s Institute of Medical Research  Clayton 3168, Australia   
</TEXT>
</DOC>


<DOC>
<DOCNO>10523041_319.2655</DOCNO>
<TEXT>
          We read with interest the paper by  Ligtenberg et al. (1) in which they screened unsuccessfully  for mutations in the FSH-receptor gene in ovarian granulosa cell  tumors. Several authors have argued that activating mutations of the  FSH-receptor might have a role in the pathogenesis of granulosa cell  tumors (1, 2, 3). The hypothesis is based in part on the reports of an  activating mutation of the LH and TSH receptors in Leydig cell adenomas  and thyroid tumors, respectively (1, 2, 3). In our original analysis of  the FSH receptor in granulosa cell tumors (2), we had restricted our  screen to exon 10, which encodes the transmembrane domains and the  intracellular domain. At the time that we conducted the study,  activating mutations of G protein-coupled receptors had been reported  only in exon 10, predominantly in the 3rd intracellular loop and the  4th transmembrane domain. Kotlar et al. (3) had restricted  their search for FSH receptor mutations to this subregion of exon 10.  Several recent studies of activating mutations in G protein-coupled  receptors have identified activating mutations occurring in the  extracellular domain, including mutations of the TSH receptor (4, 5)  and the calcium receptor (6). In view of these reports we elected to  re-examine the status of the FSH receptor in our panel of granulosa  cell tumors. The extracellular domain of the receptor is encoded by  nine exons (1). To circumvent the need for nine separate PCR reactions  for each tumor (1), we used a coupled reverse transcriptase-polymerase  chain reaction (RT-PCR) approach. This has the advantage that only  expressed receptor alleles are examined and thus any stromal tissue  will not obscure tumor-associated mutations; clearly, for an activating  mutation to be relevant it must be expressed. The disadvantage is that  archival material cannot be used, and thus the number of tumors  available is limited. We examined RNA from six granulosa cell tumors  using three overlapping amplicons spanning the extracellular  domain. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10566620_0.138</DOCNO>
<TEXT>
      Diagnosis and Treatment of Pituitary Tumors          Pamela U. Freda and   Sharon L. Wardlaw  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566620_141.120</DOCNO>
<TEXT>
    Department of Medicine, Columbia University College of Physicians  and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566620_264.477</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Sharon L. Wardlaw, M.D., Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.  E-mail: sw22{at}columbia.edusw22@columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10566621_0.245</DOCNO>
<TEXT>
      Hemiplegia after Thyrotropin Alfa in a Hypothyroid Patient with Thyroid Carcinoma Metastatic to the Brain          George E. Vargas,   Harry Uy,   Carlos Bazan,   Theresa A. Guise and   Jan M. Bruder  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566621_248.222</DOCNO>
<TEXT>
    Department of Medicine, Division of Endocrinology (G.E.V., H.U.,  T.A.G., J.M.B.) and Department of Radiology (C.B.), University of Texas  Health Science Center at San Antonio, San Antonio, Texas  78284-7877  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566621_473.235</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Jan Bruder, M.D., University of Texas Health Science Center at San Antonio, Division of Endocrinology, 7703 Floyd Curl Drive, San Antonio, Texas 78284-7877.
</TEXT>
</DOC>

<DOC>
<DOCNO>10566688_0.164</DOCNO>
<TEXT>
      Growth Hormone Replacement Therapy Is Not Associated with Any Increase in Mortality          Bengt-&Aring;ke Bengtsson  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566688_167.124</DOCNO>
<TEXT>
    Research Centre for Endocrinology and Metabolism  Sahlgrenska University Hospital  Goteborg S-413 25, Sweden.  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566688_294.43</DOCNO>
<TEXT>
    H. P. F. Koppeschaar  
</TEXT>
</DOC>

<DOC>
<DOCNO>10566689_0.108</DOCNO>
<TEXT>
      Mental Stress Follows Mental Rules          Clemens Kirschbaum  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566689_111.115</DOCNO>
<TEXT>
    Center for Psychobiological and Psychosomatic Research  University of Trier  Trier D-54286, Germany   
</TEXT>
</DOC>


<DOC>
<DOCNO>10566689_229.610</DOCNO>
<TEXT>
          In a recent study, Komesaroff et al.  (1) reported the effects of an 8-week estrogen treatment on endocrine  responses to mental stress in perimenopausal women. Among other  effects, they reported reduced ACTH and cortisol responses after  estrogen treatment. Although the data seem to support findings of  reduced hypothalamus-pituitary-adrenal (HPA) stress responses to  mental stress in premenopausal women compared to men (2), the present  results are difficult to interpret. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10566693_0.125</DOCNO>
<TEXT>
      Importance of Technique for Determination of Phenotype          Vicente Gilsanz  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566693_128.105</DOCNO>
<TEXT>
    Radiology Department  Children&#146;s Hospital Los Angeles  Los Angeles, California 90027   
</TEXT>
</DOC>


<DOC>
<DOCNO>10566693_236.813</DOCNO>
<TEXT>
          As C. Tao et al. acknowledge, the  discrepancy in results between their and our studies could be due to  the different techniques used to assess "bone density." Whereas CT  values reflect the volumetric density of cancellous bone in the  vertebral bodies, dual energy x-ray absorptiometry (DXA) measurements  are influenced not only by the density of the bone, but also by a large  number of biological parameters (1). The title of the study by Tao  et al. would be more correctly stated as "No association  was found between collagen I type 1 gene and DXA bone measurements  obtained in prepubertal children." 
</TEXT>
</DOC>

<DOC>
<DOCNO>10566694_0.166</DOCNO>
<TEXT>
      Comment on Is the Incidence of Addison&#146;s Disease Underestimated?          Marie-France Kong and   William Jeffcoate  
</TEXT>
</DOC>


<DOC>
<DOCNO>10566694_169.53</DOCNO>
<TEXT>
    City Hospital  Nottingham NG5 1PB, UK   
</TEXT>
</DOC>


<DOC>
<DOCNO>10566694_225.614</DOCNO>
<TEXT>
          Laureti et al. (1) have calculated  the prevalence of Addison&#146;s disease to be of the order of 117 per  million in Umbria and comment that this estimate is 2- to 3-fold higher  than those previously reported. They could not have been aware of our  own study of the condition in Nottingham, UK (2). In a detailed review  of all known cases, we concluded that the prevalence in the UK was of  the order of 110 per million, with an apparent incidence of 5.6 per  million. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10599679_0.194</DOCNO>
<TEXT>
      Opportunities and Challenges in Pediatric Clinical Research1          Inese Z. Beitins  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599679_197.111</DOCNO>
<TEXT>
    National Center for Research Resources, National Institutes of  Health, Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599679_311.319</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Inese Z. Beitins, M.D., FRCP(C), National Center for Research Resources, General Clinical Research Center Program/National Institutes of Health, One Rockledge Center, Room 6030, 6705 Rockledge Drive, MSC 7965, Bethesda, Maryland 20892-7965.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599680_0.152</DOCNO>
<TEXT>
      Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved?          Harvey J. Guyda  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599680_155.175</DOCNO>
<TEXT>
    Department of Pediatrics, McGill University, Montreal Children&#146;s  Hospital-McGill University Health Center, Montr&eacute;al,  Qu&eacute;bec, Canada H3H 1P3  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599680_333.564</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Harvey J. Guyda, Department of Pediatrics, McGill University, Montreal Children&#146;s Hospital-McGill University Health Center, 2300 Tupper, Suite C-414, Montr&eacute;al, Qu&eacute;bec, Canada H3H 1P3.  E-mail: harvey.guyda{at}muhc.mcgill.caharvey.guyda@muhc.mcgill.ca.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599681_0.143</DOCNO>
<TEXT>
      Pituitary Tumors in Children and Adolescents          Antony R. Lafferty and   George P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599681_146.202</DOCNO>
<TEXT>
    Section of Pediatric Endocrinology, Developmental Endocrinology  Branch, National Institute of Child Health and Human Development,  National Institutes of Health, Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599681_351.340</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Antony R. Lafferty MB ChB, Clinical Associate, Pediatric Endocrinology Section, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, MSC 1862, Bethesda, Maryland 20892-1862
</TEXT>
</DOC>

<DOC>
<DOCNO>10599682_0.211</DOCNO>
<TEXT>
      Long-Term Consequences of Castration in Men: Lessons from the Skoptzy and the Eunuchs of the Chinese and Ottoman Courts          Jean D. Wilson and   Claus Roehrborn  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599682_214.135</DOCNO>
<TEXT>
    Departments of Internal Medicine and Urology, University of Texas  Southwestern Medical Center, Dallas, Texas 75235-8857  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599682_352.251</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Jean D. Wilson, Departments of Internal Medicine and Urology, 5323 Harry Hines Boulevard, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8857.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599683_0.136</DOCNO>
<TEXT>
      The Anecdotal History of Screening for Congenital Hypothyroidism          Jean H. Dussault  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599683_139.100</DOCNO>
<TEXT>
    Research Unit in Human Genetics, CHUQ&#150;Pavillon CHUL,  Ste-Foy, QC G1V 4G2 Canada  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599683_242.184</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Research Unit in Human Genetics, CHUQ&#150;Pavillon CHUL, 2705 boul. Laurier, Ste-Foy, QC G1V 4G2 Canada.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599685_0.134</DOCNO>
<TEXT>
      Glucocorticoid-Remediable Aldosteronism          Robert G. Dluhy and   Richard P. Lifton  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599685_137.283</DOCNO>
<TEXT>
    Harvard Medical School, Endocrine Hypertension Division, Brigham  and Women&#146;s Hospital (R.G.D.), Boston, Massachusetts 02115; and  Department of Genetics, Internal Medicine, and Molecular Biophysics and  Biochemistry, Yale University, New Haven, Connecticut 06519  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599685_423.239</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Robert G. Dluhy, Endocrine-Hypertension Division, Brigham and Women&#146;s Hospital, Ambulatory Clinic Center, 221 Longwood Avenue, Boston, Massachusetts 02115.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599686_0.121</DOCNO>
<TEXT>
      Growth-Promoting Strategies in Turner&#146;s Syndrome          Paul Saenger  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599686_124.148</DOCNO>
<TEXT>
    Division of Pediatric Endocrinology, Albert Einstein College of  Medicine, Montefiore Hospital Medical Center, Bronx, New York  10467  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599686_275.234</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Division of Pediatric Endocrinology, Albert Einstein College of Medicine, Montefiore Hospital Medical Center, 111 East 210th Street, Bronx, New York 10467.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599687_0.185</DOCNO>
<TEXT>
      Insulin-Like Growth Factors and Skeletal Growth: Possibilities for Therapeutic Interventions          Judson J. Van Wyk and   Eric P. Smith  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599687_188.326</DOCNO>
<TEXT>
    Division of Endocrinology, Department of Pediatrics, University of  North Carolina School of Medicine (J.J.V.W.), Chapel Hill, North  Carolina 27599; and the Division of Endocrinology and Metabolism,  Department of Internal Medicine, University of Cincinnati School of  Medicine (E.P.S.), Cincinnati, Ohio 45229  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599687_517.227</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Judson J. Van Wyk, Department of Pediatrics, University of North Carolina School of Medicine, C.B.# 7220, Chapel Hill, North Carolina 27599.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599688_0.152</DOCNO>
<TEXT>
      Insulin-like Growth Factors in Pediatric Health and Disease          Derek Le Roith and   Andrew A. Butler  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599688_155.138</DOCNO>
<TEXT>
    Clinical Endocrinology Branch, National Institute of Diabetes  Digestive and Kidney Diseases, Bethesda, Maryland 20892-1758  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599688_296.512</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Derek Le Roith, M.D., Ph.D., Chief, Clinical Endocrinology Branch, National Institute of Diabetes Digestive and Kidney Diseases, Room 8D12, Building 10, Bethesda, Maryland 20892-1758.  E-mail derek{at}helix.nih.govderek@helix.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599691_0.104</DOCNO>
<TEXT>
      Gigantism          Erica A. Eugster and   Ora H. Pescovitz  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599691_107.206</DOCNO>
<TEXT>
    Section of Pediatric Endocrinology/Diabetology, Department of  Pediatrics, James Whitcomb Riley Hospital for Children, Indiana  University School of Medicine, Indianapolis, Indiana 46202-5225  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599691_316.502</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Erica A. Eugster, M.D., Assistant Clinical Professor of Pediatrics, Pediatric Endocrinology/Diabetology, Riley Hospital #5984, 702 Barnhill Drive, Indianapolis, Indiana 46254.  E-mail: eeugster{at}iupui.edueeugster@iupui.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599692_0.122</DOCNO>
<TEXT>
      Pediatric Pituitary Adenomas          Sandeep Kunwar and   Charles B. Wilson  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599692_125.120</DOCNO>
<TEXT>
    Department of Neurosurgery, University of California&#150;San  Francisco, San Francisco, California 94143  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599692_248.232</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Charles B. Wilson, Department of Neurosurgery, University of California&#150;San Francisco, 505 Parnassus Ave, Box 0112, San Francisco, California 94143.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599693_0.140</DOCNO>
<TEXT>
      Genetically Defined Forms of Diabetes in Children          Simeon I. Taylor and   Elif Arioglu  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599693_143.154</DOCNO>
<TEXT>
    Diabetes Branch, National Institute of Diabetes and Digestive and  Kidney Disease, National Institutes of Health, Bethesda, Maryland  20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599693_300.467</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Simeon I. Taylor, M.D., Ph.D., National Institutes of Health, Building 10, Room 9S-213, 10 Center Drive, Bethesda, Maryland 20892.  E-mail:  Simeon_Taylor{at}nih.govSimeon_Taylor@nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599698_0.152</DOCNO>
<TEXT>
      Adrenal Hyperandrogenism in Children          Lucia Ghizzoni,   George Mastorakos and   Alessandra Vottero  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599698_155.184</DOCNO>
<TEXT>
    Department of Pediatrics (L.G., A.V.), University of Parma, 43100  Parma, Italy; and Endocrine Unit (G.M.), Evgenidion Hospital, Athens  University, 11528 Athens, Greece  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599698_342.440</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Lucia Ghizzoni, M.D., Clinica Pediatrica, Universita&#146; degli Studi di Parma, Via Gramsci 14, 43100 Parma, Italy.  E-mail: lughizzo{at}unipr.itlughizzo@unipr.it.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599699_0.246</DOCNO>
<TEXT>
      Growth Hormone Receptor Deficiency in Ecuador1          Arlan L. Rosenbloom,   Jaime Guevara-Aguirre,   Ron G. Rosenfeld and   Uta Francke  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599699_249.480</DOCNO>
<TEXT>
    Department of Pediatrics (A.R.), University of Florida College of  Medicine, Children&#146;s Medical Services Center, Gainesville Florida  32608; Instituto Endocrinologia, Metabolismo y Reproduccion (J.G-A.),  Quito, Ecuador; Department of Pediatrics (R.G.R.), Oregon Health  Sciences University, Portland Oregon 97201-3098; and Department of  Genetics and Howard Hughes Medical Institute (U.F.), Stanford  University Medical Center, Stanford, California 94305-5323  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599699_732.197</DOCNO>
<TEXT>
     Address correspondence to: Arlan Rosenbloom, Department of Pediatrics, Children&#146;s Medical Services Center, 1701 SW 16th Avenue, Room 2163, Gainesville, Florida 32608.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599700_0.473</DOCNO>
<TEXT>
      Profile of the Pediatric Endocrine Clinic at New York&#150;Presbyterian Hospital, New York Weill Cornell Center1          Maria I. New,   Jihad Obeid,   Robert C. Wilson,   Monina S. Cabrera,   Amanda Goseco,   Maria C. Macapagal,   Ian Marshall,   Saroj Nimkarn,   Jose B. Quintos,   Svetlana Ten,   Figen Ugrasbul,   Laurie Vandermolen and   Madeleine D. Harbison  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599700_476.149</DOCNO>
<TEXT>
    Department of Pediatrics, Division of Pediatric Endocrinology,  Weill Medical College of Cornell University, New York, New York  10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599700_628.636</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Maria I. New, M.D., Professor and Chairman, Department of Pediatrics, Chief, Division of Pediatric Endocrinology, Harold and Percy Uris Professor of Pediatric Endocrinology and Metabolism, New York&#150;Presbyterian Hospital, 525 East 68th Street, Room M-622, New York, New York 10021.  E-mail: minew{at}mail.med.cornell.eduminew@mail.med.cornell.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599701_0.193</DOCNO>
<TEXT>
      A New "New" Syndrome in the New World: Is Multiple Postreceptor Steroid Hormone Resistance Due to a Coregulator Defect?          George P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599701_196.171</DOCNO>
<TEXT>
    Developmental Endocrinology Branch, National Institute of Child  Health and Human Development, National Institutes of Health, Bethesda,  Maryland 20892-1862  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599701_370.517</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: George P. Chrousos, M.D., Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1862.  E-mail: chrousog{at}mail.nih.govchrousog@mail.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599703_0.150</DOCNO>
<TEXT>
      Perplexing Polymorphisms: D(i)ps, Sn(i)ps, and Trips          Clifford J. Rosen and   John P. Bilezikian  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599703_153.162</DOCNO>
<TEXT>
    St. Joseph Hospital (C.J.R.), Bangor, Maine 04401; and College of  Physicians and Surgeons (J.P.B.), Columbia University, New York, New  York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599703_318.238</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: John P. Bilezikian, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, PH 8 West, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599735_0.347</DOCNO>
<TEXT>
      Balanced Translocation of 10q and 13q, Including the PTENGene, in a Boy with a Human Chorionic Gonadotropin-Secreting Tumor and the Bannayan-Riley-Ruvalcaba Syndrome          S. Faisal Ahmed,   Debbie J. Marsh,   Stanislawa Weremowicz,   Cynthia C. Morton,   Denise M. Williams and   Charis Eng  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599735_350.673</DOCNO>
<TEXT>
    Department of Pediatrics (S.F.A., D.M.W.) and the Cancer Research  Campaign Human Cancer Genetics Research Group (C.E.), University of  Cambridge, Cambridge, United Kingdom CB2 2QQ; Clinical Cancer Genetics  and Human Cancer Genetics Programs, Ohio State University Comprehensive  Cancer Center (D.J.M., C.E.), Columbus, Ohio 43210; Charles A.  Dana Human Cancer Genetics Unit, Dana-Farber Cancer Institute, Harvard  Medical School (D.J.M., C.E.), Boston, Massachusetts 02115; and the  Cytogenetics Laboratory, Departments of Pathology and Obstetrics,  Brigham and Women&#146;s Hospital and Harvard Medical School (S.W.,  C.C.M.), Boston, Massachusetts 02115  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599735_1026.488</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. S. Faisal Ahmed, Department of Pediatrics, University of Cambridge Clinical School, Box 116, Addenbrookes Hospital, Hills Road, Cambridge, United Kingdom CB2 2QQ.  E-mail: sfa21{at}cam.ac.uksfa21@cam.ac.uk.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10599736_0.186</DOCNO>
<TEXT>
      The Discovery of Growth Hormone-Releasing Hormone1          MICHAEL O. THORNER  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599736_189.95</DOCNO>
<TEXT>
    Department of Medicine, University of Virginia, Charlottesville,  Virginia 22908  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599736_287.202</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Michael O. Thorner, Department of Medicine, University of Virginia Health System, Box 466, Charlottesville, Virginia 22908.
</TEXT>
</DOC>

<DOC>
<DOCNO>10599754_0.147</DOCNO>
<TEXT>
      Comment on Health Issues for Women Athletes: Exercise-Induced Amenorrhea          Carl De Cr&eacute;e  
</TEXT>
</DOC>


<DOC>
<DOCNO>10599754_150.203</DOCNO>
<TEXT>
    Reproductive Endocrinology and Sports Medicine  Department of Applied and Experimental Reproductive Endocrinology  Institute for Gyneco-Endocrinological Research  B-3000 Leuven 3, Belgium   
</TEXT>
</DOC>


<DOC>
<DOCNO>10599754_356.1004</DOCNO>
<TEXT>
          Since the 1970s, the problem of exercise-induced  menstrual irregularities and its possible consequences (osteoporosis,  subfertility) has been recognized and studied in detail. Warren  et al. (1) present a chrestomathy of theirs and a number of  other North American authors who have delivered important contributions  to our understanding of the etiology and reproductive health of female  athletes. It is suggested that secondary amenorrhea, inadequate luteal  phase, and the female athlete triad are a caused by a disturbance of  normal GnRH pulsatility, which is provoked by weight loss or dietary  restriction. Indeed, studies of Loucks et al. (2) have  clearly pointed out how a disturbance of a critical energy balance,  possibly accompanied by low T3 levels, may lead to  menstrual problems. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10634356_0.273</DOCNO>
<TEXT>
      Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide          Pamela U. Freda,   Charalambos I. Andreadis,   Alexander G. Khandji,   Maha Khoury,   Jeffrey N. Bruce,   Thomas P. Jacobs and   Sharon L. Wardlaw  
</TEXT>
</DOC>


<DOC>
<DOCNO>10634356_276.208</DOCNO>
<TEXT>
    Departments of Medicine (P.U.F., C.I.A., M.K., T.P.J., S.L.W.),  Neurosurgery (J.N.B.), and Radiology (A.G.K.), Columbia University  College of Physicians and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>10634356_487.228</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Pamela U. Freda, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>10634416_0.210</DOCNO>
<TEXT>
      Malignant Prolactinoma Discovered by D2 Receptor Imaging          P. Petrossians,   W. De Herder,   D. Kwekkeboom,   G. Lamberigts,   A. Stevenaert and   A. Beckers  
</TEXT>
</DOC>


<DOC>
<DOCNO>10634416_213.329</DOCNO>
<TEXT>
    Departments of Endocrinology (P.P., A.B.) and Neurosurgery (A.S.),  University Hospital, B-4000 Liege, Belgium; Departments of Internal  Medicine (W.D.H.) and Nuclear Medicine (D.K.), University Hospital,  3015 Rotterdam, The Netherlands; and Department of  Endocrinology, AZ St. Jan (G.L.), B-8000 Brugge, Belgium  
</TEXT>
</DOC>


<DOC>
<DOCNO>10634416_545.211</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Prof. Albert Beckers, Service d&#146;Endocrinologie, CHU de Liege, Domaine universitaire du Sart Tilman, B-4000, Liege, Belgium.
</TEXT>
</DOC>

<DOC>
<DOCNO>10634427_0.218</DOCNO>
<TEXT>
      A Novel Method for Assessing Assisted Female Fertility: Bioelectric Impedance          Masao Jinno,   Toshihisa Hoshiai,   Yukio Nakamura,   Koji Teruya and   Tooru Tsunoda  
</TEXT>
</DOC>


<DOC>
<DOCNO>10634427_221.172</DOCNO>
<TEXT>
    Departments of Obstetrics and Gynecology (M.J., T.H., Y.N.), and  Hygiene (K.T., T.T.), School of Medicine, Kyorin University, Mitaka  City, Tokyo 181, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>10634427_396.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>10690846_0.125</DOCNO>
<TEXT>
      Familial Sex Reversal: A Review          Kyriakie Sarafoglou and   Harry Ostrer  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690846_128.130</DOCNO>
<TEXT>
    Human Genetics Program, Department of Pediatrics, New York  University School of Medicine, New York, New York 10016  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690846_261.466</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Harry Ostrer, Human Genetics Program, Department of Pediatrics, 550 First Avenue, MSB 136, New York, New York 10016.  E-mail:  harry.ostrer{at}med.nyu.eduharry.ostrer@med.nyu.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10690847_0.118</DOCNO>
<TEXT>
      Prevention of Type 1 Diabetes: Perspectives          Arlan L. Rosenbloom  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690847_121.109</DOCNO>
<TEXT>
    Department of Pediatrics  Children&#146;s Medical Services Center Gainesville, Florida  32608   
</TEXT>
</DOC>


<DOC>
<DOCNO>10690847_233.1464</DOCNO>
<TEXT>
                  &nbsp;&nbsp;  Introduction      Top  Introduction  References    &nbsp;    THE DISCUSSANTS of this question represent  opposing positions that are reflected in their obligatory Y2K  compliance statements. Schatz et al. (1) state that, "As  we move into the new millennium, there is hope that these and future  studies will make prevention of the disease a reality in the not too  distant future." Becker et al. (2) aver, "The risks of  the intervention should be weighed clearly against the risks and  discomfort of the treatment of diabetes as we approach the next  millennium." 
</TEXT>
</DOC>

<DOC>
<DOCNO>10690894_0.178</DOCNO>
<TEXT>
      Leptin, Nutrition, and Reproduction: Timing Is Everything          Stanley M. Hileman,   Dominique D. Pierroz and   Jeffrey S. Flier  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690894_181.160</DOCNO>
<TEXT>
    Department of Medicine, Division of Endocrinology, Beth Israel  Deaconess Medical Center and Harvard Medical School, Boston,  Massachusetts 02215  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690894_344.530</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Jeffrey S. Flier, Beth Israel Deaconess Medical Center and Harvard Medical School, Department of Endocrinology, 325 RN, 99 Brookline Avenue, Boston, Massachusetts 02215.  E-mail: jflier{at}caregroup.harvard.edujflier@caregroup.harvard.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10690910_0.492</DOCNO>
<TEXT>
      Preoperative Calcitonin Levels Are Predictive of Tumor Size and Postoperative Calcitonin Normalization in Medullary Thyroid Carcinoma          R&eacute;gis Cohen,   Jos&eacute;-Marie Campos,   Carole Sala&uuml;n,   Hassan Massoud Heshmati,   Jean-Louis Kraimps,   Charles Proye,   &Eacute;mile Sarfati,   Jean-Fran&ccedil;ois Henry,   Patricia Niccoli-Sire,   Elisabeth Modigliani and   Groupe D&#146;Etude Des Tumeurs &Agrave; Calcitonine (GETC)  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690910_495.124</DOCNO>
<TEXT>
    Service d&#146;Endocrinologie, H&ocirc;pital Avicenne, Universit&eacute;  Paris XIII, F-93009 Bobigny, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>10690910_622.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>10720018_0.160</DOCNO>
<TEXT>
      The Treatment of Growth Hormone Deficiency in Adults          Bengt-&Aring;ke Bengtsson and   Gudmundur Johannsson  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720018_163.142</DOCNO>
<TEXT>
    Research Center for Endocrinology and Metabolism  Sahlgrenska University Hospital Sahlgrenska, S-413 45  G&ouml;teborg, Sweden   
</TEXT>
</DOC>


<DOC>
<DOCNO>10720018_308.3453</DOCNO>
<TEXT>
                  &nbsp;&nbsp;  Introduction      Top  Introduction  GH secretion in adults  Individual responsiveness  Markers of GH action  Individualized dose titration  Safety  Summary  References    &nbsp;    ADULT GH deficiency is recognized  as a specific clinical syndrome (1). Well-controlled clinical studies  have shown that GH deficiency in adults is associated with a cluster of  cardiovascular risk factors (2). These patients have an increased  amount of body fat with an abdominal preponderance (3, 4), an increased  prevalence of hypertension (5), impaired fibrinolysis (4), glucose  intolerance (6), insulin resistance (7), and premature atherosclerosis  (6). This cluster of cardiovascular risk factors associated with GH  deficiency might explain the doubling in cardiovascular mortality  observed in hypopituitary patients (8, 9). The quality of life is  impaired, and there are data suggesting an increased prevalence of  disability pensions among these patients (10, 11). In addition, these  patients have reduced bone mineral content and density with increased  prevalence of fractures (12, 13). Randomized placebo-controlled studies  indicate that GH replacement therapy can reverse several of these  biological changes (3, 14, 15, 16, 17, 18). Although these studies have been of  relatively short duration, replacement therapy with GH in adults has  now been approved by the regulatory authorities in Europe and the  United States. The long-term experience is, however, limited. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10720020_0.264</DOCNO>
<TEXT>
      Acute Ischemic Stroke in a Young Woman with the Thiamine-Responsive Megaloblastic Anemia Syndrome          Valeria Villa,   Angela Rivellese,   Francesco Di Salle,   Ciro Iovine,   Vincenzo Poggi and   Brunella Capaldo  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720020_267.210</DOCNO>
<TEXT>
    Departments of Clinical and Experimental Medicine and  Biomorphological and Functional Sciences (F.D.S.), Federico II  University Medical School, Ospedale Pausillipon (V.P.), 80131 Naples,  Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720020_480.467</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Brunella Capaldo, M.D., Dipartimento di Medicina Clinica e Sperimentale, Universit&agrave; Federico II, Via Pansini 5, 80131 Naples, Italy.  E-mail: brucapal{at}unina.itbrucapal@unina.it.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10720021_0.362</DOCNO>
<TEXT>
      Extraocular Muscle Antibodies Positivity as the Only Serum Marker of Euthyroid Graves&#146; Ophthalmopathy following Subacute Thyroiditis: Case Report          Giovanni Amato,   Mario Rotondi,   Ida Salzano,   Annamaria De Bellis,   Giuseppina De Felice,   Ciro Costagliola,   Antonio Bellastella and   Carlo Carella  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720021_365.160</DOCNO>
<TEXT>
    Institute of Endocrinology (G.A., M.R., I.S., A.D.B., G.D.F., A.B.,  C.Ca.) and Eye Clinic (C.Co.), II University of Naples, 80128 Naples,  Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720021_528.159</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Prof. Giovanni Amato, Via Orsi, 33, 80128 Naples, Italy.  
</TEXT>
</DOC>

<DOC>
<DOCNO>10720022_0.218</DOCNO>
<TEXT>
      Recurrent Acute Suppurative Thyroiditis in an Adult Due to a Fourth Branchial Pouch Fistula          Jane A. Cases,   Bruce M. Wenig,   Carl E. Silver and   Martin I. Surks  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720022_221.193</DOCNO>
<TEXT>
    Departments of Medicine (J.A.C., M.I.S.), Pathology (B.M.W.), and  Surgery (C.E.S.), Montefiore Medical Center and The Albert Einstein  College of Medicine, Bronx, New York 10467  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720022_417.396</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Martin I. Surks, M.D., 111 East 210th Street, Bronx, New York 10467.  E-mail:  msurks{at}westnet.commsurks@westnet.com.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10720085_0.339</DOCNO>
<TEXT>
      An Unusual Kindred of the Multiple Endocrine Neoplasia Type 1 (MEN1) in Japanese1          Takumi Abe,   Katsuhiko Yoshimoto,   Matsuo Taniyama,   Kazuo Hanakawa,   Hitoshi Izumiyama,   Mitsuo Itakura and   Kiyoshi Matsumoto  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720085_342.332</DOCNO>
<TEXT>
    Departments of Neurosurgery (T.A., K.H., H.I., K.M.) and 3rd  Internal Medicine (M.T.), Showa University School of Medicine,  Tokyo142-8666; and Otsuka Department of Molecular Nutrition (K.Y.,  M.I.), School of Medicine and Institute for Genome Research (M.I.), The  University of Tokushima, Tokushima 770-8503, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720085_677.494</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Takumi Abe, M.D., Ph.D., Department of Neurosurgery, Showa University School of Medicine, 5&#150;8 Hatanodai 1, Shinagawa-ku, Tokyo 142-8666, Japan.  E-mail:  takumi{at}med.showa-u.ac.jptakumi@med.showa-u.ac.jp.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10720086_0.123</DOCNO>
<TEXT>
      Interleukin-6: The Endocrine Cytokine          Dimitris A. Papanicolaou, M.D.  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720086_126.298</DOCNO>
<TEXT>
    Pediatric and Reproductive Endocrinology Branch  NICHD, National Institutes of Health  Bethesda, Maryland 20892-1583  Alexandros N. Vgontzas, M.D.  Sleep Research and Treatment Center  Department of Psychiatry, College of Medicine  Penn State University  Hershey, Pennsylvania 17033   
</TEXT>
</DOC>


<DOC>
<DOCNO>10720086_427.531</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dimitris A. Papanicolaou, Pediatric and Reproductive Endocrinology Branch, NICHD, National Institutes of Health, Building 10, Room 9D42, 10 Center Drive, MSC 1583, Bethesda, Maryland 20892-1583.  E-mail:  papanicd{at}mail.nih.govpapanicd@mail.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10720091_0.167</DOCNO>
<TEXT>
      Role of Cytochrome b5 in the 17,20-Lyase Activity of P450c17          Walter L. Miller and   Richard J. Auchus  
</TEXT>
</DOC>


<DOC>
<DOCNO>10720091_170.123</DOCNO>
<TEXT>
    Department of Pediatrics  University of California&#150;San Francisco  San Francisco, California 94143-0978   
</TEXT>
</DOC>


<DOC>
<DOCNO>10720091_296.3907</DOCNO>
<TEXT>
          In the September 1999 issue of this journal, Mapes et al. (1)  reported the important observation that cytochrome b5 is  preferentially expressed in the monkey zona reticularis, consistent  with the biochemical observation that the presence of b5  promotes the 17,20-lyase activity of human P450c17. This b5  mediated effect was first reported in 1982 (2), confirmed in 1992 and  1995 (3, 4), and the mechanism by which b5 exerts its  activity as an allosteric factor, rather than as an electron donor, was  established with human systems in 1998 (5). Mapes et al. (1)  state that the demonstration that P450c17 has both 17-hydroxylase  and 17,20-lyase activities has fueled debate about the mechanism by  which 17,20-lyase activity is regulated, in view of the existence of  patients with isolated 17,20-lyase deficiency. There is little  remaining debate as the genetic and biochemical basis of isolated  17,20-lyase deficiency is now known. The molecular basis of 17,20-lyase  deficiency was determined in two patients by Geller et al.  (6) and in a third patient by Biason-Lauber et al. (7),  identifying missense mutations in the redox-partner binding-site in all  three cases. The mechanism by which these mutations cause loss of lyase  but not hydroxylase activity has been shown in the two index cases to  be due to disrupted interactions with both P450 oxidoreductase (6) and  with cytochrome b5 (8). The mechanism by which mutations in  the region of P450c17 that participates in redox partners interactions  has been established genetically, biochemically, and structurally (9).  Definitive understanding of the role of b5 will require the  study of b5-deficient patients that will represent a gene  knockout of nature; a mouse knockout would provide less information  because rodents do not express P450c17 in their adrenals (10). The  principal known physiologic role of cytochrome b5 is in  reducing methemoglobin, but most patients with hereditary  methemoglobinemia have defects in cytochrome b5 reductase  rather than in b5 itself (11). Only one patient with  cytochrome b5 deficiency has been reported (12) and studied  at a molecular genetic level (13). That patient was a male  pseudohermaphrodite who had female genitalia at birth, but,  unfortunately, data concerning adrenal and gonadal steroidogenesis have  not been reported for this patient. In a converse experiment of nature,  Sakai et al. (14) reported that adrenal adenomas that  overproduce 19-carbon steroids and, hence, have abundant 17,20-lyase  activity contain very large amounts of cytochrome b5. Thus,  the report of Mapes et al. (1) and a related report by  Yanase et al. (15) concerning the human adrenal provide  further anatomical evidence for the established central role of  cytochrome b5 in regulating the 17,20-lyase activity of  human P450c17. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10770165_0.189</DOCNO>
<TEXT>
      Hypopituitarism Secondary to Head Trauma          Salvatore Benvenga,   Alfredo Campenn&Iacute;,   Rosaria M. Ruggeri and   Francesco Trimarchi  
</TEXT>
</DOC>


<DOC>
<DOCNO>10770165_192.118</DOCNO>
<TEXT>
    Cattedra e Divisione di Endocrinologia, University of Messina  School of Medicine, 98125 Messina, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>10770165_313.222</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Salvatore Benvenga, M.D., Cattedra e Divisione di Endocrinologia, Policlinico Universitario, Padiglione H, 4&#176; piano, 98125 Messina, Italy.
</TEXT>
</DOC>

<DOC>
<DOCNO>10770224_0.197</DOCNO>
<TEXT>
      Complications of Inferior Petrosel Sinus Sampling          G. A. Kaltsas,   J. D. C. Newell-Price,   P. J. Trainer,   G. M. Besser and   A. B. Grossman  
</TEXT>
</DOC>


<DOC>
<DOCNO>10770224_200.108</DOCNO>
<TEXT>
    Department of Endocrinology  St. Bartholomew&#146;s Hospital  London ECIA 7BE, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>10770224_311.1277</DOCNO>
<TEXT>
          We were very interested to read the letter by  Lefournier et al. (1) in a recent issue of your journal,  commenting on possible side effects associated with inferior petrosal  sinus sampling. They noted one transient neurological complication in  their extensive experience of 166 consecutive investigations and note  that in our own recent series we reported no major complications in 128  patients (2). However, they do allude to our own detailed review (3)  where we reported a nonfatal pulmonary embolus occurring in a patient  after catheterization. It was our understanding that this occurred in a  patient following bilateral inferior petrosal sinus sampling (BIPSS),  but we have rechecked our records and note that this was erroneous: it  actually occurred following a venous catheter for parathyroid hormone  that did not involve the petrosal sinuses. We, therefore, confirm that  in our experience of now more than 130 inferior petrosal sinus  samplings we have not seen any serious local or generalized  complication. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10843144_0.203</DOCNO>
<TEXT>
      Cell Adhesion Molecules in Cardiovascular Disease and Its Risk Factors&#151;What Can Soluble Levels Tell Us?          Andrew D. Blann and   Gregory Y. H. Lip  
</TEXT>
</DOC>


<DOC>
<DOCNO>10843144_206.151</DOCNO>
<TEXT>
    Haemostasis, Thrombosis and Vascular Biology Unit  University Department of Medicine  City Hospital  Birmingham B18 7QH, United Kingdom   
</TEXT>
</DOC>


<DOC>
<DOCNO>10843144_360.242</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Gregory Y. H. Lip, University Department of Medicine, City Hospital, Haemostasis, Thrombosis and Vascular Biology, Dudley Road, Birmingham B18 7QH, United Kingdom.
</TEXT>
</DOC>

<DOC>
<DOCNO>10843146_0.153</DOCNO>
<TEXT>
      Dissecting the Genetics of Hyperparathyroidism&#151;New Clues from an Old Friend          Catharina Larsson  
</TEXT>
</DOC>


<DOC>
<DOCNO>10843146_156.143</DOCNO>
<TEXT>
    Endocrine Tumor Unit  Center for Molecular Medicine CMM  Karolinska Hospital  Karolinska Institutet  S-171 76 Stockholm, Sweden   
</TEXT>
</DOC>


<DOC>
<DOCNO>10843146_302.232</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Catharina Larsson, Endocrine Tumor Unit, Center for Molecular Medicine CMM, Karolinska Hospital L8:01, Karolinska Institutet, S-171 76 Stockholm, Sweden.
</TEXT>
</DOC>

<DOC>
<DOCNO>10843147_0.199</DOCNO>
<TEXT>
      Familial Papillary Thyroid Cancer&#151;Many Syndromes, Too Many Genes?1          Charis Eng  
</TEXT>
</DOC>


<DOC>
<DOCNO>10843147_202.278</DOCNO>
<TEXT>
    Clinical Cancer Genetics and Human Cancer Genetics  Programs  Ohio State University Comprehensive Cancer Center  Columbus, Ohio 43210  and  Cancer Research Campaign Human Cancer Genetics  Research Group  University of Cambridge  Cambridge CB2 2QQ, United Kingdom   
</TEXT>
</DOC>


<DOC>
<DOCNO>10843147_483.468</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Charis Eng, M.D., Ph.D., Ohio State University Human Cancer Genetics, 420 West 12th Avenue, Suite 690 MRF, Columbus, Ohio 43210.  medctr.osu.edu or ceng{at}hgmp.mrc.ac.ukceng@hgmp.mrc.ac.uk.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10843149_0.342</DOCNO>
<TEXT>
      Fulminant Hepatitis A in a Patient with Severe Hyperthyroidism: Rapid Recovery from Hepatic Coma after Plasmapheresis and Total Thyroidectomy          Michael Enghofer,   Klaus Badenhoop,   Stefan Zeuzem,   Andreas Schmidt-Matthiesen,   Christoph Betz,   Albrecht Encke and   Klaus Henning Usadel  
</TEXT>
</DOC>


<DOC>
<DOCNO>10843149_345.203</DOCNO>
<TEXT>
    Departments of Medicine I (M.E., K.B., K.H.U.), II (S.Z.), and IV  (C.B.), and Department of Surgery (A.S.-M., A.E.), Johann Wolfgang  Goethe University, D-60590 Frankfurt am Main, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>10843149_551.220</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Michael Enghofer, M.D., Department of Medicine I, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
</TEXT>
</DOC>

<DOC>
<DOCNO>10843200_0.168</DOCNO>
<TEXT>
      Comment on Extrapituitary Parasellar Macroadenoma in Cushing&#146;s Disease          Michael S. Vaphiades and   Ali Krisht  
</TEXT>
</DOC>


<DOC>
<DOCNO>10843200_171.276</DOCNO>
<TEXT>
    Muhammad Husain, Robert L. Archer, and Fred Faas  Departments of Ophthalmology (M.S.V.), Neurology (M.S.V., R.L.A.),  Neurosurgery (A.K.), Pathology (M.H.), and Endocrinology (F.F.)  University of Arkansas for Medical Sciences  Little Rock, Arkansas 72205-7199   
</TEXT>
</DOC>


<DOC>
<DOCNO>10843200_450.1982</DOCNO>
<TEXT>
          We enjoyed the manuscript by Pluta  et al. (1) entitled "Extrapituitary Parasellar  Microadenoma in Cushing&#146;s Disease." We were impressed by the rarity  of ACTH ectopic pituitary adenomas occupying the cavernous sinus. Pluta  et al. (1) have reported the first three cases of this type  in the literature. We have a similar patient with an ectopic pituitary  adenoma of the cavernous sinus, however, our patient also had pituitary  apoplexy. She is a 43-yr-old woman who experienced the worst headache  of her life, diplopia, ptosis, and proptosis of her right eye. She has  a history of Cushing&#146;s syndrome, diagnosed in 1991. She had multiple  24-h urine free cortisol levels that were substantially elevated,  ranging from 185&#150;374 &#181;g/24 h (20&#150;100 &#181;g/24 h). There was  no evidence of suppression with dexamethasone, and plasma  adrenocorticotropic hormone levels were high normal at 77 and 73 pg/mL  (&lt;80 pg/mL). Urinary 17-hydroxycorticoid levels were, likewise,  elevated ranging between 23 and 59 mg/24 h (2&#150;10 mg/24 h) as were  plasma cortisol levels of 43 and 35 &#181;g/dL (3&#150;16 &#181;g/dL). A magnetic  resonance imaging scan of the brain revealed a small mass in the region  of the superior aspect of the right cavernous sinus and posterior  aspect of the sella. A transsphenoidal subtotal hypophysectomy was  performed on March 25, 1992. There was no pathologic evidence of  pituitary adenoma, only normal pituitary tissue. After surgery, she had  persistent evidence of Cushing&#146;s syndrome and she subsequently  developed hypothyroidism. She was treated medically with  aminoglutethimide. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10852435_0.122</DOCNO>
<TEXT>
      Primary Prevention of Coronary Heart Disease          Christie M. Ballantyne  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852435_125.88</DOCNO>
<TEXT>
    Department of Medicine  Baylor College of Medicine   Houston, Texas 77030  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852435_216.190</DOCNO>
<TEXT>
     Address correspondence to: Robert A. Kreisberg, M.D., Dean and Vice President for Health Affairs, University of South Alabama, CSAB 170, Mobile, Alabama 36688-0002.
</TEXT>
</DOC>

<DOC>
<DOCNO>10852436_0.212</DOCNO>
<TEXT>
      Insulin Resistance Is Not Necessarily an Essential Component of Type 2 Diabetes1          John E. Gerich  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852436_215.154</DOCNO>
<TEXT>
    Department of Medicine, Physiology, and Pharmacology, University of  Rochester School of Medicine and Dentistry, Rochester, New York  14642  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852436_372.285</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. John E. Gerich, Department of Medicine, Physiology, and Pharmacology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642.  
</TEXT>
</DOC>

<DOC>
<DOCNO>10852439_0.210</DOCNO>
<TEXT>
      Sequential Parathyroid Hormone/Alendronate Therapy for Osteoporosis&#151;Robbing Peter to Pay Paul?          Mara Horwitz,   Andrew Stewart and   Susan L. Greenspan  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852439_213.129</DOCNO>
<TEXT>
    University of Pittsburgh Medical Center  Division of Endocrinology and Metabolism  Pittsburgh, Pennsylvania 15213   
</TEXT>
</DOC>


<DOC>
<DOCNO>10852439_345.557</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Susan L. Greenspan, M.D., University of Pittsburgh Medical Center, Osteoporosis Prevention and Treatment Center, 1110 Kaufmann Building, 3471 Fifth Avenue, Pittsburgh, Pennsylvania 15213.  E-mail:  greenspans{at}msx.dept-med.pitt.edugreenspans@msx.dept-med.pitt.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10852441_0.145</DOCNO>
<TEXT>
      Age-Related Decreases in Melatonin Secretion&#151;Clinical Consequences          Richard J. Wurtman  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852441_148.111</DOCNO>
<TEXT>
    Clinical Research Center  Massachusetts Institute of Technology  Cambridge, Massachusetts 02139   
</TEXT>
</DOC>


<DOC>
<DOCNO>10852441_262.254</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Richard J. Wurtman, M.D., Cecil H. Green Distinguished Professor and Director, Clinical Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
</TEXT>
</DOC>

<DOC>
<DOCNO>10852443_0.182</DOCNO>
<TEXT>
      Are Gender Differences in the Responses to Hypoglycemia Relevant to Iatrogenic Hypoglycemia in Type 1 Diabetes?          Philip E. Cryer  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852443_185.213</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes, and Metabolism  General Clinical Research Center and Diabetes Research and Training  Center  Washington University School of Medicine  St. Louis, Missouri 63110   
</TEXT>
</DOC>


<DOC>
<DOCNO>10852443_401.476</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Philip E. Cryer, M.D., Campus Box 8127, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri 63110.  E-mail:  pcryer{at}imgate.wustl.edupcryer@imgate.wustl.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10852445_0.103</DOCNO>
<TEXT>
      Sex and the Single Gene&#151;FH-1          John W. Funder  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852445_106.85</DOCNO>
<TEXT>
    Baker Medical Research Institute  Melbourne 8008, Victoria, Australia   
</TEXT>
</DOC>


<DOC>
<DOCNO>10852445_194.220</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: John W. Funder, M.D., Director, Baker Medical Research Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne 8008, Victoria, Australia.
</TEXT>
</DOC>

<DOC>
<DOCNO>10852447_0.200</DOCNO>
<TEXT>
      Exercise and Fatigue&#151;Is Neuroendocrinology an Important Factor?1          Gail K. Adler  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852447_203.133</DOCNO>
<TEXT>
    Endocrine-Hypertension Division Brigham and Women&#146;s Hospital  Harvard Medical School  Boston, Massachusetts 02115  
</TEXT>
</DOC>


<DOC>
<DOCNO>10852447_339.221</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Gail Kurr Adler, M.D., Harvard Medical School, Endocrinology/Hypertension Division, 221 Longwood Avenue, RFB 289, Boston, Massachusetts 02481.
</TEXT>
</DOC>

<DOC>
<DOCNO>10902778_0.343</DOCNO>
<TEXT>
      The Role of Receptor Activator of Nuclear Factor-B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases1          Lorenz C. Hofbauer and   Armin E. Heufelder  
</TEXT>
</DOC>


<DOC>
<DOCNO>10902778_346.143</DOCNO>
<TEXT>
    Division of Gastroenterology and Endocrinology, Zentrum f&uuml;r  Innere Medizin, Philipps University, D-35033 Marburg,  Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>10902778_492.545</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Lorenz C. Hofbauer, M.D., Division of Gastroenterology and Endocrinology, Zentrum f&uuml;r Innere Medizin, Philipps University, Baldingerstrasse, D-35033 Marburg, Germany.  E-mail:  hofbauer{at}post.med.uni-marburg.dehofbauer@post.med.uni-marburg.de.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10902779_0.208</DOCNO>
<TEXT>
      A Monoclonal Antibody Recognizing the Extracellular Domain of Human Na+/I- Symporter and Its Potential Applications          Sissy M. Jhiang  
</TEXT>
</DOC>


<DOC>
<DOCNO>10902779_211.112</DOCNO>
<TEXT>
    Departments of Physiology and Internal Medicine  The Ohio State University  Columbus, Ohio 43210   
</TEXT>
</DOC>


<DOC>
<DOCNO>10902779_326.479</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Sissy M. Jhiang, Ph.D., Departments of Physiology and Internal Medicine, The Ohio State University, 302 Hamilton Hall, 1645 Neil Avenue, Columbus, Ohio 43210.  E-mail: jhiang.l{at}osu.edujhiang.l@osu.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10902819_0.278</DOCNO>
<TEXT>
      Full Remission of Growth Hormone (GH)-Induced Retinopathy after GH Treatment Discontinuation: Long-Term Follow-Up1          Richard Hansen,   Elizabeth A. Koller and   Saul Malozowski  
</TEXT>
</DOC>


<DOC>
<DOCNO>10902819_281.247</DOCNO>
<TEXT>
    Eye Physicians of Sussex County (R.H.), Newton, New Jersey 07860  Division of Metabolism and Endocrine Drug Products (E.A.K., S.M.),  Center for Drug Evaluation and Research, Food and Drug Administration,  Rockville, Maryland 20857   
</TEXT>
</DOC>


<DOC>
<DOCNO>10902819_531.896</DOCNO>
<TEXT>
          Previously, we reported on two nondiabetic  patients who developed retinal changes mimicking diabetic retinopathy  after GH exposure (1). One of the patients, a 31-yr-old male,  presented with new-onset impairment of visual acuity: right eye,  20/40-1; left eye, count fingers after 14 months of treatment. His  funduscopic examination was notable for bilateral cotton wool spots,  dot hemorrhages, microaneurysms, and macular edema (Fig. 1, A and B). Fluorescein angiography  demonstrated dye leakage in both eye-grounds. Emergent laser surgery  was performed on the left eye, and visual acuity improved to 20/100.  Surgery was not undertaken in the right eye. 
</TEXT>
</DOC>

<DOC>
<DOCNO>10946858_0.149</DOCNO>
<TEXT>
      Thyrotropin Receptor Polymorphisms and Thyroid Diseases          Massimo Tonacchera and   Aldo Pinchera  
</TEXT>
</DOC>


<DOC>
<DOCNO>10946858_152.92</DOCNO>
<TEXT>
    Department of Endocrinology  University of Pisa  56124 Cisanello, Pisa, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>10946858_247.469</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Aldo Pinchera, Department of Endocrinology, University of Pisa, Via Paradisa 2, 56124 Cisanello, Pisa, Italy.  E-mail: a.pinchera{at}endoc.med.unipi.ita.pinchera@endoc.med.unipi.it.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10946860_0.434</DOCNO>
<TEXT>
      Triple H Syndrome: A Novel Autoimmune Endocrinopathy Characterized by Dysfunction of the Hippocampus, Hair Follicle, and Hypothalamic-Pituitary-Adrenal Axis          I. Sadaf Farooqi1,   M. Keston Jones,   Marc Evans,   Stephen O&#146;Rahilly2 and   John R. Hodges  
</TEXT>
</DOC>


<DOC>
<DOCNO>10946860_437.353</DOCNO>
<TEXT>
    University Departments of Medicine and Clinical Biochemistry  (I.S.F., S.O.R.) and Neurology (J.R.H.), and Medical Research Council  Cognition and Brain Sciences Unit (J.R.H.), Addenbrooke&#146;s Hospital,  Cambridge CB2 2QQ, United Kingdom; and Department of Medicine,  Singleton Hospital (M.K.J., M.E.), Swansea SA2 8QA, United  Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>10946860_793.510</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Prof. Stephen O&#146;Rahilly, University Departments of Medicine and Clinical Biochemistry, Box 157, Addenbrooke&#146;s Hospital, Cambridge CB2 2QQ, United Kingdom.  E-mail: sorahill{at}hgmp.mrc.ac.uksorahill@hgmp.mrc.ac.uk.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10999777_0.105</DOCNO>
<TEXT>
      More Evidence and Still No Action          Robert P. Heaney  
</TEXT>
</DOC>


<DOC>
<DOCNO>10999777_108.53</DOCNO>
<TEXT>
    Creighton University  Omaha, Nebraska   
</TEXT>
</DOC>


<DOC>
<DOCNO>10999777_164.182</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Robert P. Heaney, M.D., Creighton University, 601 North 30th Street, Suite 4841, Omaha, Nebraska 68131.
</TEXT>
</DOC>

<DOC>
<DOCNO>10999779_0.125</DOCNO>
<TEXT>
      Testosterone&#151;Fountain of Youth or Drug of Abuse?          Frances J. Hayes  
</TEXT>
</DOC>


<DOC>
<DOCNO>10999779_128.150</DOCNO>
<TEXT>
    Reproductive Endocrine Unit and National Center for Infertility  Research  Massachusetts General Hospital  Boston, Massachusetts 02114   
</TEXT>
</DOC>


<DOC>
<DOCNO>10999779_281.541</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Frances J. Hayes, MB, MRCPI, Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114.  E-mail:  Hayes.Frances{at}MGH.Harvard.eduHayes.Frances@MGH.Harvard.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>10999780_0.240</DOCNO>
<TEXT>
      Estrogen Deficiency in Men Is a Challenge for Both the Hypothalamus and Pituitary          Dirk Vanderschueren1 and   Roger Bouillon  
</TEXT>
</DOC>


<DOC>
<DOCNO>10999780_243.130</DOCNO>
<TEXT>
    Laboratory for Experimental Medicine and Endocrinology (Legendo)  Catholic University Leuven  3000 Leuven, Belgium   
</TEXT>
</DOC>


<DOC>
<DOCNO>10999780_376.524</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Roger Bouillon, Laboratory for Experimental Medicine and Endocrinology (Legendo), Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium.  E-mail: Roger.Bouillon{at}med.kuleuven.ac.bcRoger.Bouillon@med.kuleuven.ac.bc.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11061488_0.175</DOCNO>
<TEXT>
      Monitoring Osteoporosis Therapy with Bone Densitometry: A Vital Tool or Regression toward Mediocrity?          Sydney Lou Bonnick  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061488_178.101</DOCNO>
<TEXT>
    Institute for Women&#146;s Health  Texas Woman&#146;s University  Denton, Texas 76204   
</TEXT>
</DOC>


<DOC>
<DOCNO>11061488_282.214</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Sydney Lou Bonnick, M.D., FACP, Institute for Women&#146;s Health, Texas Woman&#146;s University, P.O. Box 425876, Denton, Texas 76204.
</TEXT>
</DOC>

<DOC>
<DOCNO>11061489_0.291</DOCNO>
<TEXT>
      Bone Mineral Density, Androgens, and the Polycystic Ovary: The Complex and Controversial Issue of Androgenic Influence in Female Bone          Jeanne V. Zborowski,   Jane A. Cauley,   Evelyn O. Talbott,   David S. Guzick and   Stephen J. Winters  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061489_294.416</DOCNO>
<TEXT>
    Department of Epidemiology, Graduate School of Public Health,  University of Pittsburgh (J.V.Z., J.A.C., E.O.T.), Pittsburgh,  Pennsylvania 15261; Department of Obstetrics and Gynecology, University  of Rochester School of Medicine (D.S.G.), Rochester, New York 14642;  and Division of Endocrinology and Metabolism, University of Louisville  Health Sciences Center (S.J.W.), Louisville, Kentucky 40292  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061489_713.502</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Jeanne V. Zborowski, Ph.D., Department of Epidemiology, University of Pittsburgh, Graduate School of Public Health, 507 Parran Hall, 130 DeSoto Street, Pittsburgh, Pennsylvania 15261.  E-mail: JVZST{at}pitt.eduJVZST@pitt.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11061490_0.161</DOCNO>
<TEXT>
      Somatostatin Receptor-Based Scintigraphy and Antitumor Treatment&#151;An Expanding Vista?          Robert T. Jensen  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061490_164.169</DOCNO>
<TEXT>
    National Institutes of Health  National Institute of Diabetes and Digestive and Kidney Diseases  Digestive Diseases Branch  Bethesda, Maryland 20892-1804   
</TEXT>
</DOC>


<DOC>
<DOCNO>11061490_336.308</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Robert T. Jensen, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Digestive Diseases Branch, Building 10, Room 9C-103, 10 Center Drive, MSC 1804, Bethesda, Maryland 20892-1804.
</TEXT>
</DOC>

<DOC>
<DOCNO>11061492_0.130</DOCNO>
<TEXT>
      Cardiovascular Disease in Primary Hyperparathyroidism          Shonni J. Silverberg;  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061492_133.99</DOCNO>
<TEXT>
    Department of Medicine  College of Physicians and Surgeons  New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061492_235.219</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Shonni J. Silverberg, M.D., Department of Medicine, College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>11061494_0.197</DOCNO>
<TEXT>
      Metabolic Lessons from the Study of Young Adolescents with Polycystic Ovary Syndrome&#151;Is Insulin, Indeed, the Culprit?          Sharon E. Oberfield  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061494_200.100</DOCNO>
<TEXT>
    Department of Pediatric Endocrinology  Columbia University  New York, New York 10032   
</TEXT>
</DOC>


<DOC>
<DOCNO>11061494_303.259</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Sharon E. Oberfield, M.D., Professor of Pediatrics, Department of Pediatric Endocrinology, Columbia University, 630 West 168th Street, PH-5 East Room 522, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>11061513_0.271</DOCNO>
<TEXT>
      Natural History of a Proinsulin-Secreting Insulinoma: From Symptomatic Hypoglycemia to Clinical Diabetes          Elif Arioglu,   Nicole A. Gottlieb,   Christian A. Koch,   John L. Doppman,   Neil J. Grey and   Phillip Gorden  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061513_274.468</DOCNO>
<TEXT>
    Diabetes Branch, Division of Intramural Research, National  Institute of Diabetes and Digestive and Kidney Diseases (E.A., N.A.G.,  P.G.), National Institute of Child Health and Human Development  (C.A.K.), Diagnostic Radiology Department (J.L.D.), Clinical Center,  National Institutes of Health, Bethesda, Maryland 20892; and Medical  Director of Diabetes Life Care, School of Medicine, University of  Connecticut (N.J.G.), Hartford, Connecticut 06105  
</TEXT>
</DOC>


<DOC>
<DOCNO>11061513_745.458</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Phillip Gorden, M.D., National Institutes of Health, NIDDK Director, Building 10, Room 8S235, Bethesda, Maryland 20892.  E-mail: phillip_gorden{at}nih.govphillip_gorden@nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11095413_0.243</DOCNO>
<TEXT>
      Hormonal Determinants and Disorders of Peak Bone Mass in Children1          Leslie A. Soyka,   Wesley P. Fairfield and   Anne Klibanski  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095413_246.297</DOCNO>
<TEXT>
    Neuroendocrine Unit and the General Clinical Research Center  (W.P.F., A.K.), Massachusetts General Hospital and Harvard Medical  School, Boston, Massachusetts 02114; and Department of Pediatrics  (L.A.S.), University of Massachusetts Medical School, Worcester,  Massachusetts 01655  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095413_546.478</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Anne Klibanski, M.D., Neuroendocrine Unit, Bulfinch 457, Massachusetts General Hospital, Fruit Street, Boston, Massachusetts 02114.  E-mail:  aklibanski{at}partners.orgaklibanski@partners.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11095415_0.230</DOCNO>
<TEXT>
      Megacolon as the Presenting Feature in Pheochromocytoma          Ann T. Sweeney,   Alan O. Malabanan,   Michael A. Blake,   Antonio de las Morenas,   Riad Cachecho and   James C. Melby  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095415_233.240</DOCNO>
<TEXT>
    Departments of Medicine, Section of Endocrinology Diabetes and  Nutrition (A.T.S., A.O.M., J.C.M.), Radiology (M.A.B.), Pathology  (A.d.l.M.), and Surgery (R.C.), Boston University Medical Center,  Boston, Massachusetts 02118  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095415_476.515</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. James C. Melby, Endocrine Hypertension Unit, Department of Medicine and Physiology, Boston University School of Medicine, Evans Building, Room 232, Boston, Massachusetts 02118.  E-mail:  James.Melby{at}bmc.orgJames.Melby@bmc.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11095416_0.104</DOCNO>
<TEXT>
      The Prolonged Fast          F. J. Service and   Neena Natt  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095416_107.84</DOCNO>
<TEXT>
    Department of Endocrinology, Mayo Clinic, Rochester, Minnesota  55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095416_194.192</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: F. J. Service, Mayo Clinic, Department of Endocrinology-West 18, 200 First Street SW, Rochester, Minnesota 55905.
</TEXT>
</DOC>

<DOC>
<DOCNO>11095418_0.184</DOCNO>
<TEXT>
      The Diagnosis and Treatment of Childhood and Adolescent Growth Hormone Deficiency&#151;Consensus or Confusion?          S. Douglas Frasier  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095418_187.128</DOCNO>
<TEXT>
    Division of Pediatric Endocrinology  Mattel Children&#146;s Hospital at UCLA  Los Angeles, California 90095-1752   
</TEXT>
</DOC>


<DOC>
<DOCNO>11095418_318.275</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: S. Douglas Frasier, M.D., Emeritus Professor of Pediatrics, Division of Pediatric Endocrinology, Mattel Children&#146;s Hospital at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095-1752.
</TEXT>
</DOC>

<DOC>
<DOCNO>11095419_0.362</DOCNO>
<TEXT>
      Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society1          GH Research Society2  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095419_365.88</DOCNO>
<TEXT>
    Medical Department M, Aarhus Kommunehospital, DK-8000, Aarhus C,  Denmark  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095419_456.173</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: GRS Secretariat, Medical Department M, Aarhus Kommunehospital, DK-8000, Aarhus C, Denmark.
</TEXT>
</DOC>

<DOC>
<DOCNO>11095420_0.116</DOCNO>
<TEXT>
      New Ideas in Thyroxine-Binding Globulin Biology          Jacob Robbins  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095420_119.176</DOCNO>
<TEXT>
    Genetics and Biochemistry Branch  National Institute of Diabetes and Digestive and Kidney Diseases  National Institutes of Health  Bethesda, Maryland 20892-1587   
</TEXT>
</DOC>


<DOC>
<DOCNO>11095420_298.309</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Jacob Robbins, M.D., Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 6C 201A, Bethesda, Maryland 20892-1587.
</TEXT>
</DOC>

<DOC>
<DOCNO>11095422_0.158</DOCNO>
<TEXT>
      Leptin as a Therapeutic Agent&#151;Trials and Tribulations          Christos S. Mantzoros and   Jeffrey S. Flier  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095422_161.156</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism  Department of Internal Medicine  Beth Israel Deaconess Medical Center  Boston, Massachusetts 02215   
</TEXT>
</DOC>


<DOC>
<DOCNO>11095422_320.237</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Christos S. Mantzoros, M.D., D.Sc., Division of Endocrinology, RN 325, Beth Israel Deaconess Medical Center, 99 Brookline Avenue, Boston, Massachusetts 02215.
</TEXT>
</DOC>

<DOC>
<DOCNO>11095424_0.114</DOCNO>
<TEXT>
      Carney Complex&#151;Clarity and Complexity          Carl D. Malchoff  
</TEXT>
</DOC>


<DOC>
<DOCNO>11095424_117.117</DOCNO>
<TEXT>
    University of Connecticut Health Center  Surgical Research Center  Farmington, Connecticut 06030-1110   
</TEXT>
</DOC>


<DOC>
<DOCNO>11095424_237.228</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Carl D. Malchoff, M.D., University of Connecticut Health Center, Surgical Research Center, 263 Farmington Avenue, Farmington, Connecticut 06030-1110.
</TEXT>
</DOC>

<DOC>
<DOCNO>11134087_0.159</DOCNO>
<TEXT>
      Endocrinology of Parturition1          Gerson Weiss  
</TEXT>
</DOC>


<DOC>
<DOCNO>11134087_162.134</DOCNO>
<TEXT>
    New Jersey Medical School, Department of Obstetrics, Gynecology and  Women&#146;s Health, Newark, New Jersey 07103-2714  
</TEXT>
</DOC>


<DOC>
<DOCNO>11134087_299.488</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Gerson Weiss, M.D., New Jersey Medical School, Department of Obstetrics, Gynecology and Women&#146;s Health, 185 South Orange Avenue, Newark, New Jersey 07103-2714.  E-mail: weissge{at}umdnj.eduweissge@umdnj.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11134090_0.145</DOCNO>
<TEXT>
      Paying the Price for Cure&#151;Treating Cancer Survivors with Growth Hormone          Charles Sklar  
</TEXT>
</DOC>


<DOC>
<DOCNO>11134090_148.136</DOCNO>
<TEXT>
    Long-Term Follow-Up Program, Department of Pediatrics,   Memorial Sloan-Kettering Cancer Center, New York, New York 10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>11134090_287.248</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Charles Sklar, M.D., Director, Long-Term Follow-Up Program, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021.
</TEXT>
</DOC>

<DOC>
<DOCNO>11134164_0.185</DOCNO>
<TEXT>
      Isolated Familial Somatotropinomas: Does the Disease Map to 11q13 or to 2p16?          Constantine A. Stratakis and   Lawrence S. Kirschner  
</TEXT>
</DOC>


<DOC>
<DOCNO>11134164_188.213</DOCNO>
<TEXT>
    Unit on Genetics and Endocrinology (UGEN)  Developmental Endocrinology Branch  National Institute of Child Health and Human Development  National Institutes of Health  Bethesda, Maryland 20892-1862   
</TEXT>
</DOC>


<DOC>
<DOCNO>11134164_404.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11134167_0.180</DOCNO>
<TEXT>
      Author&#146;s Response: In Vivo Measurements of Renal 11&#223;-Hydroxysteroid Dehydrogenase Type 2 Activity          P. Ferrari  
</TEXT>
</DOC>


<DOC>
<DOCNO>11134167_183.101</DOCNO>
<TEXT>
    Division of Nephrology and Hypertension  University of Berne  3010 Berne, Switzerland   
</TEXT>
</DOC>


<DOC>
<DOCNO>11134167_287.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11157991_0.128</DOCNO>
<TEXT>
      In Memoriam: David H. P. Streeten          Arnold M. Moses and   Ruth S. Weinstock  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157991_131.97</DOCNO>
<TEXT>
    State University of New York Upstate Medical University  Syracuse, New York 13210   
</TEXT>
</DOC>


<DOC>
<DOCNO>11157991_231.226</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Ruth S. Weinstock, M.D., Ph.D., State University of New York Upstate Medical University, 750 East Adams Street (CWB 353), Syracuse, New York 13210.
</TEXT>
</DOC>

<DOC>
<DOCNO>11157992_0.185</DOCNO>
<TEXT>
      Adrenal Suppression Versus Clinical Glucocorticoid Deficiency in the Premature Infant: No Simple Answers          George P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157992_188.132</DOCNO>
<TEXT>
    Pediatric and Reproductive Endocrinology Branch, NICHD, National  Institutes of Health, Bethesda, Maryland 20892-1583  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157992_323.204</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: George Chrousos, M.D., National Institutes of Health, 10 Center Drive, Building 10, Room 9D42, Bethesda, Maryland 20892-1583.
</TEXT>
</DOC>

<DOC>
<DOCNO>11157996_0.92</DOCNO>
<TEXT>
      Parathyroid Carcinoma          Elizabeth Shane  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157996_95.120</DOCNO>
<TEXT>
    Department of Medicine, Columbia University College of Physicians  and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157996_218.231</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Elizabeth Shane, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032
</TEXT>
</DOC>

<DOC>
<DOCNO>11157997_0.230</DOCNO>
<TEXT>
      Pathophysiology of X-Linked Hypophosphatemia, Tumor-Induced Osteomalacia, and Autosomal Dominant Hypophosphatemia: A PerPHEXing Problem          L. Darryl Quarles and   Marc K. Drezner  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157997_233.208</DOCNO>
<TEXT>
    Departments of Medicine and Pathology  Duke University Medical Center  Durham, North Carolina  and   Department of Medicine  University of Wisconsin&#150;Madison  Madison, Wisconsin 53792-5148   
</TEXT>
</DOC>


<DOC>
<DOCNO>11157997_444.534</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Marc K. Drezner, M.D., Section of Endocrinology, Diabetes and Metabolism, University of Wisconsin Medical School, H4/554 Clinical Science Center, 600 Highland Avenue, Madison, Wisconsin 53792-5148.  E-mail:  mkd{at}medicine.wisc.edumkd@medicine.wisc.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11157998_0.478</DOCNO>
<TEXT>
      The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate Wasting          Kenneth E. White,   Kenneth B. Jonsson,   Gwenaelle Carn,   Geeta Hampson,   Tim D. Spector,   Michael Mannstadt,   Bettina Lorenz-Depiereux,   Akimitsu Miyauchi,   In Myung Yang,   &Ouml;sten Ljunggren,   Thomas Meitinger,   Tim M. Strom,   Harald J&uuml;ppner and   Michael J. Econs  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157998_481.1005</DOCNO>
<TEXT>
    Departments of Medicine (K.E.W., G.C., M.J.E.) and Medical and  Molecular Genetics (M.J.E.), Indiana University School of Medicine,  Indianapolis, Indiana 46202; Endocrine Unit, Department of Medicine  (K.B.J., M.M., H.J.), and MassGeneral Hospital for Children (H.J.),  Massachusetts General Hospital and Harvard Medical School, Boston,  Massachusetts 02114; Department of Chemical Pathology (G.H.) and Twin  Research Unit (T.D.S.), St. Thomas&#146; Hospital, London, SE1 7EH, United  Kingdom; Abteilung Medizinische Genetik, Klinikum Innenstadt (B.L.-D.,  T.M., T.M.S.), Ludwig-Maximilians-Universit&auml;t, 80336  M&uuml;nchen, Germany; Department of Medicine, Kobe University School  of Medicine, Kusunoki-cho, Chuo-ku, Kobe 650, and National Sanatorium  Hyogo Chuo Hospital 1314 Ohara, Sanda 669-1515, Japan (A.M.);  Department of Internal Medicine (I.M.Y.), Kuyunghee University, Seoul,  Korea; and Department of Medical Sciences (O.L.), University of  Uppsala, Uppsala 751 85, Sweden  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157998_1489.1738</DOCNO>
<TEXT>
          The gene mutated in autosomal dominant hypophosphatemic rickets (ADHR),  a phosphate wasting disorder, has been identified as FGF-23, a protein  that shares sequence homology with fibroblast growth factors (FGFs).  Patients with ADHR display many of the clinical and laboratory  characteristics that are observed in patients with oncogenic  hypophosphatemic osteomalacia (OHO), a disorder thought to arise by the  secretion of a phosphate wasting factor from different mesenchymal  tumors. In the present studies, we therefore investigated whether  FGF-23 is a secreted factor and whether it is abundantly expressed in  OHO tumors. After transient transfection of OK-E, COS-7, and HEK293  cells with the plasmid encoding full-length FGF-23, all three cell  lines efficiently secreted two protein species into the medium that  were approximately 32 and 12 kDa upon SDS-PAGE and subsequent Western  blot analysis using an affinity-purified polyclonal antibody to FGF-23.  Furthermore, Northern blot analysis using total RNA from five different  OHO tumors revealed extremely high levels of FGF-23 mRNA, and Western  blot analysis of extracts from a sixth tumor detected the 32 kDa FGF-23  protein species. In summary, FGF-23, the gene mutated in ADHR, is a  secreted protein and its mRNA is abundantly expressed by several  different OHO tumors. Our findings indicate that FGF-23 may be a  candidate phosphate wasting factor, previously designated  "phosphatonin". 
</TEXT>
</DOC>

<DOC>
<DOCNO>11157999_0.161</DOCNO>
<TEXT>
      Pathogenesis of Graves&#146; Ophthalmopathy&#151;Current Understanding          W. M. Wiersinga and   M. F. Prummel  
</TEXT>
</DOC>


<DOC>
<DOCNO>11157999_164.129</DOCNO>
<TEXT>
    Department of Endocrinology  Academic Medical Center  University of Amsterdam  Amsterdam 1105 AZ, The Netherlands   
</TEXT>
</DOC>


<DOC>
<DOCNO>11157999_296.260</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Wilmar M. Wiersinga, M.D., Department of Endocrinology, Academic Medical Center, University of Amsterdam, F5-171, Meibergdreef 9, P.O. Box 22700, Amsterdam 1105 AZ, The Netherlands.
</TEXT>
</DOC>

<DOC>
<DOCNO>11158035_0.222</DOCNO>
<TEXT>
      Insulin Resistance and Cardiovascular Disease1          Samy I. McFarlane,   Maryann Banerji and   James R. Sowers  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158035_225.181</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes, and Hypertension, State  University of New York Downstate and Brooklyn Veterans Affairs Medical  Center, Brooklyn, New York 11203  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158035_409.551</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: James R. Sowers, M.D., F.A.C.P., Division of Endocrinology, Diabetes, and Hypertension, State University of New York Health Science Center, 450 Clarkson, Box 1205, Brooklyn, New York 11203.  E-mail:  jsowers{at}netmail.hscbklyn.edujsowers@netmail.hscbklyn.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11158065_0.383</DOCNO>
<TEXT>
      Expression and Tissue Localization of Soluble Guanylyl Cyclase in the Human Placenta Using Novel Antibodies Directed against the 2 Subunit          Ana-Maria Bamberger,   Markus Koglin,   J&ouml;rg Kempfert,   Thomas L&ouml;ning,   Hasso Scholz and   S&ouml;nke Behrends  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158065_386.158</DOCNO>
<TEXT>
    Departments of Gynecopathology (A.-M.B., T.L.) and Pharmacology  (M.K., J.K., H.S., S.B.), University clinic Eppendorf, 20246 Hamburg,  Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158065_547.2048</DOCNO>
<TEXT>
          The cytoplasmic or soluble forms of guanylyl cyclase (sGC) are  heme-containing heterodimeric enzymes that are regulated by nitric  oxide (NO) and carbon monoxide (CO). These gaseous messenger molecules  are produced in the human placenta and are potential regulators of  vasodilation and trophoblast invasion. The 2-subunit of  sGC has only recently been shown to naturally occur in placental  extracts. In the present study, two novel antibodies directed against  different epitopes of the 2 subunit, were generated.  Western Blot analysis confirmed the presence of a 82 kDa protein,  identical with 2 protein overexpressed in Sf9 cells.  According to RNase protection analysis the alternatively spliced  2i variant was absent from human placenta.  Immunohistochemical analysis showed the presence of 2  protein in syncytiotrophoblast and villous and umbilical blood vessels,  which are known sites of NO production. Strong expression was observed  in the extravillous (intermediate) trophoblast, where the expression of  CO-generating hemeoxygenases has recently been documented. Localization  of 2 subunit expression suggests a role for sGC in  mediating the actions of both NO and CO. The novel antibodies  characterized in the present study will be powerful tools to further  elucidate the role of the NO/CO/cGMP signaling pathways in pathologic  states such as preeclampsia and intrauterine growth retardation. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11158071_0.331</DOCNO>
<TEXT>
      Increased PAI-1 and tPA Antigen Levels Are Reduced with Metformin Therapy in HIV-Infected Patients with Fat Redistribution and Insulin Resistance          C. Hadigan,   J. B. Meigs,   J. Rabe,   R. B. D&#146;Agostino,   P. W. F. Wilson,   I. Lipinska,   G. H. Tofler and   S. Grinspoon  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158071_334.281</DOCNO>
<TEXT>
    Neuroendocrine Unit (C.H., J.R., S.G.), General Medicine Division  (J.B.M), Massachusetts General Hospital, The Framingham Heart Study  (R.B.D., P.W.F.W., G.H.T.), Beth-Israel Deaconess Medical Center (I.L.,  G.H.T.), and Harvard Medical School, Boston Massachusetts  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158071_618.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11158072_0.244</DOCNO>
<TEXT>
      CCN Proteins Are Distinct from, and Should Not Be Considered Members of, the Insulin-Like Growth Factor-Binding Protein Superfamily          Gary R. Grotendorst,   Lester F. Lau and   Bernard Perbal  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158072_247.449</DOCNO>
<TEXT>
    Department of Cell Biology and Anatomy (G.R.G.), University of Miami  School of Medicine, Miami, Florida 33136; Department of Molecular  Genetics (L.F.L.), University of Illinois College of Medicine, Chicago,  Illinois 60607; and Laboratoire d&#146;Oncologie Virale et  Mol&eacute;culaire (B.P.), UFR de Biochimie, Universit&eacute; Paris 7,  75005 Paris and Unit&eacute; INSERM 515, H&ocirc;pital Saint-Antoine,  Paris 75012, France   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158072_699.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158073_0.146</DOCNO>
<TEXT>
      Leptin Actions on the Reproductive Axis          Paolo Magni,   Luciano Martini and   Marcella Motta  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158073_149.83</DOCNO>
<TEXT>
    Institute of Endocrinology  University of Milan  20133 Milan, Italy   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158073_235.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158074_0.178</DOCNO>
<TEXT>
      Nomenclature of the Insulin-Like Growth Factor-Binding Protein Superfamily          Ron G. Rosenfeld,   Vivian Hwa and   Youngman Oh  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158074_181.99</DOCNO>
<TEXT>
    Department of Pediatrics  Oregon Health Sciences University  Portland, Oregon 97201   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158074_283.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158075_0.193</DOCNO>
<TEXT>
      Paraneoplastic Hypercortisolism as a Risk Factor for Severe Infections in Patients with Malignant Diseases          Rena Vassilopoulou-Sellin, M.D.  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158075_196.91</DOCNO>
<TEXT>
    University of Texas, M.D. Anderson Cancer Center  Houston, Texas 77030-4095   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158075_290.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158076_0.124</DOCNO>
<TEXT>
      Hashimoto&#146;s Encephalitis          Gopinath S. Sunil and   Cary N. Mariash  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158076_127.125</DOCNO>
<TEXT>
    Division of Endocrinology and Diabetes  Medical School  University of Minnesota  Minneapolis, Minnesota 55455   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158076_255.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158081_0.199</DOCNO>
<TEXT>
      CCN Proteins Are Distinct from, and Should Not Be Considered Members of, the Insulin-Like Growth Factor-Binding Protein Superfamily          Thomas Remer  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158081_202.78</DOCNO>
<TEXT>
    Research Institute of Child Nutrition  44225 Dortmund, Germany   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158081_283.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158083_0.197</DOCNO>
<TEXT>
      Metabolic Abnormalities in Patients with Adrenal Incidentaloma          Jos&eacute;-Manuel Fern&aacute;ndez-Real,   Jose Gonzalbez and   Wifredo Ricart  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158083_200.142</DOCNO>
<TEXT>
    Unitat de Diabetologia, Endocrinologia i Nutrici&oacute;  University Hospital of Girona "Dr Josep Trueta"  17007 Girona, Spain   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158083_345.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11158084_0.188</DOCNO>
<TEXT>
      Authors&#146; Response: Metabolic Abnormalities in Patients with Adrenal Incidentaloma          Riccardo Rosse and   Libuse Tauchmanov&agrave;  
</TEXT>
</DOC>


<DOC>
<DOCNO>11158084_191.136</DOCNO>
<TEXT>
    Department of Molecular and Clinical Endocrinology and Oncology  University "Federico II" in Naples  Naples 80131, Italy   
</TEXT>
</DOC>


<DOC>
<DOCNO>11158084_330.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11231968_0.107</DOCNO>
<TEXT>
      Amiodarone-Induced Thyrotoxicosis          Gilbert H. Daniels  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231968_110.116</DOCNO>
<TEXT>
    Thyroid Unit and Department of Medicine, Massachusetts General  Hospital, Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231968_229.443</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Gilbert H. Daniels M.D., Thyroid Unit ACC 730, Massachusetts General Hospital, Boston, Massachusetts 02114.  E-mail: Gdaniels{at}Partners.orgGdaniels@Partners.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11231971_0.236</DOCNO>
<TEXT>
      Risk of Breast Cancer with Progestins in Combination with Estrogen as Hormone Replacement Therapy          Richard J. Santen,   JoAnn Pinkerton,   Christopher McCartney and   Gina R. Petroni  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231971_239.170</DOCNO>
<TEXT>
    University of Virginia Health System, Departments of Medicine,  Obstetrics and Gynecology, and Health Evaluation Sciences,  Charlottesville, Virginia 22908  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231971_412.218</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Richard Stanten, Division of Endocrinology, University of Virginia Health System, P.O. Box 800379, Charlottesville, Virginia 22908.
</TEXT>
</DOC>

<DOC>
<DOCNO>11231972_0.164</DOCNO>
<TEXT>
      The Genetics of Paget&#146;s Disease of the Bone          Robin J. Leach,   Frederick R. Singer and   G. David Roodman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231972_167.429</DOCNO>
<TEXT>
    Departments of Cellular and Structural Biology (R.J.L.), Pediatrics  (R.J.L.), and Medicine (G.D.R.), The University of Texas Health Science  Center at San Antonio, San Antonio, Texas 78229-3900; Department of  Medicine (G.D.R.), The Veterans Administration Hospital, San Antonio,  Texas 78284; and John Wayne Cancer Institute at St. John&#146;s Hospital  and Health Center (F.R.S.), Santa Monica, California 90404  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231972_599.512</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: G. D. Roodman, M.D., Ph.D., Department of Medicine/Hematology (7880), University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229-3900.  E-mail:  roodman{at}uthscsa.eduroodman@uthscsa.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11231973_0.161</DOCNO>
<TEXT>
      Why Do Older Women with Diabetes Have an Increased Fracture Risk?          Dorothy A. Nelson and   Scott J. Jacober  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231973_164.82</DOCNO>
<TEXT>
    Wayne State University School of Medicine  Detroit, Michigan 48201   
</TEXT>
</DOC>


<DOC>
<DOCNO>11231973_249.503</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dorothy A. Nelson, Ph.D., Department of Internal Medicine, Wayne State University, Hutzel Hospital, 1 Lobby Center, 4707 St. Antoine, Detroit, Michigan 48201.  E-mail: dnelson{at}intmed.wayne.edudnelson@intmed.wayne.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11231975_0.158</DOCNO>
<TEXT>
      Soy Phytoestrogens, Lipid Reductions, and Atherosclerosis Delay in Ovariectomized Primates          B. Anderson;  
</TEXT>
</DOC>


<DOC>
<DOCNO>11231975_161.251</DOCNO>
<TEXT>
    Department of Nutrition  Schools of Public Health and Medicine  University of North Carolina  Chapel Hill, North Carolina 27599-7400  and  Sanford C. Garner  Department of Surgery  Duke University Medical Center  Durham, North Carolina   
</TEXT>
</DOC>


<DOC>
<DOCNO>11231975_415.488</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: John Anderson, Ph.D., Department of Nutrition, Schools of Public Health and Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7400.  E-mail: jjb_anderson{at}unc.edujjb_anderson@unc.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11232030_0.179</DOCNO>
<TEXT>
      Ectopic Lingual Thyroid Masquerading as Thyroid Cancer Metastases          Shehzad Basaria,   William H. Westra and   David S. Cooper  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232030_182.238</DOCNO>
<TEXT>
    Department of Medicine, Division of Endocrinology (S.B., D.S.C.),  and Department of Pathology (W.H.W.), The Johns Hopkins University  School of Medicine, and Sinai Hospital of Baltimore (D.S.C.),  Baltimore, Maryland 21215  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232030_423.531</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: David S. Cooper, M.D., Director, Division of Endocrinology, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215.  E-mail: dcooper{at}lifebridgehealth.orgdcooper@lifebridgehealth.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11232036_0.283</DOCNO>
<TEXT>
      Human Melatonin Regulation Is Not Mediated by the Three Cone Photopic Visual System          George C. Brainard,   John P. Hanifin,   Mark D. Rollag,   Jeffrey Greeson,   Brenda Byrne,   Gena Glickman,   Edward Gerner and   Britt Sanford  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232036_286.207</DOCNO>
<TEXT>
    Departments of Neurology, Thomas Jefferson University,  Philadelphia, Pennsylvania 19107; and Department of Anatomy, Uniformed  Services University of Health Sciences, Bethesda, Maryland 20814  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232036_496.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11232037_0.234</DOCNO>
<TEXT>
      The Effect of Recombinant Human TSH on the Thyroid 123I Uptake in Iodide Treated Normal Subjects          J. E. Lawrence,   C. H. Emerson,   S. L. Sullaway and   L. E. Braverman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232037_237.308</DOCNO>
<TEXT>
    Brigham and Women&#146;s Hospital and Harvard Medical School (J.E.L.,  S.L.S.), Boston, Massachusetts; The University of Massachusetts Medical  School (C.H.E.), Worcester, Massachusetts; and Boston Medical Center  and Boston University School of Medicine (L.E.B.), Boston,  Massachusetts 02118  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232037_548.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11232038_0.290</DOCNO>
<TEXT>
      Hydrocortisone Suspension and Hydrocortisone Tablets Are Not Bioequivalent in the Treatment of Children with Congenital Adrenal Hyperplasia          Deborah P. Merke,   David Cho,   Karim Anton Calis,   Margaret F. Keil and   George P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232038_293.261</DOCNO>
<TEXT>
    Warren Grant Magnuson Clinical Center (D.P.M., D.C., K.A.C.),  Pediatric and Reproductive Endocrinology Branch, National Institute of  Child Health and Human Development (D.P.M., M.F.K., G.P.C.), National  Institutes of Health, Bethesda, Maryland  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232038_557.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11232039_0.317</DOCNO>
<TEXT>
      Evidence for Association of Polycystic Ovary Syndrome in Caucasian Women with a Marker at the Insulin Receptor Gene Locus          Stefania Tucci,   Walter Futterweit,   Erlinda S. Concepcion,   David A. Greenberg,   Ronald Villanueva,   Terry F. Davies and   Yaron Tomer  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232039_320.213</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Medicine  (S.T., W.F., E.S.C., R.V., T.F.D., Y.T.), and Department of Psychiatry  (D.A.G.), Mount Sinai School of Medicine, New York, New York  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232039_536.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11232040_0.251</DOCNO>
<TEXT>
      Insulin Inhibits NFB and MCP-1 Expression in Human Aortic Endothelial Cells          Ahmad Aljada,   Husam Ghanim,   Rana Saadeh and   Paresh Dandona  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232040_254.152</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism, State  University of New York at Buffalo and Kaleida Health, Buffalo, New York  14209  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232040_409.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11232041_0.358</DOCNO>
<TEXT>
      Decreased Expression of Wnt7a mRNA Is Inversely Associated with the Expression of Estrogen Receptor- in Human Uterine Leiomyoma          Shuanfang Li,   Tung-Chin Chiang,   Gloria R. Davis,   Rachele M. Williams,   Valerie P. Wilson and   John A. McLachlan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232041_361.278</DOCNO>
<TEXT>
    Center for Bioenvironmental Research and Departments of  Pharmacology (S.L., T.-C.C., R.M.W., V.P.W., J.A.M.), Tulane/Xavier  Universities, and Department of Obstetrics and Gynecology (G.R.D.),  Tulane University Medical Center, New Orleans, Louisiana  70112-2699  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232041_642.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11232042_0.205</DOCNO>
<TEXT>
      Final Adult Height in Short Healthy Children Treated with Growth Hormone and Gonadotropin-Releasing Hormone Analogs          Roberto Lanes and   Peter Gunczler  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232042_208.106</DOCNO>
<TEXT>
    Unidad de Endocrinologia Pediatrica  Hospital de Clinicas Caracas  Caracas 1010A, Venezuela  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232042_317.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11232045_0.137</DOCNO>
<TEXT>
      Growth Signals and Puberty          Kelly J. Suter,   Clifford R. Pohl and   Mark E. Wilson  
</TEXT>
</DOC>


<DOC>
<DOCNO>11232045_140.94</DOCNO>
<TEXT>
    Yerkes Primate Research Center  Emory University  Lawrenceville, Georgia 30043   
</TEXT>
</DOC>


<DOC>
<DOCNO>11232045_237.48</DOCNO>
<TEXT>
          
</TEXT>
</DOC>

<DOC>
<DOCNO>11238470_0.117</DOCNO>
<TEXT>
      Diabetic Dyslipidemia: Causes and Consequences          Ira J. Goldberg  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238470_120.143</DOCNO>
<TEXT>
    Division of Preventive Medicine and Nutrition, Columbia University  College of Physicians and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238470_266.500</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Ira J. Goldberg, Division of Preventive Medicine and Nutrition, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.  E-mail: ijg3{at}columbia.eduijg3@columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11238472_0.128</DOCNO>
<TEXT>
      Is Fat Intake a Risk Factor for Fat Gain in Children?          Eric J&eacute;quier  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238472_131.91</DOCNO>
<TEXT>
    Institute of Physiology, University of Lausanne, 1005 Lausanne,  Switzerland  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238472_225.223</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Eric J&eacute;quier, Institut de Physiologie, University of Lausanne, Case postale, CH-1000, Rue du Bugnon 7, CH-1005 Lausanne, Switzerland.
</TEXT>
</DOC>

<DOC>
<DOCNO>11238474_0.192</DOCNO>
<TEXT>
      Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes          Thomas A. Buchanan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238474_195.99</DOCNO>
<TEXT>
    University of Southern California School of Medicine, Los Angeles,  California 90089  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238474_297.491</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Thomas A. Buchanan, M.D., University of Southern California School of Medicine, 6602 General Hospital, 1200 North State Street, Los Angeles, California 90089.  E-mail: buchanan{at}hsc.usc.edubuchanan@hsc.usc.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11238475_0.171</DOCNO>
<TEXT>
      Editorial: Evaluation and Treatment of Sporadic Nontoxic Goiter&#151;Some Answers and More Questions          Mary H. Samuels  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238475_174.133</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Clinical Nutrition  Oregon Health Sciences University  Portland, Oregon 97201   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238475_310.220</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Mary H. Samuels, M.D., Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health Sciences University, Portland, Oregon 97201.
</TEXT>
</DOC>

<DOC>
<DOCNO>11238477_0.112</DOCNO>
<TEXT>
      Editorial: The Role of Androgens in Women          Peter J. Snyder  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238477_115.133</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism  University of Pennsylvania  Philadelphia, Pennsylvania 19104-6149   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238477_251.218</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Peter J. Snyder, Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6149.
</TEXT>
</DOC>

<DOC>
<DOCNO>11238541_0.247</DOCNO>
<TEXT>
      Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity          Eva Rask,   Tommy Olsson,   Stefan Soderberg,   Ruth Andrew,   Dawn E. W. Livingstone,   Owe Johnson and   Brian R. Walker  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238541_250.400</DOCNO>
<TEXT>
    Departments of Public Health and Clinical Medicine (E.R., T.O.,  SS., O.J.), Ume University Hospital,  Ume, Sweden; and  Department of Medical Sciences (R.A., D.E.W.L., B.R.W.), University of  Edinburgh, Western General Hospital, Edinburgh, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238541_653.217</DOCNO>
<TEXT>
     Address correspondence to: Brian R. Walker, M.D., Department of Medical Sciences, Endocrinology Unit, The University of Edinburgh, Western General Hospital, EH4 2XU Edinburgh, United Kingdom.
</TEXT>
</DOC>

<DOC>
<DOCNO>11238542_0.281</DOCNO>
<TEXT>
      Raloxifene Affects Brain Activation Patterns in Postmenopausal Women during Visual Encoding          Simone J. M. Neele,   Serge A. R. B. Rombouts,   Marije A. Bierlaagh,   Frederik Barkhof,   Phillip Scheltens and   J. Coen Netelenbos  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238542_284.234</DOCNO>
<TEXT>
    Departments of Endocrinology (S.J.M.N., J.C.N.), Clinical Physics  and Informatics (S.A.R.B.R., M.A.B.), Radiology (F.B.), and Neurology  (P.S.), Academic Hospital Vrije Universiteit, 1007 MB Amsterdam, The  Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238542_521.192</DOCNO>
<TEXT>
     Address correspondence to: S. J. M. Neele, M.D., Department of Endocrinology, Academic Hospital Vrije Universiteit, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.
</TEXT>
</DOC>

<DOC>
<DOCNO>11238543_0.105</DOCNO>
<TEXT>
      Allopregnanolone Assays          Beverley E. Pearson Murphy  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238543_108.67</DOCNO>
<TEXT>
    Montreal General Hospital  Montreal, Canada H3G 1A4   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238543_178.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11238546_0.239</DOCNO>
<TEXT>
      Defective 11&#223;-HSD Reductase Activity in a Patient with Congenital Adrenal Hyperplasia          Anna Nordenstrom,   Claude Marcus,   Magnus Axelson,   Anna Wedell and   Martin Ritz&eacute;n  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238546_242.301</DOCNO>
<TEXT>
    Department of Pediatrics (A.N., C.M.), Huddinge University  Hospital, Karolinska Institutet, S-141 86 Stockholm; and Departments of  Clinical Chemistry (M.A.), Molecular Medicine (A.W.), and Woman and  Child (M.R.) Karolinska Hospital, Karolinska Institutet S-171 76  Stockholm, Sweden   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238546_546.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11238549_0.255</DOCNO>
<TEXT>
      Chernobyl Thyroid Tumor Bank          G. A. Thomas,   E. D. Williams and   on behalf of the members of the Scientific Project Panel of the  NISCTB1  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238549_258.107</DOCNO>
<TEXT>
    University of Cambridge  Strangeways Research Laboratory  CB4 8RN Cambridge, United Kingdom   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238549_368.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11238550_0.442</DOCNO>
<TEXT>
      Different Significance of ret/PTC1 and ret/PTC3 Rearrangements in Thyroid Carcinogenesis: Lesson from Two Subgroups of Patients with Papillary Thyroid Carcinomas Showing the Highest Incidence of ret/PTC Activation1          Francesco Cetta,   Monica Gori,   Giulia Montalto,   Michele Zuckermann and   Paolo Toti  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238550_445.134</DOCNO>
<TEXT>
    Institutes of Surgical Clinics (F.C., M.G., G.M., M.Z.) and  Pathology (P.T.)  University of Siena  53100 Siena, Italy   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238550_582.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11238551_0.114</DOCNO>
<TEXT>
      Metformin and the Polycystic Ovary Syndrome          John E. Nestler  
</TEXT>
</DOC>


<DOC>
<DOCNO>11238551_117.116</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism  Medical College of Virginia  Richmond, Virginia 23298-0111   
</TEXT>
</DOC>


<DOC>
<DOCNO>11238551_236.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297566_0.209</DOCNO>
<TEXT>
      Obesity as a Neuroendocrine Disease: Lessons to Be Learned from Proopiomelanocortin and Melanocortin Receptor Mutations in Mice and Men*          Sharon L. Wardlaw  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297566_212.120</DOCNO>
<TEXT>
    Department of Medicine, Columbia University College of Physicians  and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297566_335.501</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Dr. Sharon L. Wardlaw, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.  E-mail: sw22{at}columbia.edusw22@columbia.edu.'//--> * Supported by NIH Grants
</TEXT>
</DOC>

<DOC>
<DOCNO>11297567_0.180</DOCNO>
<TEXT>
      Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer          Ernest L. Mazzaferri and   Richard T. Kloos  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297567_183.217</DOCNO>
<TEXT>
    The Center for Health Outcome Policy and Evaluation  Studies (E.L.M.) and Divisions of Endocrinology, Diabetes and  Metabolism and Nuclear Medicine, The Ohio State University,  Columbus, Ohio 43210-1228  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297567_403.419</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Ernest L. Mazzaferri, M.D., MACP, 4020 SW 93rd Drive, Gainesville, Florida 32608-4653.  E-mail: mazz01{at}bellsouth.netmazz01@bellsouth.net.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11297568_0.136</DOCNO>
<TEXT>
      Unnatural Growth Hormone-Releasing Peptide Begets Natural Ghrelin          Cyril Y. Bowers  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297568_139.106</DOCNO>
<TEXT>
    Endocrine Section, Tulane University School of Medicine, New  Orleans, Louisiana 70112-2699  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297568_248.219</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Cyril Y. Bowers, M.D., Endocrine Section, Tulane University School of Medicine, 1430 Tulane Avenue, SL53, New Orleans, Louisiana 70112-2699.
</TEXT>
</DOC>

<DOC>
<DOCNO>11297570_0.132</DOCNO>
<TEXT>
      Evolving Surgical Management for Patients with Pheochromocytoma          Quan-Yang Duh  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297570_135.166</DOCNO>
<TEXT>
    Department of Surgery  University of California&#150;San Francisco  Surgical Service, Veterans Affairs Medical Center  San Francisco, California 94121   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297570_304.251</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Quan-Yang Duh, M.D., Department of Surgery, University of California&#151;San Francisco, Surgical Service, Veterans Affairs Medical Center, San Francisco, California 94121.
</TEXT>
</DOC>

<DOC>
<DOCNO>11297572_0.166</DOCNO>
<TEXT>
      Of Mice and Men, Recapitulation of Blomstrand&#146;s Chondrodysplasia          T. John Martin and   Matthew T. Gillespie  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297572_169.99</DOCNO>
<TEXT>
    St. Vincent&#146;s Institute of Medical Research  Fitzroy 3065, Victoria, Australia   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297572_271.494</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: T. John Martin, M.D., St. Vincent&#146;s Institute of Medical Research, 9 Princes Street, Fitzroy 3065, Victoria, Australia.  E-mail:  j.martin{at}medicine.unimelb.edu.auj.martin@medicine.unimelb.edu.au.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11297615_0.282</DOCNO>
<TEXT>
      Regulated Expression of Prostaglandin E2 Receptors EP2 and EP4 in Human Ovarian Granulosa-Luteal Cells          Kirsi Narko,   Kirsi Saukkonen,   Ilkka Ketola,   Ralf B&uuml;tzow,   Markku Heikinheimo and   Ari Ristim&auml;ki  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297615_285.335</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology (K.N., K.S., R.B., A.R.),  Department of Pathology (R.B., A.R.), and Children&#146;s Hospital (I.K.,  M.H.), Helsinki University Central Hospital and Haartman Institute,  University of Helsinki, Finland; Department of Pediatrics (M.H.),  Washington University, St. Louis, Missouri  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297615_623.1622</DOCNO>
<TEXT>
          Prostaglandins (PGs) have been implicated in regulation of ovarian  function. We have previously shown that the expression of  cyclooxygenase-2 and the receptor for PGF2 are  expressed in periovulatory human granulosa cells and upregulated by  gonadotropins and cytokines in cultured human ovarian granulosa-luteal  (GL) cells. We now show that transcripts for PGE2 receptor  subtypes EP2 and EP4 are expressed in freshly isolated human granulosa  cells and in mouse ovaries as detected by Northern blot analysis.  However, EP2 and EP4 receptor mRNA levels were low or nondetectable in  cultured human GL cells suggesting that these transcripts may be under  hormonal and/or cytokine regulation in the ovaries in vivo.  Indeed, the proinflammatory cytokine interleukin-1&#223; (IL-1&#223;)  stimulated expression of EP2 and EP4 transcripts in concentration- and  time-dependent manner in the GL cells. Furthermore, the transcript for  EP2 receptor was localized in the corpus luteum of the mouse ovary by  in situ hybridization, and EP2 protein was expressed in  human corpus luteum as detected by immunohistochemistry. Our data  suggest that IL-1&#223; induces expression of EP2 and EP4 receptors in  human GL cells, and that EP2 receptor is expressed in both human and  murine luteal glands. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11297627_0.132</DOCNO>
<TEXT>
      Aromatase Inhibitors in Pubertal Boys: Clinical Implications          Vincenzo Rochira  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297627_135.108</DOCNO>
<TEXT>
    Department of Internal Medicine  University of Modena and Reggio Emilia  41100 Modena, Italy   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297627_246.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297628_0.156</DOCNO>
<TEXT>
      Author&#146;s Response: Aromatase Inhibitors in Pubertal Boys&#151;Clinical Implications          Nelly Mauras  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297628_159.103</DOCNO>
<TEXT>
    Division of Endocrinology  Nemours Children&#146;s Clinic  Jacksonville, Florida 32207    
</TEXT>
</DOC>


<DOC>
<DOCNO>11297628_265.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297633_0.275</DOCNO>
<TEXT>
      Optimal Range of Plasma Concentration of True 1&#150;84 Parathyroid Hormone in Patients on Maintenance Dialysis          A. Fournier,   M. E. Cohen Solal,   R. Oprisiu,   H. Mazouz,   P. Morinire,   G. Choukroun and   R. Bouillon  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297633_278.151</DOCNO>
<TEXT>
    Nephrologie&#151;CHU (A.F., M.E.C.S., R.O., H.M., P.M., G.C.), Amiens,  France; and LEGENDO University Hospital (R.B.)  Leuven, Belgium   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297633_432.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297634_0.281</DOCNO>
<TEXT>
      Parathyroid Hormone-Immunoradiometric Assays as Noninvasive Predictors of Renal Osteodystrophy: The Need for Bone Histomorphometric Validation          William G. Goodman,   Markus R. John,   Harald J&uuml;ppner and   Isidro B. Salusky  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297634_284.288</DOCNO>
<TEXT>
    Departments of Pediatrics and Medicine (W.G.G., I.B.S.), University of  California at Los Angeles School of Medicine, Los Angeles, California  90095; and Endocrine Unit, Massachusetts General Hospital and Harvard  Medical School (M.R.J., H.J.), Boston, Massachusetts 02114   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297634_575.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297635_0.131</DOCNO>
<TEXT>
      What Are "Normal" Testosterone Levels for Women?          Susan Davis and   Jane Tran  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297635_134.77</DOCNO>
<TEXT>
    The Jean Hailes Foundation  Clayton, Victoria 3168, Australia   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297635_214.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297636_0.127</DOCNO>
<TEXT>
      Postmenopausal Testosterone          Gail Laughlin and   Elizabeth Barrett-Connor  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297636_130.134</DOCNO>
<TEXT>
    Department of Family and Preventive Medicine  University of California&#150;San Diego  La Jolla, California 92093-0607   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297636_267.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297638_0.114</DOCNO>
<TEXT>
      Long-Term Consequences of Castration in Men          John S. Jenkins  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297638_117.127</DOCNO>
<TEXT>
    Emeritus Professor of Endocrinology  St. George&#146;s Hospital Medical School  SW17 ORE London, United Kingdom   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297638_247.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297639_0.356</DOCNO>
<TEXT>
      Homocysteine, Folate, Vitamin B12, and Transcobalamins in Patients Undergoing Successive Hypo- and Hyperthyroid States          Fran&ccedil;oise Barb&eacute;,   Marc Klein,   Abalo Chango,   Sophie Fr&eacute;mont,   Philippe G&eacute;rard,   Georges Weryha,   Jean-Louis Gu&eacute;ant and   Jean-Pierre Nicolas  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297639_359.313</DOCNO>
<TEXT>
    Departments of Biochemistry A, INSERM XR308 (F.B., A.C., S.F., P.G.,  J.-P.N.) and INSERM 0014 (P.G., J.-L.G.). and Department of  Endocrinology (M.K., G.W.), Centre Hospitalier Universitaire de Nancy,  H&ocirc;pital de Brabois&#150;H&ocirc;pital d&#146;Adultes  54511 Vandoeuvre-les-Nancy, France   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297639_675.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11297640_0.245</DOCNO>
<TEXT>
      Total Plasma Homocysteine in Hypo- and Hyperthyroidism: Covariations and Causality          Ernst A. Lien,   Steinar Hustad,   Bj&oslash;rn G. Nedreb&oslash;,   Ottar Nyg&aring;rd and   Per M. Ueland  
</TEXT>
</DOC>


<DOC>
<DOCNO>11297640_248.125</DOCNO>
<TEXT>
    LOCUS for Homocysteine and Related Vitamins  Armauer Hansens hus  University of Bergen  N-5021 Bergen, Norway   
</TEXT>
</DOC>


<DOC>
<DOCNO>11297640_376.514</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Eldon D. Lehmann, Department of Imaging (MR Unit), National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Sydney Street, London SW3 6NP, United Kingdom.  E-mail:  info-www{at}2aida.orginfo-www@2aida.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11344171_0.392</DOCNO>
<TEXT>
      Distinct Radiological and Clinical Appearance of Lymphocytic Hypophysitis          K&uuml;rad &Uuml;nl&uuml;hizarci,   Fahri Bayram,   Ramiz &Ccedil;olak,   Figen &Ouml;zt&uuml;rk,   Ahmet Sel&ccedil;uklu,   Ahmet Candan Durak and   Fahrettin Keletimur  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344171_395.200</DOCNO>
<TEXT>
    Departments of Endocrinology and Metabolism (K.U., F.B., R.C.,  F.K.), Pathology (F.O.), Neurosurgery (A.S.), and Radiology (A.C.D.),  Erciyes University Medical School, Kayseri, Turkey  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344171_598.280</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Prof. Dr. Fahrettin Keletimur, Department of Endocrinology and Metabolism, Erciyes University Medical School, Kayseri, Turkey.  
</TEXT>
</DOC>

<DOC>
<DOCNO>11344173_0.255</DOCNO>
<TEXT>
      Critical Evaluation of the Safety of Recombinant Human Growth Hormone Administration: Statement from the Growth Hormone Research Society1            
</TEXT>
</DOC>


<DOC>
<DOCNO>11344173_258.220</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Michael O. Thorner, M.D., Department of Medicine, Box 800466, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908.
</TEXT>
</DOC>


<DOC>
<DOCNO>11344173_481.2011</DOCNO>
<TEXT>
              &nbsp;&nbsp;  Introduction      Top  Introduction  GH, insulin-like growth factor...  Safety aspects of GH...  Safety aspects of GH...  Safety aspects of...  Closing remarks    &nbsp;    This document reflects what has been learned about  the safety of recombinant human GH since its introduction to the market  in 1985. These lessons are the result of an unprecedented level of  scrutiny that has lasted more than 15 yr and continues today. The  Creutzfeldt-Jakob disease epidemic due to contamination of  pituitary-derived GH, the Japanese reports on a potential association  between GH and leukemia, and the fact that GH was the second  recombinant product brought onto the market were important  considerations behind the need for such careful surveillance. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11344174_0.156</DOCNO>
<TEXT>
      Growth Hormone and Cardiovascular Disease: An Area in Rapid Growth          Asha M. Thomas and   Lars Berglund  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344174_159.85</DOCNO>
<TEXT>
    Department of Medicine  Columbia University  New York, New York 10032   
</TEXT>
</DOC>


<DOC>
<DOCNO>11344174_247.456</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Lars Berglund, M.D., Department of Medicine, Room PH 10-305, Columbia University, 630 West 168th Street, New York, New York 10032.  E-mail:  lfb9{at}columbia.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11344176_0.135</DOCNO>
<TEXT>
      The Not-So-Odd Couple&#151;The Clinician and the Experimentalist          Gerard Karsenty  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344176_138.108</DOCNO>
<TEXT>
    Department of Molecular and Human Genetics  Baylor College of Medicine  Houston, Texas 77030   
</TEXT>
</DOC>


<DOC>
<DOCNO>11344176_249.220</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Gerard Karsenty, M.D., Ph.D., Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030.
</TEXT>
</DOC>

<DOC>
<DOCNO>11344178_0.145</DOCNO>
<TEXT>
      The Role of Combination Treatment for Osteoporosis          Robert R. Recker and   Robert P. Heaney  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344178_148.94</DOCNO>
<TEXT>
    Osteoporosis Research Center  Creighton University  Omaha, Nebraska 68131-5149   
</TEXT>
</DOC>


<DOC>
<DOCNO>11344178_245.2336</DOCNO>
<TEXT>
                  &nbsp;&nbsp;  Introduction      Top  Introduction  Why consider combination...  Conclusion  References    &nbsp;    Combination treatments, pharmaceutical or  otherwise, have been common in medical practice dating from ancient  Greek physicians to the modern day. Modern examples include rifampin  and isoniazid for mycobacterium infections, or combination drug therapy  for heart failure, angina, asthma, hypertension, cancer, and many more.  In this issue of The Journal of Clinical Endocrinology &amp;  Metabolism, Harris et al. (1) describe the  results of combination therapy for preservation of bone mass in  postmenopausal women. The results show that when a bisphosphonate  (BIS), risedronate, is added to conventional hormone replacement  therapy (HRT) in postmenopausal women, the increases in bone density at  nearly every skeletal site are at least marginally enhanced compared  with HRT alone. The report adds to three others (2, 3, 4) and  one abstract (5) describing results of this approach using  several regimens. Further, there are at least three ongoing studies  looking at this issue. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11344180_0.171</DOCNO>
<TEXT>
      La plus &ccedil;a change, la plus c&#146;est la m&ecirc;me chose&#151;Will Bioassays Make a Comeback?          William Rosner  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344180_174.112</DOCNO>
<TEXT>
    Department of Endocrinology  St. Luke&#146;s-Roosevelt Hospital Center  New York, New York 10019   
</TEXT>
</DOC>


<DOC>
<DOCNO>11344180_289.217</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: William Rosner, M.D., Department of Endocrinology, St. Luke&#146;s-Roosevelt Hospital Center, 1000 Tenth Avenue, New York, New York 10019.
</TEXT>
</DOC>

<DOC>
<DOCNO>11344246_0.265</DOCNO>
<TEXT>
      Kallikrein 4 (KLK4), A New Member of the Human Kallikrein Gene Family Is Up-Regulated By Estrogen and Progesterone in the Human Endometrial Cancer Cell Line, KLE          Stephen A. Myers and   Judith A. Clements  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344246_268.145</DOCNO>
<TEXT>
    Centre for Molecular Biotechnology, School of Life Sciences,  Queensland University of Technology, Brisbane, QLD, 4001,  Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344246_416.485</DOCNO>
<TEXT>
     Address correspondence to: Judith A. Clements, M.D., Queensland University of Technology, Centre for Molecular Biotechnology, School of Life Sciences, GPO Box 2434 Brisbane, Queensland, 4001, Australia.  E-mail: j.clements{at}qut.edu.auj.clements@qut.edu.au.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11344252_0.222</DOCNO>
<TEXT>
      Nesidioblastosis in Adults: A Clinical Enigmag          Boaz Hirshberg,   H. R. Alexander,   D. L. Bartlett,   M. C. Skarulis,   S. K. Libutti and   P. Gorden  
</TEXT>
</DOC>


<DOC>
<DOCNO>11344252_225.71</DOCNO>
<TEXT>
    National Institutes of Health  Bethesda, Maryland 20892   
</TEXT>
</DOC>


<DOC>
<DOCNO>11344252_299.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11397818_0.121</DOCNO>
<TEXT>
      From the Editor-in-Chief          John P. Bilezikian, M.D., Editor-in-Chief  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397818_124.96</DOCNO>
<TEXT>
    The Journal of Clinical Endocrinology &amp; Metabolism, New York, New York 10032   
</TEXT>
</DOC>


<DOC>
<DOCNO>11397818_223.813</DOCNO>
<TEXT>
          For the Annual Meeting of The Endocrine Society this month,  President Benita Katzenellenbogen has selected the theme  "Reproductive Hormones and Human Health." The June issue of  JCEM features 11 Commentaries and 1 Book Review devoted to  this subject. These commentaries cover broadly many different endocrine  systems such as reproductive endocrinology per se, as well  as the influence of thyroid hormone, the neuroendocrine system, calcium  metabolism, and diabetes on this topic. In addition, 42 original  articles have been selected for special emphasis in this issue because  they, too, are focused on this theme. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11397819_0.203</DOCNO>
<TEXT>
      Reproductive Function in Human Immunodeficiency Virus Infection1          Joan C. Lo and   Morris Schambelan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397819_206.179</DOCNO>
<TEXT>
    Division of Endocrinology, San Francisco General Hospital, and  Department of Medicine University of California&#150;San Francisco, San  Francisco, California 94110  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397819_388.188</DOCNO>
<TEXT>
     Address correspondence to: Joan C. Lo, M.D., Division of Endocrinology, San Francisco General Hospital, Building 30, Room 3501-K, San Francisco, California 94110.
</TEXT>
</DOC>

<DOC>
<DOCNO>11397820_0.132</DOCNO>
<TEXT>
      Calcium and Bone Metabolism in Pregnancy and Lactation*          Christopher S. Kovacs  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397820_135.163</DOCNO>
<TEXT>
    Faculty of Medicine&#150;Endocrinology, Health Sciences Centre,  Memorial University of Newfoundland, St. John&#146;s, Newfoundland A1B 3V6,  Canada  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397820_301.552</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Christopher S. Kovacs, M.D., FRCPC, FACP, Faculty of Medicine&#150;Endocrinology, Health Sciences Centre, Memorial University of Newfoundland, St. John&#146;s, Newfoundland A1B 3V6, Canada.  E-mail:  ckovacs{at}mun.cackovacs@mun.ca.'//--> * Supported in part by a Scholarship Award and
</TEXT>
</DOC>

<DOC>
<DOCNO>11397821_0.153</DOCNO>
<TEXT>
      Hypothyroidism in Pregnancy: Consequences to Neonatal Health          R. C. Smallridge and   P. W. Ladenson  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397821_156.225</DOCNO>
<TEXT>
    Division of Endocrinology (R.C.S.), Mayo Clinic, Jacksonville,  Florida 32224; and Division of Endocrinology and Metabolism (P.W.L.),  The Johns Hopkins University School of Medicine, Baltimore, Maryland  21287  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397821_384.465</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: R. C. Smallridge, M.D., Division of Endocrinology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224.  E-mail:  smallridge.robert{at}mayo.edusmallridge.robert@mayo.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11397822_0.148</DOCNO>
<TEXT>
      The Use of Antithyroid Drugs in Pregnancy and Lactation          Susan J. Mandel and   David S. Cooper  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397822_151.305</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes, and Metabolism (S.J.M.),  University of Pennsylvania School of Medicine, Philadelphia,  Pennsylvania 19104; and Division of Endocrinology (D.S.C.), Sinai  Hospital of Baltimore, The Johns Hopkins University School of Medicine,  Baltimore, Maryland 21215  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397822_459.502</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Susan J. Mandel, M.D., M.P.H., Division of Endocrinology, Diabetes, and Metabolism, 778 CRB, 415 Curie Boulevard, Philadelphia, Pennsylvania 19104.  E-mail: smandel{at}mail.med.upenn.edusmandel@mail.med.upenn.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11397823_0.264</DOCNO>
<TEXT>
      Damaged Reproduction: The Most Important Consequence of Iodine Deficiency          John T. Dunn1 and   Francois Delange1  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397823_267.165</DOCNO>
<TEXT>
    Department of Medicine (J.T.D.), University of Virginia,  Charlottesville, Virginia 22908; and University of Brussels (F.D.),  B1170 Brussels, Belgium  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397823_435.215</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: John T. Dunn, M.D., Department of Medicine, University of Virginia, Health Sciences Center, Box 800414, Charlottesville, Virginia 22908.
</TEXT>
</DOC>

<DOC>
<DOCNO>11397825_0.201</DOCNO>
<TEXT>
      Effects of Age on Testicular Function and Consequences of Testosterone Treatment1          Peter J. Snyder  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397825_204.124</DOCNO>
<TEXT>
    Department of Medicine, University of Pennsylvania School of  Medicine, Philadelphia, Pennsylvania 19104-6149  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397825_331.164</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Peter J. Snyder, M.D., 415 Curie Boulevard, Philadelphia, Pennsylvania 19104-6149
</TEXT>
</DOC>

<DOC>
<DOCNO>11397826_0.157</DOCNO>
<TEXT>
      Reproductive Technologies for Male Infertility          O. Khorram,   P. Patrizio,   C. Wang and   R. Swerdloff  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397826_160.275</DOCNO>
<TEXT>
    Departments of Obstetrics and Gynecology (O.K.) and Internal  Medicine (C.W., R.S.), Harbor&#150;UCLA Medical Center, Torrance,  California 90509; and Department of Obstetrics and Gynecology (P.P.),  University of Pennsylvania, Philadelphia, Pennsylvania 19104  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397826_438.248</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Ronald Swerdloff, M.D., Division of Endocrinology, Department of Internal Medicine, Harbor&#150;UCLA Medical Center, 1000 West Carson Street, Torrance, California 90509.
</TEXT>
</DOC>

<DOC>
<DOCNO>11397827_0.141</DOCNO>
<TEXT>
      Androgen Replacement Therapy in the Aging Male&#151;A Critical Evaluation          A. Vermeulen  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397827_144.114</DOCNO>
<TEXT>
    Department of Internal Medicine, Section of Endocrinology,  University Hospital, 9000 Gent, Belgium  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397827_261.494</DOCNO>
<TEXT>
     Address  correspondence and requests for reprints to: A. Vermeulen, M.D., Department  of Internal Medicine, Section of Endocrinology, University Hospital, 185 De  Pintelaan, 9000 Gent, Belgium. E-mail: "; document.getElementById("em0").innerHTML = 'Alex_Vermeulen@hotmail.com.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11397828_0.114</DOCNO>
<TEXT>
      Erectile Dysfunction          Pejman Cohan and   Stanley G. Korenman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397828_117.150</DOCNO>
<TEXT>
    Department of Medicine, Division of Endocrinology, Diabetes and  Hypertension, University of California, Los Angeles, California  90095  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397828_270.424</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Pejman Cohan, M.D., 200 UCLA Medical Plaza, Suite 530, Los Angeles, California 90095.  E-mail: pcohan{at}mednet.ucla.edupcohan@mednet.ucla.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11397830_0.113</DOCNO>
<TEXT>
      BOOK REVIEW: Polycystic Ovary Syndrome          Leonid Poretsky,     
</TEXT>
</DOC>


<DOC>
<DOCNO>11397830_116.155</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Leonid Poretsky, M.D., Beth Israel Medical Center, New York, New York 10003.
</TEXT>
</DOC>


<DOC>
<DOCNO>11397830_274.159</DOCNO>
<TEXT>
      Polycystic Ovary Syndrome, G. T. Kovacs, Editor; Cambridge  University Press, Publ. (Cambridge, UK), 2000, 225 pgs.
</TEXT>
</DOC>

<DOC>
<DOCNO>11397863_0.261</DOCNO>
<TEXT>
      Dynamics of Ovarian Function in an Adult Woman with McCune-Albright Syndrome1          Joop S. E. Laven,   Serge Lumbroso,   Charles Sultan and   Bart C. J. M. Fauser  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397863_264.464</DOCNO>
<TEXT>
    Division of Reproductive Medicine, Department of Obstetrics and  Gynecology (J.S.E.L., B.C.J.M.F.), Erasmus University Medical Center  Rotterdam, 3015 GD Rotterdam, The Netherlands; Department of  Hormonology (S.L.), University Hospital Montpellier, 34295 Montpellier,  France; Department of Hormonology and Unit of Pediatric Endocrinology  and Gynecology, Department of Pediatrics (C.S.), University Hospital  Montpellier, 34295 Montpellier, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397863_731.535</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Joop S. E. Laven, M.D., Ph.D., Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.  E-mail:  laven{at}gyna.azr.nllaven@gyna.azr.nl.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11397873_0.323</DOCNO>
<TEXT>
      RAPID COMMUNICATION: Predominant Intracellular Overexpression of the Na+/I- Symporter (NIS) in a Large Sampling of Thyroid Cancer Cases          Orsolya Doh&aacute;n,   Zubair Baloch,   Zsuzsa B&aacute;nr&eacute;vi,   Virginia Livolsi and   Nancy Carrasco  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397873_326.349</DOCNO>
<TEXT>
    Department of Molecular Pharmacology (O.D., N.C.), Albert Einstein  College of Medicine, Bronx, New York 10461; Department of Pathology  (Z.Ba., V.L.), University of Pennsylvania, Philadelphia, Pennsylvania  19104; and Department of Pathology (Z.B&aacute;.), Faculty of Health  Sciences of the Semmelweis University, Budapest, Hungary  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397873_678.204</DOCNO>
<TEXT>
     Address correspondence to: Nancy Carrasco, M.D., Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, F-209, Bronx, New York 10461.
</TEXT>
</DOC>

<DOC>
<DOCNO>11397907_0.346</DOCNO>
<TEXT>
      RAPID COMMUNICATION: Inhibitory Effect of a Two Day Fast on Reactive Oxygen Species (ROS) Generation by Leucocytes and Plasma Ortho-Tyrosine and Meta-Tyrosine Concentrations          Paresh Dandona,   Priya Mohanty,   Wael Hamouda,   Husam Ghanim,   Ahmad Aljada,   Rajesh Garg and   Vikramjeet Kumar  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397907_349.126</DOCNO>
<TEXT>
    Division of Endocrinology, State University of New York at Buffalo  and Kaleida Health, Buffalo, New York 14209  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397907_478.199</DOCNO>
<TEXT>
     Address correspondence to: Paresh Dandona, M.D., Division of Endocrinology, State University of New York at Buffalo, Kaleida Health, 3 Gates Circle, Buffalo, New York 14209.
</TEXT>
</DOC>

<DOC>
<DOCNO>11397908_0.166</DOCNO>
<TEXT>
      LETTER TO THE EDITOR: An Extraordinarily Inaccurate Assay for Free Testosterone Is Still with Us          William Rosner  
</TEXT>
</DOC>


<DOC>
<DOCNO>11397908_169.112</DOCNO>
<TEXT>
    Department of Endocrinology  St. Luke&#146;s-Roosevelt Hospital Center  New York, New York 10019   
</TEXT>
</DOC>


<DOC>
<DOCNO>11397908_284.191</DOCNO>
<TEXT>
     Address correspondence to: William Rosner, M.D., Department of Endocrinology, St. Luke&#146;s-Roosevelt Hospital Center, 1000 Tenth Avenue, New York, New York 10019.
</TEXT>
</DOC>

<DOC>
<DOCNO>11443144_0.165</DOCNO>
<TEXT>
      CLINICAL REVIEW 131: Gene Therapy for Thyroid Cancer: Where Do We Stand?          Leslie J. DeGroot and   Rusheng Zhang  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443144_168.106</DOCNO>
<TEXT>
    Thyroid Study Unit, Department of Medicine, University of Chicago,  Chicago, Illinois 60637  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443144_277.197</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Leslie J. DeGroot, Thyroid Study Unit, Department of Medicine, University of Chicago, Chicago, Illinois 60637.
</TEXT>
</DOC>

<DOC>
<DOCNO>11443145_0.128</DOCNO>
<TEXT>
      CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem?          Shlomo Melmed  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443145_131.137</DOCNO>
<TEXT>
    Cedars-Sinai Research Institute-University of California at Los  Angeles School of Medicine, Los Angeles, California 90048  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443145_271.437</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Shlomo Melmed, M.D., Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room 2015, Los Angeles, California 90048.  E-mail: melmed{at}cshs.orgmelmed@cshs.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11443146_0.146</DOCNO>
<TEXT>
      CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem          Paul J. Jenkins and   Michael Besser  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443146_149.126</DOCNO>
<TEXT>
    Department of Endocrinology, St. Bartholomew&#146;s Hospital, West  Smithfield, London, United Kingdom EC1A 7BE  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443146_278.482</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Paul Jenkins, Department of Endocrinology, St. Bartholomew&#146;s Hospital, West Smithfield, London, United Kingdom EC1A 7BE.  E-mail:  p.j.jenkins{at}mds.qmw.ac.ukp.j.jenkins@mds.qmw.ac.uk.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11443147_0.143</DOCNO>
<TEXT>
      HOT TOPIC: Endocrinology Resources on the Internet          Matthew I. Kim and   Paul W. Ladenson  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443147_146.157</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Medicine,  The Johns Hopkins University School of Medicine, Baltimore, Maryland  21287  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443147_306.528</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Paul W. Ladenson, M.D., Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287-0003.  E-mail:  ladenson{at}welch.jhu.eduladenson@welch.jhu.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11443148_0.204</DOCNO>
<TEXT>
      EDITORIAL: Polycystic Ovarian Syndrome&#151;Relationship to Epilepsy and Antiepileptic Drug Therapy          Hadine Joffe,   Ann E. Taylor and   Janet E. Hall  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443148_207.385</DOCNO>
<TEXT>
    Women&#146;s Center for Behavioral Endocrinology, McLean Hospital  (H.J.),  Belmont, Massachusetts 02478; and Perinatal and Reproductive Psychiatry  Clinical Research Program, Department of Psychiatry (H.J.), and  Reproductive Endocrine Unit, Department of Medicine (A.E.T., J.E.H.),  Massachusetts General Hospital, Harvard Medical School, Boston,  Massachusetts 02114   
</TEXT>
</DOC>


<DOC>
<DOCNO>11443148_595.413</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Hadine Joffe, M.D., McLean Hospital, 115 Mill Street, Belmont, Massachusetts 02478.  E-mail: hjoffe{at}partners.orghjoffe@partners.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11443150_0.148</DOCNO>
<TEXT>
      BOOK REVIEW: The Osteoporotic Syndrome - Detection, Prevention, and Treatment          B. L. Riggs,     
</TEXT>
</DOC>


<DOC>
<DOCNO>11443150_151.242</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: B. Lawrence Riggs, M.D., Mayo Clinic and Foundation, Department of Endocrinology/Metabolism and Internal Medicine, 200 First Street SW, Rochester, Minnesota 55905.
</TEXT>
</DOC>


<DOC>
<DOCNO>11443150_396.170</DOCNO>
<TEXT>
      The Osteoporotic Syndrome: Detection, Prevention, and Treatment,  L. V. Avioli, Editor; Academic Press, Publ.,  2000, 205 pgs.
</TEXT>
</DOC>

<DOC>
<DOCNO>11443152_0.223</DOCNO>
<TEXT>
      If Gonadotropin-Releasing Hormone Plus Growth Hormone (GH) Really Improves Growth Outcomes in Short Non-GH-Deficient Children, Then What?          Paul B. Kaplowitz, M.D., Ph.D.  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443152_226.119</DOCNO>
<TEXT>
    Department of Pediatrics  Virginia Commonwealth University School of Medicine  Richmond, Virginia 23298   
</TEXT>
</DOC>


<DOC>
<DOCNO>11443152_348.215</DOCNO>
<TEXT>
     Address correspondence and requests for reprints to: Paul B. Kaplowitz, M.D., Ph.D., Department of Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298.
</TEXT>
</DOC>

<DOC>
<DOCNO>11443208_0.222</DOCNO>
<TEXT>
      The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy          Christine Spitzweg,   Kevin J. Harrington,   Lori A. Pinke,   Richard G. Vile and   John C. Morris  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443208_225.168</DOCNO>
<TEXT>
    Departments of Endocrinology (C.S., J.C.M.), Molecular Medicine  Program (K.J.H., R.G.V.), and Urology (L.A.P.), Mayo Clinic, Rochester,  Minnesota 55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443208_396.464</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John C. Morris, M.D., Division of Endocrinology, Mayo Clinic, Guggenheim 625, 200 First Street SW, Rochester, Minnesota 55905.  E-mail:  morris.john{at}mayo.edumorris.john@mayo.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11443209_0.193</DOCNO>
<TEXT>
      Progress in Understanding the Etiology of Thyroid Autonomy1          Knut Krohn and   Ralf Paschke  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443209_196.161</DOCNO>
<TEXT>
    Third Medical Department (K.K., R.P.) and Interdisciplinary Center  for Clinical Research (K.K.), University of Leipzig, D-04103 Leipzig,  Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443209_360.501</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: R. Paschke, M.D., Third Medical Department, University of Leipzig, Ph. Rosenthal Strasse 27, D-04103 Leipzig, Germany.  E-mail:  pasr{at}server3.medizin.uni-leipzig.depasr@server3.medizin.uni-leipzig.de.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11443223_0.237</DOCNO>
<TEXT>
      RAPID COMMUNICATION: A Novel Melanocortin 4 Receptor (MC4R) Gene Mutation Associated with Morbid Obesity          Mehmet Mergen,   Hatice Mergen,   Metin Ozata,   Reyhan Oner and   Cihan Oner  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443223_240.236</DOCNO>
<TEXT>
    Department of Endocrinology and Metabolism (M.M., M.O.), Gulhane  School of Medicine, Etlik-Ankara, Turkey; and Department of Molecular  Biology, Hacettepe University Faculty of Science (H.M., R.O., C.O.),  Ankara, Turkey  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443223_479.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11443224_0.258</DOCNO>
<TEXT>
      RAPID COMMUNICATION: Inhibitory Effect of Pioglitazone on Carotid Arterial Wall Thickness in Type 2 Diabetes          Hiroyuki Koshiyama,   Dai Shimono,   Naomitsu Kuwamura,   Jun Minamikawa and   Yoshio Nakamura  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443224_261.151</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Internal  Medicine, Hyogo Prefectural Amagasaki Hospital, Hyogo 660-0828,  Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11443224_415.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11502765_0.127</DOCNO>
<TEXT>
      The Endocrinology of Prostate Cancer          Mary Ellen Taplin and   Shuk-Mei Ho  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502765_130.208</DOCNO>
<TEXT>
    Department of Medicine, Division of Oncology (M.E.T.), and  Department of Surgery, Division of Urology (S.-M.H.), University of  Massachusetts School of Medicine, Worcester, Massachusetts 01655  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502765_341.520</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Shuk-Mei Ho, Room 4-746A, Division of Urology, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655.  E-mail: Shuk-mei.Ho{at}umassmed.eduShuk-mei.Ho@umassmed.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11502766_0.161</DOCNO>
<TEXT>
      Editorial: The Rational Use of Growth Hormone in HIV-Infected Patients          Steven Grinspoon and   Marie Gelato  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502766_164.245</DOCNO>
<TEXT>
    Neuroendocrine Unit (S.G.), Massachusetts General  Hospital and Harvard Medical School, Boston, Massachusetts 02114; and  Division of Endocrinology (M.G.), SUNY Health Sciences Center&#150;Stony  Brook, Stony Brook, New York 11794  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502766_412.467</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr.  Steven Grinspoon, Neuroendocrine Unit, Bulfinch 457B, Massachusetts  General Hospital, Boston, Massachusetts 02114.  E-mail:  sgrinspoon{at}partners.orgsgrinspoon@partners.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11502844_0.288</DOCNO>
<TEXT>
      RAPID COMMUNICATIONS: Mutations in the Preproghrelin/Ghrelin Gene Associated with Obesity in Humans          Olavi Ukkola,   Eric Ravussin,   Peter Jacobson,   Eric E. Snyder,   Monique Chagnon,   Lars Sj&ouml;str&ouml;m and   Claude Bouchard  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502844_291.298</DOCNO>
<TEXT>
    Pennington Biomedical Research Center (O.V., E.R., P.J., E.E.S.,  M.C., C.B.), Baton Rouge, Louisiana; Department of Internal Medicine  and Biocenter Oulu (O.U.), University of Oulu, Finland; and Department  of Medicine, Sahlgrenska University Hospital (L.S.), G&ouml;teborg,  Sweden  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502844_592.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11502851_0.231</DOCNO>
<TEXT>
      Authors&#146; Response: Prevalence of Primary Aldosteronism in Unselected Hypertensive Populations&#151;Screening and Definitive Diagnosis          Carlos E. Fardella and   Lorena Mosso  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502851_234.130</DOCNO>
<TEXT>
    Department of Endocrinology  Faculty of Medicine  Pontificia Universidad Cat&oacute;lica de Chile  Santiago, Chile   
</TEXT>
</DOC>


<DOC>
<DOCNO>11502851_367.452</DOCNO>
<TEXT>
     Address correspondence to: Carlos E. Fardella, M.D., Department Endocrinology, Faculty of Medicine, P. Universidad Cat&oacute;lica de Chile, Marcoleta 391, Santiago, Chile.  E-mail: cfardella{at}med.puc.clcfardella@med.puc.cl.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11502852_0.134</DOCNO>
<TEXT>
      Distinguishing Unilateral Aldosteronoma from Bilateral Disease          Arunabha Ganguly  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502852_137.67</DOCNO>
<TEXT>
    J. A. Haley Veterans Hospital  Tampa, Florida 33612   
</TEXT>
</DOC>


<DOC>
<DOCNO>11502852_207.207</DOCNO>
<TEXT>
     Address correspondence to: Arunabha Ganguly, M.D., J. A. Haley Veterans Hospital, Research Service (151), Building 2, Room 208, 13000 Bruce B. Downs Boulevard, Tampa, Florida 33612.
</TEXT>
</DOC>

<DOC>
<DOCNO>11502853_0.158</DOCNO>
<TEXT>
      Author&#146;s Response: Distinguishing Unilateral Aldosteronoma from Bilateral Disease          John L. Phillips  
</TEXT>
</DOC>


<DOC>
<DOCNO>11502853_161.98</DOCNO>
<TEXT>
    Urologic Oncology Branch  National Cancer Institute  Bethesda, Maryland 20892-1501   
</TEXT>
</DOC>


<DOC>
<DOCNO>11502853_262.184</DOCNO>
<TEXT>
     Address correspondence to: John L. Phillips, M.D., Urologic Oncology Branch, National Cancer Institute, Building 10, Room 2B47, Bethesda, Maryland 20892-1501.
</TEXT>
</DOC>

<DOC>
<DOCNO>11502854_0.84</DOCNO>
<TEXT>
      The Endocrine Society Awards            
</TEXT>
</DOC>


<DOC>
<DOCNO>11502854_87.490</DOCNO>
<TEXT>
          RECIPIENTS of the Awards of The Endocrine Society are  selected by the Awards Committee. The Endocrine Society Awards may be  made to endocrinologists, members or non-members, from anywhere in the  world. Nominations may be made by Society members only. A complete  listing of all past Awardees is in The Endocrine Society Member  Directory and within the Society&#146;s Web site, www.endo-society.org. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11502854_580.272</DOCNO>
<TEXT>
    Nominations must be submitted on the appropriate form by April 15.  Forms may be obtained by writing to the Executive Director of the  Society. It is important to document the nominee&#146;s contributions to  endocrinology. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11502855_0.96</DOCNO>
<TEXT>
      THE ENDOCRINE SOCIETY 2001 ANNUAL AWARDS            
</TEXT>
</DOC>


<DOC>
<DOCNO>11502855_99.145</DOCNO>
<TEXT>
          Citation for the 2001 Fred Conrad Koch Award of The Endocrine  Society to Dr. Robert J. Lefkowitz
</TEXT>
</DOC>


<DOC>
<DOCNO>11502855_247.1043</DOCNO>
<TEXT>
    Dr. Robert J. Lefkowitz is the 2001 recipient of the Fred Conrad  Koch Award, which is the highest honor The Endocrine Society bestows  for scientific achievement. Dr. Lefkowitz     is the James B. Duke Professor of Medicine and Biochemistry and an  Investigator at the Howard Hughes Medical Institute at Duke University  Medical Center. Dr. Lefkowitz is a scientist of enormous accomplishment  who has been a creative scientific pioneer in the most real sense of  the word. He and his colleagues have discovered, or initiated,  essentially all of the molecular, biochemical, and physiologic  principles that govern the superfamily of heptahelical G  protein-coupled receptors (GPCRs), which play such a prominent role in  almost every endocrine regulatory system. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11549624_0.161</DOCNO>
<TEXT>
      The Importance of &#223;-Cell Failure in the Development and Progression of Type 2 Diabetes          Steven E. Kahn  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549624_164.197</DOCNO>
<TEXT>
    Division of Metabolism, Endocrinology and Nutrition, Department of  Medicine, University of Washington and Veterans Affairs Puget Sound  Health Care System, Seattle, Washington 98108  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549624_364.479</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Steven E. Kahn M.B., Ch.B., Veterans Affairs Puget Sound Health Care System (151), 1660 South Columbian Way, Seattle, Washington 98108.  E-mail:  skahn{at}u.washington.eduskahn@u.washington.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11549625_0.128</DOCNO>
<TEXT>
      Body Mass Index in Childhood&#151; Measuring a Moving Target          Mary Horlick  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549625_131.99</DOCNO>
<TEXT>
    Division of Pediatric Endocrinology, Columbia University, New York, New  York 10032   
</TEXT>
</DOC>


<DOC>
<DOCNO>11549625_233.431</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Mary Horlick, M.D., Division of Pediatric Endocrinology, Columbia University, New York, New York 10032.  E-mail: mnh1{at}columbia.edumnh1@columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11549706_0.256</DOCNO>
<TEXT>
      Plasma Ghrelin Concentration and Energy Balance: Overfeeding and Negative Energy Balance Studies in Twins          Eric Ravussin,   Matthias Tsch&ouml;p,   Silvia Morales,   Claude Bouchard and   Mark L. Heiman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549706_259.211</DOCNO>
<TEXT>
    Pennington Biomedical Research Center (E.R., S.M., C.B.), Baton  Rouge, Louisiana; and Endocrine Research, Lilly Research Laboratories  (M.T., M.L.H.), Eli Lilly and Company, Indianapolis, Indiana  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549706_473.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11549707_0.363</DOCNO>
<TEXT>
      A Low Dose of Ghrelin Stimulates Growth Hormone (GH) Release Synergistically with GH-Releasing Hormone in Humans          Yuji Hataya,   Takashi Akamizu,   Kazuhiko Takaya,   Naotetsu Kanamoto,   Hiroyuki Ariyasu,   Misa Saijo,   Kenji Moriyama,   Akira Shimatsu,   Masayasu Kojima,   Kenji Kangawa and   Kazuwa Nakao  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549707_366.422</DOCNO>
<TEXT>
    Department of Medicine and Clinical Science, Kyoto University  Graduate School of Medicine (Y.H., T.A., K. T., N.K., H.A., K.H., M.S.,  K.M., K.N.), Kyoto 606-8507; Department of Biochemistry, National  Cardiovascular Center Research Institute (M.K., K.K.), Osaka 565-8565;  and Clinical Research Institute, Center for Endocrine and Metabolic  Diseases, Kyoto National Hospital (A.S.), Kyoto 612-8555, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549707_791.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11549708_0.291</DOCNO>
<TEXT>
      Simvastatin Increases Serum Osteocalcin Concentration in Patients Treated for Hypercholesterolaemia          Michael Ho-Ming Chan,   Tony Wing-Lai Mak,   Rossa Wai-Kwun Chiu,   Chun-Chung Chow,   Iris Hiu-Shuen Chan and   Christopher Wai-Kei Lam  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549708_294.305</DOCNO>
<TEXT>
    Departments of Chemical Pathology (M.H.-M.C., R.W.-K.C., I.H.-S.C.,  C.W.-K.L.) and Medicine &amp; Therapeutics (C.-C.C.), The Chinese  University of Hong Kong, Prince of Wales Hospital, and Department of  Clinical Pathology (T.W.-L.M.), North District Hospital, New  Territories, Hong Kong  
</TEXT>
</DOC>


<DOC>
<DOCNO>11549708_602.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11600505_0.189</DOCNO>
<TEXT>
      Primary Lymphoma of the Pituitary: An Emerging Clinical Entity          Andrea Giustina,   Monica Gola,   Mauro Doga and   Enrico Agabiti Rosei  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600505_192.199</DOCNO>
<TEXT>
    Department of Internal Medicine (A.G., E.A.R.), University of  Brescia, 25125 Brescia; and Endocrine Unit, Division of Medicine (M.G.,  M.D.), Carlo Poma Hospital, 46100 Mantova, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600505_394.466</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Andrea Giustina, Endocrine Section c/o 2a Medicina, Spedali Civili, 25125 Brescia, Italy.  E-mail:  giustina{at}master.cci.unibs.itgiustina@master.cci.unibs.it.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600506_0.123</DOCNO>
<TEXT>
      Sexual Dimorphism in Skeletal Size, Density, and Strength          Ego Seeman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600506_126.149</DOCNO>
<TEXT>
    Department of Endocrinology and Medicine, Austin and Repatriation  Medical Centre, University of Melbourne, 3084 Melbourne,  Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600506_278.228</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Ego Seeman, B.Sc., MBBS, FRACP, M.D., Department of Endocrinology, Austin and Repatriation Medical Center, Heidelberg 3084, Melbourne, Australia.
</TEXT>
</DOC>

<DOC>
<DOCNO>11600507_0.173</DOCNO>
<TEXT>
      Subclinical Hypothyroidism Is Mild Thyroid Failure and Should be Treated          Michael T. McDermott and   E. Chester Ridgway  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600507_176.137</DOCNO>
<TEXT>
    Division of Endocrinology, Metabolism and Diabetes, University of  Colorado Health Sciences Center, Denver, Colorado 80262  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600507_316.544</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael T. McDermott, M.D., Division of Endocrinology, Metabolism and Diabetes, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Box B-151, Denver, Colorado 80262.  E-mail:  michael.mcdermott{at}uchsc.edumichael.mcdermott@uchsc.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600508_0.155</DOCNO>
<TEXT>
      The Treatment of Subclinical Hypothyroidism Is Seldom Necessary          James W. Chu and   Lawrence M. Crapo  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600508_158.148</DOCNO>
<TEXT>
    Division of Endocrinology, Stanford University School of Medicine  and Santa Clara Valley Medical Center, San Jose, California  95128  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600508_309.1953</DOCNO>
<TEXT>
          Subclinical hypothyroidism (SH) is a common  disorder with a prevalence ranging from 1&#150;10% of the adult population  in most community studies (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14). The risk of developing  SH increases with female gender, advanced age, and greater dietary  iodine intake. The view that most subjects with SH should be treated  with L-thyroxine has gained increasing credence  (15, 16, 17). A limited number of placebo-controlled  randomized trials involving a small number of patients with SH have  been performed (18, 19, 20, 21, 22), and several of these studies show  that L-thyroxine therapy may reduce symptoms of  hypothyroidism (18, 22). Other studies in subjects with SH  have shown that L-thyroxine lowers low-density  lipoprotein (LDL) cholesterol, improves cardiac function, and  diminishes neuropsychiatric symptoms (15, 16, 17). A recent  cross-sectional observational study noted an association between SH and  atherosclerotic disease (13). On initial assessment then,  it appears that the position advocating L-thyroxine therapy  for most subjects with SH enjoys strong experimental support. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11600509_0.219</DOCNO>
<TEXT>
      A Highly Complex Organization of the Regulatory Region of the Human CYP19 (Aromatase) Gene Revealed by the Human Genome Project          Siby Sebastian and   Serdar E. Bulun  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600509_222.139</DOCNO>
<TEXT>
    Departments of Obstetrics and Gynecology and Molecular Genetics,  University of Illinois at Chicago, Chicago, Illinois 60612  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600509_364.473</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Serdar E. Bulun, M.D., Department of Obstetrics and Gynecology, University of Illinois at Chicago, 820 South Wood Street M/C 808, Chicago, Illinois 60612.  E-mail: sbulun{at}uic.edusbulun@uic.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600511_0.257</DOCNO>
<TEXT>
      SPECIAL REPORT: Report of National Institute on Aging Advisory Panel1 on Testosterone Replacement in Men           National Institute on Ageing Advisory Panel,     
</TEXT>
</DOC>


<DOC>
<DOCNO>11600511_260.15</DOCNO>
<TEXT>
      
</TEXT>
</DOC>


<DOC>
<DOCNO>11600511_278.481</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael Thorner, MB BS, DSc, FRCP, Department of Internal Medicine, University of Virginia Health System, McKim Box 800466, Charlottesville, Virginia 22908.  E-mail: mot{at}virginia.edumot@virginia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600512_0.157</DOCNO>
<TEXT>
      Limitations of the Fasting Glucose to Insulin Ratio as an Index of Insulin Sensitivity          Michael J. Quon  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600512_160.133</DOCNO>
<TEXT>
    Cardiology Branch  National Heart, Lung, and Blood Institute  National Institutes of Health  Bethesda, Maryland 20892   
</TEXT>
</DOC>


<DOC>
<DOCNO>11600512_296.522</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael J. Quon, M.D., Ph.D., Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 10, Room 8C-218, 10 Center Drive MSC 1755, Bethesda, Maryland 20892-1755.  E-mail:  quonm{at}nih.govquonm@nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600514_0.220</DOCNO>
<TEXT>
      The Stimulatory G Protein -Subunit Gene: Mutations and Imprinting Lead to Complex Phenotypes          Lee S. Weinstein  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600514_223.162</DOCNO>
<TEXT>
    Metabolic Diseases Branch  National Institute of Diabetes,  Digestive, and Kidney Diseases  National Institutes of Health  Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600514_388.545</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Lee S. Weinstein, M.D., Metabolic Diseases Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Building 10, Room 8C101, Bethesda, Maryland 20892-1752.  E-mail:  leew{at}amb.niddk.nih.govleew@amb.niddk.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600517_0.91</DOCNO>
<TEXT>
      GH and Cardiac Failure          Ross C. Cuneo  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600517_94.191</DOCNO>
<TEXT>
    Metabolic Research Unit  Department of Medicine  University of Queensland  and  Department of Diabetes and Endocrinology  Princess Alexandra Hospital  Brisbane, Australia 4102   
</TEXT>
</DOC>


<DOC>
<DOCNO>11600517_288.604</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Ross C. Cuneo, MBBS, FRACP, Ph.D., Associate Professor of Medicine, Metabolic Research Unit, Department of Medicine, University of Queensland, and Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia 4102.  E-mail: cuneo2{at}medicine.pa.uq.edu.aucuneo2@medicine.pa.uq.edu.au.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600521_0.258</DOCNO>
<TEXT>
      The Effect of Pubertal Delay by GnRH Agonist in GH-Deficient Children on Final Height          D. Mul,   J .M. Wit,   W. Oostdijk,   J. Van den Broeck and   on behalf of the Dutch Advisory Group on Growth Hormone  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600521_261.329</DOCNO>
<TEXT>
    Department of Pediatrics/Subdivision Endocrinology (D.M.), Erasmus  University Medical Centre/Sophia Children&#146;s Hospital, Rotterdam 3000  CB; Department of Pediatrics (J.M.W., W.O.), Leiden University Medical  Center, Leiden 2300 RC; and Dutch Growth Foundation (J.V.d.B.),  Rotterdam 3015 GJ, The Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600521_593.216</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: D. Mul, M.D., Subdivision Endocrinology, Sp 3429, Sophia Children&#146;s Hospital, P.O. Box 2060, Rotterdam 3000 CB, The Netherlands.
</TEXT>
</DOC>

<DOC>
<DOCNO>11600570_0.286</DOCNO>
<TEXT>
      Effect of Spontaneous GH Secretion and the GH Sampling Period on the Accuracy of Models for Predicting Growth Responses to GH Treatment          Berit Kristr&ouml;m,   Chatarina L&ouml;fqvist,   Sten Rosberg and   Kerstin Albertsson Wikland  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600570_289.254</DOCNO>
<TEXT>
    Department of Pediatrics (B.K., C.L., S.R., K.A.W.), G&ouml;teborg  Pediatric Growth Research Center, G&ouml;teborg University,  S-41685 G&ouml;teborg; and Department of Pediatrics (B.K.),  Ume&aring; University, S-90195 Ume&aring;, Sweden  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600570_546.581</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Berit Kristr&ouml;m, University of G&ouml;teborg, G&ouml;teborg Pediatric Growth Research Center, The Queen Silvias Children&#146;s Hospital, Sahlgrenska University Hospital, East, S-416 85 G&ouml;thenburg, Sweden.  E-mail: berit.kristrom{at}pediatri.umu.seberit.kristrom@pediatri.umu.se.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600587_0.255</DOCNO>
<TEXT>
      The Glucocorticoid Receptor Is Specifically Expressed in the Stromal Compartment of the Human Endometrium          Ana-Maria Bamberger,   Karin Milde-Langosch,   Thomas L&ouml;ning and   Christoph M. Bamberger  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600587_258.183</DOCNO>
<TEXT>
    University Hospital Eppendorf, Institute of Pathology, Department  of Gynecopathology (A.-M.B., K.M.-L., T.L.), Department of Medicine  (C.M.B.), 20246 Hamburg, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600587_444.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11600588_0.262</DOCNO>
<TEXT>
      Expression and Antiproliferative Effect of a Second Form of Gonadotropin-Releasing Hormone in Normal and Neoplastic Ovarian Surface Epithelial Cells          Kyung-Chul Choi,   Nelly Auersperg and   Peter C. K. Leung  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600588_265.132</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology, University of British  Columbia, Vancouver, British Columbia, Canada V6H 3V5  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600588_400.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11600589_0.288</DOCNO>
<TEXT>
      Alteration of the Adrenomedullin Receptor Components Gene Expression Associated with the Blood Pressure in Pregnancy-induced Hypertension          Yasuo Makino,   Kazuhiko Shibata,   Ikuko Makino,   Kenji Kangawa and   Tatsuhiko Kawarabayashi  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600589_291.266</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology (Y.M., I.M., T.K.) and  Research Laboratory of Biodynamics (K.S.), School of Medicine, Fukuoka  University, Fukuoka 814-0180; and National Cardiovascular Center  Research Institute (K.K.), Osaka, 565-8565, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600589_560.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11600590_0.345</DOCNO>
<TEXT>
      Ghrelin, a Natural GH Secretagogue Produced by the Stomach, Induces Hyperglycemia and Reduces Insulin Secretion in Humans          Fabio Broglio,   Emanuela Arvat,   Andrea Benso,   Cristina Gottero,   Giampiero Muccioli,   Mauro Papotti,   Aart Jan van der Lely,   Romano Deghenghi and   Ezio Ghigo  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600590_348.442</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Internal  Medicine (F.B., E.A., A.B., C.G., E.G.); Department of Anatomy,  Pharmacology and Forensic Medicine (G.M.); Department of Biomedical  Sciences and Oncology (M.P.); University of Turin, Italy; Division of  Endocrinology, Department of Internal Medicine, Erasmus University of  Rotterdam (A.J.V.D.L.), The Netherlands; and Europeptides (R.D.),  Argenteuil, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600590_793.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11600591_0.153</DOCNO>
<TEXT>
      What Is the Significance of IGF-Binding Protein-3 Proteolysis in the Circulation?          Robert C. Baxter  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600591_156.131</DOCNO>
<TEXT>
    Kolling Institute of Medical Research, University of Sydney, Royal North  Shore Hospital, Sydney NSW 2065, Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600591_290.467</DOCNO>
<TEXT>
     Address correspondence to: Robert C. Baxter, Ph.D., D.Sc., Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, Sydney NSW 2065, Australia.  E-mail: robaxter{at}med.usyd.edu.aurobaxter@med.usyd.edu.au.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11600592_0.207</DOCNO>
<TEXT>
      Tools Now Exist to Measure Circulating IGF-Binding Protein-3 Proteolysis, to Study Its Regulation and Its Effects on IGF-I Bioavailability          Michel Binoux  
</TEXT>
</DOC>


<DOC>
<DOCNO>11600592_210.150</DOCNO>
<TEXT>
    Institut National de la Sant&eacute; et de la Recherche M&eacute;dicale,  Unit&eacute; 515  H&ocirc;pital Saint Antoine  Paris, France   
</TEXT>
</DOC>


<DOC>
<DOCNO>11600592_363.148</DOCNO>
<TEXT>
     Address correspondence to: Michel Binoux, M.D., INSERM Unit&eacute; 515, H&ocirc;pital Saint Antoine, 75571 Paris, France.
</TEXT>
</DOC>

<DOC>
<DOCNO>11600599_0.122</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health            
</TEXT>
</DOC>


<DOC>
<DOCNO>11600599_125.15</DOCNO>
<TEXT>
      
</TEXT>
</DOC>


<DOC>
<DOCNO>11600599_143.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11701660_0.112</DOCNO>
<TEXT>
      In Memoriam: Ernst Knobil (1926&#150;2000)          Jimmy D. Neill  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701660_115.146</DOCNO>
<TEXT>
    Distinguished Professor Department of Physiology and Biophysics  University of Alabama School of Medicine Birmingham, Alabama 35294  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701660_264.210</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Jimmy  D. Neill, Department of Physiology and Biophysics, University of  Alabama School of Medicine, Birmingham, Alabama 35294.
</TEXT>
</DOC>

<DOC>
<DOCNO>11701662_0.186</DOCNO>
<TEXT>
      Cardiac Steroidogenesis&#151;New Sites of Synthesis, or Much Ado About Nothing?          Celso E. Gomez-Sanchez and   Elise P. Gomez-Sanchez  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701662_189.177</DOCNO>
<TEXT>
    Division of Endocrinology  G. V. (Sonny) Montgomery Veterans Affairs Medical Center  and The University of Mississippi Medical Center  Jackson, Mississippi 39216   
</TEXT>
</DOC>


<DOC>
<DOCNO>11701662_369.531</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Celso Gomez-Sanchez, M.D., Division of Endocrinology, The University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216.  E-mail: cgomez-sanchez{at}medicine.umsmed.educgomez-sanchez@medicine.umsmed.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11701664_0.208</DOCNO>
<TEXT>
      Is the Diminuto/Dwarf1 Gene Involved in Physiologic Adrenocortical Size Regulation and Tumor Formation?          Christian A. Koch and   George P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701664_211.178</DOCNO>
<TEXT>
    National Institutes of Health  Pediatric and Reproductive Endocrinology Branch  National Institute of Child Health and Human Development  Bethesda, Maryland 20892   
</TEXT>
</DOC>


<DOC>
<DOCNO>11701664_392.601</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: George P. Chrousos, M.D., FACP, FAAP, MACE, National Institutes of Health, Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, Building 10, Room 9D42, Bethesda, Maryland 20892.  E-mail: chrousog@mail.nih.gov and  kochc{at}exchange.nih.govkochc@exchange.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11701666_0.257</DOCNO>
<TEXT>
      Tc99m-Sestamibi Uptake in Osteitis Fibrosa Cystica Simulating Metastatic Bone Disease          Mishaela R. Rubin,   Virginia A. LiVolsi,   Francisco Bandeira,   Gustavo Caldas and   John P. Bilezikian  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701666_260.426</DOCNO>
<TEXT>
    Departments of Medicine (M.R.R., J.P.B.) and Pharmacology (J.P.B.),  Columbia University College of Physicians and Surgeons, New York, New  York 10032; Department of Pathology and Laboratory Medicine, University  of Pennsylvania Health System (V.A.L.), Philadelphia, Pennsylvania  19104; and Department of Medicine, Agamenon Magalh&atilde;es Hospital,  University of Pernambuco (F.B., G.C.), Recife, Brazil 2723  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701666_689.482</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John P. Bilezikian, M.D., Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.  E-mail: jpb2{at}columbia.edujpb2@columbia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11701747_0.299</DOCNO>
<TEXT>
      Comment on "Estrogen Receptors  and &#223; Are Differentially Expressed in Developing Bone" (JCEM, 2001; 86:2309&#150;2314)          Isobel P. Braidman,   Judith A. Hoyland and   Peter Selby  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701747_302.90</DOCNO>
<TEXT>
    University of Manchester Medical School M13 9PT Manchester, United  Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11701747_395.236</DOCNO>
<TEXT>
     Address correspondence to: Isobel P.  Braidman, Ph.D., Musculoskeletal Research Group, University of  Manchester Medical School, Stopford Building, First Floor, Oxford Road,  M13 9PT Manchester, United Kingdom.
</TEXT>
</DOC>

<DOC>
<DOCNO>11701748_0.122</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health            
</TEXT>
</DOC>


<DOC>
<DOCNO>11701748_125.341</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly  here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided  below. \ 
</TEXT>
</DOC>


<DOC>
<DOCNO>11701748_469.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>11701749_0.228</DOCNO>
<TEXT>
      National Hormone & Peptide Program: Peptide Hormones (Recombinant and Natural), Hypothalamic Peptides, Hormones-Anitsera, Other Reagents & Hormones Assay Services Available            
</TEXT>
</DOC>


<DOC>
<DOCNO>11701749_231.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>11701749_256.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>11739417_0.110</DOCNO>
<TEXT>
      EDITORIAL: A SHOX to the System          Ron G. Rosenfeld  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739417_113.104</DOCNO>
<TEXT>
    Department of Pediatrics  Oregon Health &amp; Science University  Portland, Oregon 97201   
</TEXT>
</DOC>


<DOC>
<DOCNO>11739417_220.655</DOCNO>
<TEXT>
          As is frequently the case with exciting  discoveries, the identification of the SHOX gene has raised  more questions than it has answered. Thus, recent observations  concerning SHOX (short stature homeobox-containing gene)  and, in particular, genotype-phenotype correlations (see Ref.  1) have identified it as a gene critical to normal growth,  but have also resulted in uncertainty concerning the contribution of  SHOX abnormalities to the short stature of Turner syndrome  (TS) and idiopathic short stature (ISS). 
</TEXT>
</DOC>

<DOC>
<DOCNO>11739419_0.151</DOCNO>
<TEXT>
      Glucocorticoid-Induced Osteoporosis: Summary of a Workshop          Ernesto Canalis and   Andrea Giustina  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739419_154.174</DOCNO>
<TEXT>
    Saint Francis Hospital and Medical Center, Hartford, Connecticut  06105-1299; and Department of Internal Medicine, University of Brescia,  25123 Brescia, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739419_331.499</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Ernesto Canalis, M.D., Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, Connecticut 06105-1299.  E-mail: ecanalis{at}stfranciscare.orgecanalis@stfranciscare.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11739475_0.325</DOCNO>
<TEXT>
      Hydrocortisone Suppresses Intranuclear Activator-Protein-1 (AP-1) Binding Activity in Mononuclear Cells and Plasma Matrix Metalloproteinase 2 and 9 (MMP-2 and MMP-9)          Ahmad Aljada,   Husam Ghanim,   Priya Mohanty,   Debbie Hofmeyer,   Devjit Tripathy and   Paresh Dandona  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739475_328.152</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism, State  University of New York at Buffalo and Kaleida Health, Buffalo, New York  14209  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739475_483.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11739476_0.253</DOCNO>
<TEXT>
      Ghrelin Enhances Appetite and Increases Food Intake in Humans          A. M. Wren,   L. J. Seal,   M. A. Cohen,   A. E. Brynes,   G. S. Frost,   K. G. Murphy,   W. S. Dhillo,   M. A. Ghatei and   S. R. Bloom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739476_256.225</DOCNO>
<TEXT>
    Endocrine Unit (A.M.W., L.J.S., M.A.C., K.G.M., W.S.D., M.A.G.,  S.R.B.) and Department of Dietetics (A.E.B., G.F.S.), Imperial College  School of Medicine, Hammersmith Hospital, London W12 ONN, United  Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739476_484.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11739480_0.205</DOCNO>
<TEXT>
      Authors&#146; Response: The QoL-AGHDA Questionnaire&#151;Can it Be Used to Assess Quality of Life in Hypopituitarism?          Ariel Barkan and   Patricia Wren  
</TEXT>
</DOC>


<DOC>
<DOCNO>11739480_208.224</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, University of Michigan  Medical Center (A.B.), and Health Behavior and Health Education, School  of Public Health, University of Michigan (P.W.), Ann Arbor, Michigan.   
</TEXT>
</DOC>


<DOC>
<DOCNO>11739480_435.252</DOCNO>
<TEXT>
     Address correspondence to: Ariel L. Barkan, M.D., Department of Internal Medicine/Division of Endocrinology and Metabolism, University of Michigan Medical Center, 3920 Taubman Center, Room 0354, Ann Arbor, Michigan 48109-0354.
</TEXT>
</DOC>

<DOC>
<DOCNO>11739481_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>11739481_126.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>


<DOC>
<DOCNO>11739481_181.18</DOCNO>
<TEXT>
       
</TEXT>
</DOC>

<DOC>
<DOCNO>11788612_0.124</DOCNO>
<TEXT>
      Sometimes, Bigger Is Better          John P. Bilezikian, M.D., Editor-in-Chief  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788612_127.295</DOCNO>
<TEXT>
          With this issue of the JCEM, the New York-based editorial office approaches a half-way point as we enter our third year of service to our readers and to the Society. It is fitting to reflect on the past with a view toward the future. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11788612_425.1204</DOCNO>
<TEXT>
    The Journal continues to attract exceedingly high-quality, original research in clinical endocrinology. The volume of manuscripts we are receiving is truly unprecedented. For every quarter, since January 2000, we have received more manuscripts than the quarter before. The increase in quarterly submissions, comparing the first quarter of 2000 with the third quarter of 2001, is a remarkable 44%. For the current entire calendar year, we will have received for review approximately 25% more manuscripts than the year before. The increase in submissions comes from all over the world, with more than 45 countries represented. The United States led the list with 27% of all submissions. Italy (11%), United Kingdom (9%), Japan (8%), Germany (7%), France (5%), and The Netherlands (4%) were also well represented. By region, papers from Europe constituted 51% of all manuscripts, followed by North America (30%), Asia (11%), and other regions (7%). This breakdown is essentially unchanged from the figures for 2000. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11788613_0.190</DOCNO>
<TEXT>
      Endometrial Cancer: Hormonal Factors, the Perimenopausal "Window of Risk," and Isoflavones          G. E. Hale,   C. L. Hughes and   J. M. Cline  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788613_193.467</DOCNO>
<TEXT>
    Center for Women&#146;s Health (G.E.H.), Cedars-Sinai Medical Center, Los Angeles, California 90048; Department of Medical and Scientific Services, Quintiles Inc. (C.L.H.), Research Triangle Park, North Carolina 27709-3979; Department of Obstetrics and Gynecology (C.L.H.), Duke University Medical Center, Durham, North Carolina 27710; and Department of Pathology (J.M.C.), Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788613_663.471</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Claude L. Hughes, M.D., Ph.D., Quintiles Inc., P.O. Box 13979, Research Triangle Park, North Carolina 27709-3979.  E-mail: claude.hughes{at}quintiles.comclaude.hughes@quintiles.com.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11788614_0.169</DOCNO>
<TEXT>
      Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials          Katharina Modelska and   Steven Cummings  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788614_172.169</DOCNO>
<TEXT>
    University of California Coordinating Center, Department of Medicine, Prevention Sciences Group, University of California, San Francisco, California 94105  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788614_344.464</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Katharina Modelska, M.D., University of California, 74 New Montgomery Street, Suite 600, San Francisco, California 94105.  E-mail: kmodelska{at}psg.ucsf.edukmodelska@psg.ucsf.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11788615_0.178</DOCNO>
<TEXT>
      The Postnatal Gonadotropin and Sex Steroid Surge&#151;Insights from the Androgen Insensitivity Syndrome          Charmian A. Quigley  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788615_181.94</DOCNO>
<TEXT>
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788615_278.184</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Charmian A. Quigley, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
</TEXT>
</DOC>

<DOC>
<DOCNO>11788618_0.166</DOCNO>
<TEXT>
      Editorial: The Mystery&#151;and Importance&#151;of Diabetic Atherosclerotic Vascular Disease          Kevin Jon Williams  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788618_169.234</DOCNO>
<TEXT>
    Dorrance H. Hamilton Research Laboratories  Division of Endocrinology, Diabetes &amp; Metabolic Diseases  Department of Medicine  Jefferson Medical College  Thomas Jefferson University  Philadelphia, Pennsylvania 19107   
</TEXT>
</DOC>


<DOC>
<DOCNO>11788618_406.626</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Kevin Jon Williams, Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes &amp; Metabolic Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, 1020 Locust Street, Suite 348, Philadelphia, Pennsylvania 19107.  E-mail:  K_Williams{at}Lac.jci.tju.eduK_Williams@Lac.jci.tju.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11788620_0.175</DOCNO>
<TEXT>
      Vulnerability within a Robust Complex System&#151;DAX-1 Mutations and Steroidogenic Axis Development          Edward R. B. McCabe  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788620_178.144</DOCNO>
<TEXT>
    Mattel Children&#146;s Hospital at UCLA and Department of Pediatrics, UCLA School of Medicine, Los Angeles, California 90095-1752  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788620_325.501</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Edward R.B. McCabe, M.D., Ph.D., Department of Pediatrics, 22-412 MDCC, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, California 90095-1752.  E-mail: emccabe{at}mednet.ucla.eduemccabe@mednet.ucla.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11788638_0.662</DOCNO>
<TEXT>
      Detection of Insulin Resistance by Simple Quantitative Insulin Sensitivity Check Index QUICKI for Epidemiological Assessment and Prevention          Ji&iacute; Heb&iacute;ek,   Vladim&iacute;r Janout,   Jana Malin&iacute;kov&aacute;,   Dagmar Hor&aacute;kov&aacute; and   Ludk &iacute;ek  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788638_665.235</DOCNO>
<TEXT>
    Department of Physiology, Department of Preventive Medicine,  Department of Exercise Medicine, Faculty of Medicine, Palack  University, Olomouc, Czech Republic 77515, Europe  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788638_903.2610</DOCNO>
<TEXT>
          The aim of the present study was to evaluate the recently defined  simple insulin sensitivity check index QUICKI (Katz et al. 2000) for  insulin resistance diagnostics in common clinical and epidemiological  practice. Both the QUICKI (1/log insulin + log glycemia in mg/dL) and  HOMA (insulin * glycemia in &#181;mol/L/22.5) indexes were calculated from  fasting values in 259 adult healthy volunteers and patients, and in 47  healthy and obese children of prepubertal age of both sexes. In adults,  a fall in the QUICKI index (mean &#177; SEM in healthy subjects = 0.366 &#177;  0.029) as well as an increase in the HOMA index (in healthy subjects  1.57 &#177; 0.87) corresponded to metabolic and clinical manifestations of  insulin resistance in various groups of outpatients. The QUICKI index  had lower dispersion variances and the 95% confidence limits displayed  a higher discrimination capacity. Patients with glucose intolerance or  diabetes, hyperlipidemia typical for insulin resistance, or with  combination of these metabolic disorders were characterized by QUICKI  index values that were significantly lower than those of healthy  volunteers. The QUICKI index in healthy prepubertal children indicated  a higher insulin resistance compared to adults (mean 0.339 &#177; 0.020);  an increase in the QUICKI index in obese children with BMI over 25 was  not significant, although obese children showed a significant increase  of serum leptin and triglycerides and a decrease of HDL-cholesterol.  Adult patients with QUICKI index below 0.357 (which is at the lower  limit of 95% confidence limits in healthy persons) represented a group  with typical manifestations of metabolic syndrome, differing in these  parameters significantly from the group of patients of comparable age  with a QUICKI index greater than 0.357. The present study suggests  suitability of the QUICKI index for diagnosis of insulin resistance in  clinical and epidemiological practice. However, a normal QUICKI index  range needs to be established for each laboratory with an appropriate  control group because of significant interlaboratory variations in  insulin determinations and/or possible differences in various  populations. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11788639_0.383</DOCNO>
<TEXT>
      High-Dose Growth Hormone (GH) Treatment in Non-GH-Deficient Children Born Small for Gestational Age Induces Growth Responses Related to Pretreatment GH Secretion and Associated with a Reversible Decrease in Insulin Sensitivity          Francis de Zegher,   Ken Ong,   Maria van Helvoirt,   Angelica Mohn,   Katie Woods and   David Dunger  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788639_386.308</DOCNO>
<TEXT>
    Deparment of Paediatrics (F.d.z., M.v.H.), University of Leuven,  3000 Leuven, Belguim; Department of Paediatrics (K.O., K.W., D.D.),  University of Cambridge, Cambridge CB1 7TF, United Kingdom; and  Department of Paediatrics (A.M., K.W.), University of Oxford, Oxford  OX3 4DU, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788639_697.1534</DOCNO>
<TEXT>
          GH therapy variably reduces the height deficit of short children  born small for gestational age (SGA) but is associated with  hyperinsulinemia. Intermittent, higher-dose GH regimens may be  alternatives to continuous, lower-dose treatment. We examined whether  the growth response to GH therapy is related to pre-treatment indices  of endogenous somatotropic activity, and studied the reversibility of  the insulin resistant state induced by GH. 13 non-GH deficient short  SGA children were randomised to high-dose GH (100 mcg/kg/day) by daily  sc injection (n = 9), or no GH treatment (n = 4) for 2 years (2/4  controls subsequently received GH treatment). Overnight GH profiles  were performed at baseline; intravenous glucose tolerance tests were  performed at baseline, yearly on GH treatment, and 3 months post-GH  treatment. Fasting glucose, insulin and proinsulin levels were  measured, insulin sensitivity estimated using Bergman&#146;s minimal model,  and glucose tolerance calculated from rate of glucose disappearance. In  all GH-treated children, gain in height SDS (mean gain yr 1 = +1.2 SDS)  was inversely related to baseline peak overnight GH (r = -0.88, n =  10, p = 0.0008), IFG-I (r = -0.74, n = 11, p = 0.009), and fasting  insulin levels (r = -0.71, n = 11, p = 0.014). 
</TEXT>
</DOC>

<DOC>
<DOCNO>11788684_0.235</DOCNO>
<TEXT>
      Thyroglobulin Is a Thyroid Specific Gene for the Familial Autoimmune Thyroid Diseases          Yaron Tomer,   David A. Greenberg,   Erlinda Concepcion,   Yoshiyuki Ban and   Terry F. Davies  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788684_238.239</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Bone Diseases, Department  of Medicine (Y.T., E.C., Y.B., T.F.D.), and Departments of Psychiatry  and Biomathematics (D.A.D.), Mount Sinai School of Medicine, New York,  New York 10029  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788684_480.1817</DOCNO>
<TEXT>
          The autoimmune thyroid diseases (AITDs) develop as a result of a  complex interaction between predisposing genes and non-genetic factors.  We have completed a whole genome scan in 56 families which revealed 7  major AITD loci (LOD scores &gt;2), and additional minor loci (LOD scores  &gt;1). One of the minor loci was on chromosome 8q24 giving a maximum LOD  score (MLS) of 1.8 at marker D8S284. This locus contained the  thyroglobulin (Tg) gene which was a strong candidate gene for AITD.  Because of this we analyzed the Tg gene region in detail using an  expanded dataset of 102 families. The new linkage analysis showed  stronger evidence for linkage at the Tg gene locus with an MLS of 3.5  between markers D8S514 and D8S284 (NPL = 2.0). We then proceeded to  analyze the Tg gene directly. We identified a new microsatellite inside  intron 27 of the Tg gene (designated Tgms2). Tgms2 showed strong  evidence for linkage with AITD (MLS = 2.9), further suggesting that the  Tg gene was linked to AITD. Association studies comparing 224 Caucasian  AITD patients to 134 Caucasian controls showed an association of Tgms2  with AITD (p = 0.05, relative risk [RR] = 1.4). The association was  stronger when only the probands from the linked families (n = 32) were  used (p = 0.004, RR = 2.3). Transmission disequilibrium test (TDT)  analysis also showed an association of Tgms2 with AITD (p = 0.02). We  concluded therefore that the Tg gene was a major AITD susceptibility  gene because it was both linked and associated with AITD. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11788685_0.278</DOCNO>
<TEXT>
      A Novel Heterozygous Mutation in Peroxisome Proliferator-Activated Receptor- Gene in a Patient with Familial Partial Lipodystrophy          Anil K. Agarwal and   Abhimanyu Garg  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788685_281.195</DOCNO>
<TEXT>
    Department of Internal Medicine, Division of Nutrition and  Metabolic Diseases and Center for Human Nutrition, University of Texas  Southwestern Medical Center, Dallas, Texas 75390  
</TEXT>
</DOC>


<DOC>
<DOCNO>11788685_479.1795</DOCNO>
<TEXT>
          Familial partial lipodystrophies (FPL) are a heterogeneous group of  genetic disorders characterized by marked loss of subcutaneous (sc) fat  from the extremities. Affected individuals show an increased  preponderance of insulin resistance, diabetes mellitus and  dyslipidemia. Recently, lamin A/C gene mutations were found in patients  with FPL, Dunnigan variety. However, the genetic basis of other  phenotypes remains unknown. We studied peroxisome  proliferator-activated receptor- (PPAR) gene as a candidate gene  in seven FPL patients who did not appear to have Dunnigan variety.  Analysis of the coding region of PPARG revealed C to T  heterozygous mutation at nucleotide 1273 in exon 6 which changes a  highly conserved residue, arginine at position 425 to cysteine (R425C)  in the patient FX200.21. The patient is a 64-year-old nonHispanic white  woman who developed diabetes mellitus and hypertriglyceridemia at age  32 years and lipodystrophy of the extremities and face at age 50 years.  She also had hirsutism. Anthropometry and whole body magnetic resonance  imaging revealed marked loss of sc fat particularly from the  extremities but sc truncal fat was slightly increased. None of the four  unaffected family members harbored the mutation. We conclude that  heterozygous, R425C, mutation in PPARG could be the  molecular basis for one of the familial partial lipodystrophy  phenotypes. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11788686_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>11788686_126.1539</DOCNO>
<TEXT>
                  &nbsp;&nbsp;  Introduction      Top  Introduction  HUMAN TISSUE RESOURCES  HUMAN AND ANIMAL CELL...  ANIMAL RESOURCES  MISCELLANEOUS RESOURCES    &nbsp;    Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11788686_1668.1277</DOCNO>
<TEXT>
            &nbsp;&nbsp;  HUMAN TISSUE RESOURCES      Top  Introduction  HUMAN TISSUE RESOURCES  HUMAN AND ANIMAL CELL...  ANIMAL RESOURCES  MISCELLANEOUS RESOURCES    &nbsp;    NCI - Cooperative Human Tissue Network (CHTN)
</TEXT>
</DOC>

<DOC>
<DOCNO>11836262_0.218</DOCNO>
<TEXT>
      Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies          Robert A. Kreisberg and   Albert Oberman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836262_221.244</DOCNO>
<TEXT>
    Department of Medicine (R.A.K.), University of South Alabama, Mobile, Alabama 36688-0002; and Department of Medicine (A.O.), Division of Preventive Medicine, The University of Alabama at Birmingham, Birmingham, Alabama 35205-4785  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836262_468.487</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Robert A. Kreisberg, M.D., Department of Medicine, University of South Alabama, CSAB 170, Mobile, Alabama 36688-0002.  E-mail: rkreisberg{at}usamail.usouthal.edurkreisberg@usamail.usouthal.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11836265_0.139</DOCNO>
<TEXT>
      Aldosterone&#151;An Independent Risk Factor in Cardiovascular Disease          James C. Melby  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836265_142.141</DOCNO>
<TEXT>
    Department of Medicine and Evans, Department of Clinical Research, University Medical Center, Boston, Massachusetts 02118-2393  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836265_286.231</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: James C. Melby, M.D., Department of Medicine and Evans Department of Clinical Research, University Medical Center, Boston, Massachusetts 02118-2393.
</TEXT>
</DOC>

<DOC>
<DOCNO>11836267_0.183</DOCNO>
<TEXT>
      Aggressive Pituitary Tumors in MEN1: Do They Refute the Two-Hit Model of Tumorigenesis?          Stephen J. Marx and   Lynnette K. Nieman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836267_186.261</DOCNO>
<TEXT>
    Metabolic Diseases Branch (S.J.M.), National Institute of Diabetes and Digestive and Kidney Diseases; and Pediatric and Reproductive Endocrinology Branch (L.K.N.), National Institute of Child Health and Human Development, Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836267_450.445</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Stephen J. Marx, M.D., Building 10, Room 9C-101, NIH, Bethesda, Maryland 20892-1802.  E-mail: StephenM{at}intra.niddk.nih.govStephenM@intra.niddk.nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11836269_0.129</DOCNO>
<TEXT>
      The Clinical Laboratory Evaluation of GH Responsiveness          Philip A. Gruppuso  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836269_132.130</DOCNO>
<TEXT>
    Department of Pediatrics, Rhode Island Hospital and Brown University Medical School, Providence, Rhode Island 02903  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836269_265.206</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Philip A. Gruppuso, M.D., Department of Pediatrics, 593 Eddy Street, Rhode Island Hospital, Providence, Rhode Island 02903.
</TEXT>
</DOC>

<DOC>
<DOCNO>11836271_0.149</DOCNO>
<TEXT>
      Diagnosis of GH Deficiency in Adults&#151;How Good Do the Criteria Need to Be?          Mark E. Molitch  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836271_152.139</DOCNO>
<TEXT>
    Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois 60611  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836271_294.295</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Mark E. Molitch, M.D., Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School (Tarry 15-731), 303 East Chicago Avenue, Chicago, Illinois 60611.  
</TEXT>
</DOC>

<DOC>
<DOCNO>11836273_0.109</DOCNO>
<TEXT>
      Guarding our Nation&#146;s Thyroid Health          John T. Dunn  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836273_112.121</DOCNO>
<TEXT>
    Division of Endocrinology, Department of Medicine, University of Virginia, Charlottesville, Virginia 22908  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836273_236.394</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. J. T. Dunn, Box 800414, HSC/UVA, Charlottesville, Virginia 22908.  E-mail: jtd{at}virginia.edujtd@virginia.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11836344_0.325</DOCNO>
<TEXT>
      Expression of PDS/Pds, the Pendred Syndrome Gene, in Endometrium          Koichi Suzuki,   Ines E. Royaux,   Lorraine A. Everett,   Atsumi Mori-Aoki,   Sayuri Suzuki,   Kazuaki Nakamura,   Takafumi Sakai,   Ryohei Katoh,   Shuji Toda,   Eric D. Green and   Leonard D. Kohn  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836344_328.870</DOCNO>
<TEXT>
    Department of Microbiology, Leprosy Research Center, National  Institute of Infectious Diseases, Tokyo, Japan (K.S.); Genome  Technology Branch, National Human Genome Research Institute, National  Institutes of Health, Bethesda, Maryland (I.E.R., L.A.E., E.D.G.);  Department of Internal Medicine, Tottori University School of Medicine,  Yonago, Japan (A.M-A.); Laboratory of Molecular Endocrinology, MedStar  Research Institute, Washington Hospital Center, Washington, D.C. (K.S.,  S.S.); Laboratory of Cell Biology, Department of Regulation Biology,  Saitama University, Urawa, Japan (K.N., T.S.); Department of Pathology,  Yamanashi Medical University, Tamaho, Japan (R.K.); Department of  Pathology, Saga Medical School, Saga, Japan (S.T.); and Ohio University  School of Osteopathic Medicine and Edison Biotechnology Institute,  Athens, Ohio (L.D.K.)  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836344_1201.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11836345_0.333</DOCNO>
<TEXT>
      Effects of Recombinant Human Growth Hormone on Hepatic Lipid and Carbohydrate Metabolism in HIV-Infected Patients with Fat Accumulation          Jean-Marc Schwarz,   Kathleen Mulligan,   Jeongae Lee,   Joan C. Lo,   Michael Wen,   Mustafa A. Noor,   Carl Grunfeld and   Morris Schambelan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836345_336.303</DOCNO>
<TEXT>
    Department of Nutritional Sciences and Toxicology (J.-M.S., J.L.,  M.W.), University of California Berkeley, Berkeley, California  94720-3104; and Department of Medicine (J.-M.S., K.M., J.C.L., M.A.N.,  C.G., M.S.), University of California San Francisco, San Francisco,  California 94143  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836345_642.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11836347_0.203</DOCNO>
<TEXT>
      Comment on "Thyrotropin Receptor Expression in Cardiac Muscle Tissue"          Donald F. Sellitti,   Sonia Q. Doi,   Takashi Akamizu and   Hiroyuki Koshiyama  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836347_206.236</DOCNO>
<TEXT>
    Uniformed Services University of the Health Sciences, (D.F.S., S.Q.D.), Bethesda, Maryland; Kyoto University Graduate School of Medicine (T.A.), Kyoto, Japan; and Hyogo Prefecutural Amagasaki Hospital (H.K.), Hyogo, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836347_445.252</DOCNO>
<TEXT>
     Address correspondence to: Donald F. Sellitti, Ph.D., Department of Medicine, Division of Endocrinology, Uniformed Services University of the Health Sciences, Room A 3060, 4301 Jones Bridge Road, Bethesda, Maryland 20814-4799.
</TEXT>
</DOC>

<DOC>
<DOCNO>11836350_0.179</DOCNO>
<TEXT>
      Authors&#146; Response: Severe Embryopathy and Exposure to Methimazole in Early Pregnancy          David S. Cooper and   Susan Mandel  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836350_182.206</DOCNO>
<TEXT>
    Sinai Hospital of Baltimore and Johns Hopkins University School of Medicine (D.S.C.), Baltimore, Maryland; and University of Pennsylvania School of Medicine (S.M.), Philadelphia, Pennsylvania  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836350_391.224</DOCNO>
<TEXT>
     Address requests for reprints to: David S. Cooper, M.D., Division of Endocrinology, Sinai Hospital of Baltimore, Hoffberger Building, Suite 56, 2401 West Belvedere Avenue, Baltimore, Maryland 21215.
</TEXT>
</DOC>

<DOC>
<DOCNO>11836351_0.131</DOCNO>
<TEXT>
      QUICKI Is a Useful and Accurate Index of Insulin Sensitivity          Michael J. Quon  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836351_134.132</DOCNO>
<TEXT>
    Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836351_269.483</DOCNO>
<TEXT>
     Address all correspondence to: Michael J. Quon, Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 10, Room 8C-218, 10 Center Drive, MSC 1755, Bethesda, Maryland 20892-1755.  E-mail: quonm{at}nih.govquonm@nih.gov.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11836352_0.205</DOCNO>
<TEXT>
      QUICKI Is Not a Useful and Accurate Index of Insulin Sensitivity following Exercise Training          Glen E. Duncan,   Alan D. Hutson and   Peter W. Stacpoole  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836352_208.222</DOCNO>
<TEXT>
    Departments of Medicine (Division of Endocrinology and Metabolism) (G.E.D., P.W.S.), Biostatistics (A.D.H.), and Biochemistry and Molecular Biology (P.W.S.), University of Florida, Gainesville, Florida 32610  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836352_433.415</DOCNO>
<TEXT>
     Address requests for reprints to: Glen E. Duncan, Ph.D., RCEPSM, Box 100226 JHMHSC, University of Florida, Gainesville, Florida 32610-0226.  E-mail: gduncan{at}ufl.edugduncan@ufl.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11836353_0.155</DOCNO>
<TEXT>
      Different Presentation of Bone Mass in Mice and Humans with Congenital Leptin Deficiency          Metin Ozata  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836353_158.121</DOCNO>
<TEXT>
    Department of Endocrinology and Metabolism, G&uuml;lhane School of Medicine, TR-06018 Etlik/Ankara, Turkey  
</TEXT>
</DOC>


<DOC>
<DOCNO>11836353_282.475</DOCNO>
<TEXT>
     Address requests for reprints to: Metin Ozata, M.D., Associate Professor of Medicine, Department of Endocrinology and Metabolism, G&uuml;lhane School of Medicine, TR-06018 Etlik/Ankara, Turkey.  or  metinozata{at}hotmail.commetinozata@hotmail.com.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11836354_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>11836354_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11836354_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>11889146_0.128</DOCNO>
<TEXT>
      In-Patient Hyperglycemia&#151;Are We Ready to Treat It Yet?          Irl B. Hirsch  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889146_131.84</DOCNO>
<TEXT>
    University of Washington School of Medicine Seattle, Washington 98195  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889146_218.1291</DOCNO>
<TEXT>
          The definition of hyperglycemia in the absence of diabetes (stress hyperglycemia) varies, but it is often defined as a plasma glucose level above 200 mg/dl (11.1 mmol/liter). The majority of studies examining the frequency of acutely ill patients reaching this glucose level have not been able to determine which of these patients had preexisting diabetes because hemoglobin A1c (HbA1c) levels were not measured. An exception to this was a report of 397 subjects with an acute myocardial infarction using HbA1c to diagnose preexisting diabetes (1). Undiagnosed diabetes was found in 4.3% of this population and contributed to 9.6% of hospital mortality. More recently, Levetan et al. (2) surveyed 1034 hospitalized patients and reported that over one third had one or more documented plasma glucose levels over 200 mg/dl (11.1 mmol/liter), with a mean of 299 mg/dl (16.6 mmol/liter). Although many of these patients likely had diabetes before their hospitalizations, only 7% had diabetes mentioned as a possible diagnosis in the daily progress notes. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11889148_0.158</DOCNO>
<TEXT>
      For Osteoporosis, Are Two Antiresorptive Drugs Better Than One?          Bruce Ettinger and   John P. Bilezikian  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889148_161.269</DOCNO>
<TEXT>
    Division of Research, Kaiser Permanente Medical Care Program, Division of Research (B.E.), Oakland, California 94661; and Departments of Medicine and Pharmacology (J.P.B.), College of Physicians and Surgeons, Columbia University, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889148_433.1403</DOCNO>
<TEXT>
          Antiresorptive drugs have had an enormous impact on the therapy of osteoporosis. By inhibiting osteoclast-mediated bone resorption but via different mechanisms, drugs like alendronate and raloxifene reduce bone dynamics that are typically elevated in postmenopausal women. Accelerated bone resorption is believed to be a major pathogenetic mechanism in postmenopausal bone loss, and antiresorptive drugs can return to the premenopausal range the somewhat elevated levels of bone turnover found in such women. However, none of the available antiresorptive drugs restores bone density from osteoporotic to normal levels, nor is fracture incidence reduced to premenopausal levels. Clearly, there are factors beyond bone turnover, like age, that are important in the interplay between drug efficacy and fracture. Nevertheless, it is tempting to consider the possibility that combination therapy with antiresorptive drugs, either through additive effects on suppression of bone turnover or through other as yet unknown mechanisms, might provide benefits over and above what could be achieved with either one alone. There have been and will be more clinical trials to test this hypothesis. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11889171_0.308</DOCNO>
<TEXT>
      Identification of Suppressors of Cytokine Signaling (SOCS) Proteins in Human Gestational Tissues: Differential Regulation Is Associated with the Onset of Labor          Marion Blumenstein,   Jennifer M. Bowen-Shauver,   Jeffrey A. Keelan and   Murray D. Mitchell  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889171_311.319</DOCNO>
<TEXT>
    Liggins Institute (M.B., J.K., M.M.) and Division of Pharmacology  and Clinical Pharmacology (J.K., M.M.), Faculty of Medical and Health  Sciences, University of Auckland, Auckland, New Zealand; and Department  of Physiology and Biophysics (J.B.-S.), University of Illinois at  Chicago, Chicago, Illinois  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889171_633.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11889218_0.263</DOCNO>
<TEXT>
      Presence of Functional Oxytocin Receptors in Cultured Human Myoblasts          Christophe Breton,   Christine Haenggeli,   Claude Barberis,   Freddy Heitz,   Charles R. Bader,   Laurent Bernheim and   Eliane Tribollet  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889218_266.593</DOCNO>
<TEXT>
    D&eacute;partement de Biologie Animale, Universit&eacute; de Lilles  1, 59650 Villeneuve d&#146;Ascq Cedex, France (C.B.); D&eacute;partement de  Physiologie, Centre M&eacute;dical Universitaire, 1 rue Michel Servet,  1211 Geneva 4, Switzerland (C.H., F.H., L.B., E.T.); INSERM, U.469,  CCIPE, 141 rue de la Cardonille, 34094 Montpellier Cedex 5, France  (C.B.); Division de Recherche Clinique Neuro-Musculaire,  D&eacute;partement des Neurosciences Cliniques et Dermatologie,  H&ocirc;pital Cantonal Universitaire, 24 rue Micheli-du-Crest,  1211 Geneva 14, Switzerland (C.R.B.)  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889218_862.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11889219_0.369</DOCNO>
<TEXT>
      Insulin Inhibits the Pro-Inflammatory Transcription Factor Early Growth Response Gene-1 (Egr)-1 Expression in Mononuclear Cells (MNC) and Reduces Plasma Tissue Factor (TF) and Plasminogen Activator Inhibitor-1 (PAI-1) Concentrations          Ahmad Aljada,   Husam Ghanim,   Priya Mohanty,   Neeti Kapur and   Paresh Dandona  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889219_372.152</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism, State  University of New York at Buffalo and Kaleida Health, Buffalo, New  York 14209  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889219_527.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11889220_0.200</DOCNO>
<TEXT>
      A Novel Melanocortin 3 Receptor Gene (MC3R) Mutation Associated with Severe Obesity          Yung-Seng Lee,   Larry Kok-Seng Poh and   Kah-Yin Loke  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889220_203.116</DOCNO>
<TEXT>
    Paediatric Endocrine Section, Department of Paediatrics, National  University of Singapore, Singapore  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889220_322.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11889221_0.312</DOCNO>
<TEXT>
      Expression of Gonadotropin-Releasing Hormone II (GnRH-II) Receptor in Human Endometrial and Ovarian Cancer Cells and Effects of GnRH-II on Tumor Cell Proliferation          Carsten Gr&uuml;ndker,   Andreas R. G&uuml;nthert,   Robert P. Millar and   G&uuml;nter Emons  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889221_315.238</DOCNO>
<TEXT>
    Department of Gynecology and Obstetrics, Georg-August-University  (C.G., A.R.G., G.E.), D-37070 G&ouml;ttingen, Germany; and Medical  Research Council, Human Reproductive Sciences Unit (R.P.M.), Edinburgh  EH3 9ET, Scotland  
</TEXT>
</DOC>


<DOC>
<DOCNO>11889221_556.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11889224_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>11889224_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11889224_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>11889225_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>11889225_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>11889225_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>11932265_0.235</DOCNO>
<TEXT>
      Should the Nonaromatizable Androgen Dihydrotestosterone Be Considered as an Alternative to Testosterone in the Treatment of the Andropause?          Christina Wang and   Ronald S. Swerdloff  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932265_238.157</DOCNO>
<TEXT>
    Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and Research and Education Institute, Torrance, California 90509  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932265_398.437</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Christina Wang, M.D., Harbor-UCLA Medical Center, 1000 West Carson Street, Torrance, California 90509-2910. E-mail: . wang{at}gcrc.rei.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11932267_0.157</DOCNO>
<TEXT>
      The Genetics of Absorptive Hypercalciuria&#151;A Note of Caution          Michael J. Econs and   Tatiana Foroud  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932267_160.165</DOCNO>
<TEXT>
    Departments of Medicine (M.J.E.) and Medical and Molecular Genetics (M.J.E., T.F.), Indiana University School of Medicine, Indianapolis, Indiana 46202  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932267_328.368</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael J. Econs, M.D., Associate Professor of Medicine and Medical and Molecular Genetics, Director, Division of Endocrinology and Metabolism, Department of Medicine, Clinical Building, 459, 541 North Clinical Drive, Indiana University School of Medicine, Indianapolis, Indiana 46202.
</TEXT>
</DOC>

<DOC>
<DOCNO>11932269_0.209</DOCNO>
<TEXT>
      Using Baseline and Recombinant Human TSH-Stimulated Tg Measurements to Manage Thyroid Cancer without Diagnostic 131I Scanning          Leonard Wartofsky  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932269_212.94</DOCNO>
<TEXT>
    Department of Medicine, Washington Hospital Center, Washington, D.C. 20010-2975  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932269_309.479</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Leonard Wartofsky, Department of Medicine, Washington Hospital Center, 110 Irving Street NW, Washington, D.C. 20010-2975. E-mail: . leonard.wartofsky{at}medstar.net' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11932337_0.170</DOCNO>
<TEXT>
      IL-15 Regulation in Human Endometrial Stromal Cells          Carolyn L. Dunn,   Hilary O. D. Critchley and   Rodney W. Kelly  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932337_173.205</DOCNO>
<TEXT>
    MRC Human Reproductive Sciences Unit (C.L.D., R.W.K.) and  Obstetrics and Gynaecology (H.O.D.C.), University of Edinburgh, Centre  for Reproductive Biology, Edinburgh EH3 9ET, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932337_381.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11932338_0.211</DOCNO>
<TEXT>
      Insulin, Unlike Food Intake, Does Not Suppress Ghrelin in Human Subjects          A. Caix&aacute;s,   C. Bashore,   W. Nash,   F. Pi-Sunyer and   B. Laferr&egrave;re  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932338_214.165</DOCNO>
<TEXT>
    Obesity Research Center, St. Luke&#146;s/Roosevelt Hospital Center,  Columbia University College of Physicians and Surgeons, New York, New  York 10025  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932338_382.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11932341_0.370</DOCNO>
<TEXT>
      Analysis of the Separate Secretion of Very Low-Density Lipoprotein (VLDL)-1 and VLDL-2 by the Liver Will Be a Principal Factor in Resolving the Proatherogenic Lipoprotein Profile in Hypopituitarism          T. B. Twickler,   H. C. M. T. Prinsen,   W. R. de Vries,   H. P. F. Koppeschaar and   M. G. M. de Sain-van der Velden  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932341_373.130</DOCNO>
<TEXT>
    Department of Vascular Medicine and Metabolism, University Medical Center Utrecht, Utrecht 3508 AB, The Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932341_506.485</DOCNO>
<TEXT>
     Address all correspondence to: T. B. Twickler, M.D., Department of Vascular Medicine and Metabolism, University Medical Center Utrecht, KC02.069.1, PO Box 85090, 3508 AB, Utrecht, The Netherlands. E-mail: . th.b.twickler{at}digd.azu.nl' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11932342_0.214</DOCNO>
<TEXT>
      What Treatment Should Be Given to the Cryopreserved Ovarian Tissue after Thawing?          Justo Callejo,   Cristina Salvador,   Pilar Prats and   Jos&eacute; M. Lailla  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932342_217.109</DOCNO>
<TEXT>
    Hospital Universitari San Joan de D&eacute;u, Universitat de Barcelona, Barcelona 08950, Spain  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932342_329.484</DOCNO>
<TEXT>
     Address all correspondence to: Justo Callejo, M.D., Department of Obstetrics and Gynecology, Hospital Universitari Sant Joan de Deu, PoSant Joan de D&eacute;u no 2., ESPLUGUES Barcelona 08950, Spain. E-mail: . jcallejo{at}medicina.ub.es' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11932345_0.209</DOCNO>
<TEXT>
      Acromegaly and Colorectal Cancer: Risk Assessment Should Be Based on Population-Based Studiesc          Andrew G. Renehan and   Stephen M. Shalet  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932345_212.138</DOCNO>
<TEXT>
    Departments of Surgery (A.G.R.) and Endocrinology (S.M.S.), Christie Hospital NHS Trust, Manchester M20 4BX, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932345_353.62</DOCNO>
<TEXT>
          To the editor:
</TEXT>
</DOC>

<DOC>
<DOCNO>11932347_0.277</DOCNO>
<TEXT>
      Authors&#146; Response: Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method          H. Leslie,   H. Courtney,   B. Sheridan and   A. B. Atkinson  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932347_280.108</DOCNO>
<TEXT>
    Sir George E. Clark Metabolic Unit, Royal Victoria Hospital, Belfast BT12 6BA, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932347_391.185</DOCNO>
<TEXT>
     Address correspondence to: A. B. Atkinson, M.D., Sir George E. Clark Metabolic Unit, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, United Kingdom.
</TEXT>
</DOC>

<DOC>
<DOCNO>11932348_0.107</DOCNO>
<TEXT>
      SHOX: A Geneticist&#146;s View          Gudrun Rappold  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932348_110.95</DOCNO>
<TEXT>
    Institute of Human Genetics, University of Heidelberg, Heidelberg 69120, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932348_208.469</DOCNO>
<TEXT>
     Address correspondence to: Gundrun Rappold, M.D., University of Heidelberg, Institute of Human Genetics, Im Neuenheimer Feld 328, Heidelberg 69120, Germany. E-mail: . gundrun_rappold{at}med.uni-heidelberg.de' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11932349_0.181</DOCNO>
<TEXT>
      Author&#146;s Response: Hyperparathyroidism Due to the So-Called Bone Hunger Syndrome in Prostate Cancer Patients          Robin Murray  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932349_184.72</DOCNO>
<TEXT>
    Peter McCallum Cancer Institute, Victoria 8006, Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932349_259.168</DOCNO>
<TEXT>
     Address correspondence to: Robin Murray, M.D., Peter McCallum Cancer Institute, Locked Bag 1, A&#146;Beckett Street, Victoria 8006, Australia.
</TEXT>
</DOC>

<DOC>
<DOCNO>11932351_0.130</DOCNO>
<TEXT>
      Author&#146;s Response: SHOX&#151;A Geneticist&#146;s View          Ron G. Rosenfeld  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932351_133.101</DOCNO>
<TEXT>
    Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97201  
</TEXT>
</DOC>


<DOC>
<DOCNO>11932351_237.436</DOCNO>
<TEXT>
     Address correspondence to: Ron G. Rosenfeld, M.D., Department of Pediatrics, Oregon Health and Science University, 707 SW Gaines Road, Portland, Oregon 97201-3098. E-mail: . rosenfer{at}ohsu.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11932352_0.122</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health            
</TEXT>
</DOC>


<DOC>
<DOCNO>11932352_125.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11932352_465.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>11932353_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>11932353_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>11932353_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>11994318_0.109</DOCNO>
<TEXT>
      Remembrance: The Berson and Yalow Saga          Adolph Friedman  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994318_112.66</DOCNO>
<TEXT>
    The Endocrine Society Bethesda, Maryland 20814-4426  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994318_181.194</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Adolph Friedman, M.D., The Endocrine Society, 4350 East West Highway, Suite 500, Bethesda, Maryland 20814-4426.
</TEXT>
</DOC>

<DOC>
<DOCNO>11994320_0.124</DOCNO>
<TEXT>
      Nonpalpable Thyroid Nodules&#151;Managing an Epidemic          Douglas S. Ross  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994320_127.100</DOCNO>
<TEXT>
    Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994320_230.443</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Douglas S. Ross, M.D., Thyroid Associates ACC-730, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: . dross{at}partners.org' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>11994322_0.163</DOCNO>
<TEXT>
      Cortisol, Cushing&#146;s Syndrome, and a Shrinking Brain&#151;New Evidence for Reversibility          Bruce S. McEwen  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994322_166.99</DOCNO>
<TEXT>
    Laboratory of Neuroendocrinology The Rockefeller University New York, New York 10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994322_268.1439</DOCNO>
<TEXT>
          Ever since the discovery of type 2 (glucocorticoid) and type 1 (mineralocorticoid) receptors in the brain (1), the adrenal steroids have acquired somewhat of a bad reputation as far as their effects on the nervous system. They have been implicated in damage processes associated with aging and the exacerbation of damage after ischemia and seizures (2). True as these may be, there is another side to the story that has been slowly emerging: adrenal steroids have beneficial effects on brain function, and the brain is not as brittle and damage prone as we had begun to believe. Moreover, changes in brain volumes that have been interpreted in the past as signs of irreversible damage have turned out to be reversible, at least in part. The latest addition to this story is the study in this issue by Bourdeau et al. (3) at the Centre Hospitalier de l&#146;Universite de Montreal reporting reversal of brain volume changes in Cushing&#146;s syndrome after correction of hypercortisolism. Before considering these new results, it is important to consider the more beneficial actions of adrenal steroids and the new appreciation of the resilience of the brain. 
</TEXT>
</DOC>

<DOC>
<DOCNO>11994393_0.312</DOCNO>
<TEXT>
      Low Dose Leptin Administration Reverses Effects of Sustained Weight-Reduction on Energy Expenditure and Circulating Concentrations of Thyroid Hormones          Michael Rosenbaum,   Ellen M. Murphy,   Steven B. Heymsfield,   Dwight E. Matthews and   Rudolph L. Leibel  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994393_315.159</DOCNO>
<TEXT>
    Columbia University (M.R., E.M.M., S.B.H., R.L.L.), New York, New  York; and University of Vermont Medical Center (D.E.M.), Burlington,  Vermont  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994393_477.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11994394_0.198</DOCNO>
<TEXT>
      Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies          Wasim A. Haque,   Iichiro Shimomura,   Yuji Matsuzawa and   Abhimanyu Garg  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994394_201.343</DOCNO>
<TEXT>
    Division of Nutrition and Metabolic Diseases, Center for Human  Nutrition, Departments of Internal Medicine (W.A.H., A.G.),  University of Texas Southwestern Medical Center, Dallas, Texas 75390;  and Department of Internal Medicine and Molecular Science (I.S.,  Y.M.), Graduate School of Medicine, Osaka University, Osaka, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994394_547.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11994395_0.297</DOCNO>
<TEXT>
      Metastin Receptor Is Overexpressed in Papillary Thyroid Cancer and Activates MAP Kinase in Thyroid Cancer Cells          Matthew D. Ringel,   Elena Hardy,   Victor J. Bernet,   Henry B. Burch,   Frank Schuppert,   Kenneth D. Burman and   Motoyasu Saji  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994395_300.294</DOCNO>
<TEXT>
    Department of Medicine, Washington Hospital Center and MedStar  Research Institute (M.D.R., E.H., K.D.B., M.S.), Washington, D.C.;  Department of Medicine, Walter Reed Army Medical Center (V.J.B., H.B.),  Washington, D.C.; and Hospital Bad Oeynhausen (F.S.), Oeynhausen,  Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994395_597.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11994396_0.391</DOCNO>
<TEXT>
      Peroxisome Proliferator Activated Receptor  Expression Is Reduced in the Colonic Mucosa of Acromegalic Patients          Fausto Bogazzi,   Federica Ultimieri,   Francesco Raggi,   Aurelio Costa,   Maurizio Gasperi,   Elisabetta Cecconi,   Franco Mosca,   Luigi Bartalena and   Enio Martino  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994396_394.250</DOCNO>
<TEXT>
    Department of Endocrinology and Metabolism (F.B., F.U., F.R., M.G.,  E.C., E.M.), Department of Oncology and Transplantation (A.C., F.M.),  University of Pisa, Pisa, Chair of Endocrinology, University of  Insubria (L.B.), Varese, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994396_647.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11994397_0.313</DOCNO>
<TEXT>
      Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue          Philip G. McTernan,   Claire L. McTernan,   Rajkumar Chetty,   Keely Jenner,   Ffolliott M. Fisher,   Michelle N. Lauer,   John Crocker,   Anthony H. Barnett and   Sudhesh Kumar  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994397_316.274</DOCNO>
<TEXT>
    Division of Medical Sciences, Department of Medicine (P.G.M.,  C.L.M., R.C., F.M.F., M.N.L., A.H.B., S.K.), University of Birmingham,  Birmingham, B15 2TH; and Cellular Pathology Department, Heartlands  Hospital (K.J., J.C.), Birmingham B9 5SS, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>11994397_593.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>11994398_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>11994398_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>11994398_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12050192_0.213</DOCNO>
<TEXT>
      Variable Degrees of 1- Hydroxylase Activity&#151;Fine Tuning the Rachitic Rheostat          Thomas O. Carpenter  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050192_216.110</DOCNO>
<TEXT>
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520-8064  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050192_329.504</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Thomas O. Carpenter, M.D., Department of Pediatrics, Yale University School of Medicine, P.O. Box 208064, 333 Cedar Street, New Haven, Connecticut 06520-8064. E-mail: . thomas.carpenter{at}yale.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050194_0.176</DOCNO>
<TEXT>
      Functional Genomics and Proteomics in Term and Preterm Parturition          Roberto Romero,   Helena Kuivaniemi and   Gerard Tromp  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050194_179.317</DOCNO>
<TEXT>
    Perinatology Research Branch, Intramural Division, National Institute of Child Health and Human Development (R.R.), Bethesda, Maryland 20892; and Center for Molecular Medicine and Genetics (H.K., G.T.) and Department of Surgery (H.K.), Wayne State University School of Medicine, Detroit, Michigan 48201  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050194_499.500</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Roberto Romero, M.D., Perinatology Research Branch, National Institute of Child Health and Human Development, 4707 St. Antoine Boulevard, Detroit, Michigan 48201. E-mail: . warfiela{at}mail.nih.gov' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050197_0.120</DOCNO>
<TEXT>
      From the Editor-in-Chief          John P. Bilezikian, M.D. Editor-in-Chief  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050197_123.3588</DOCNO>
<TEXT>
          It has become traditional to emphasize in The Endocrine Society journals for the month of June, the main theme of the Annual Endocrine Society Meeting. This year, President Bill Crowley has selected for us to focus on: The Impact of the Human Genome on Endocrinology. The 84th Annual Meeting of The Endocrine Society itself will have many special features and events that illustrate how pervasive this theme has become in our specialty. For this month&#146;s issue of JCEM, we are pleased to amplify this focus with a number of invited, special feature articles that will cover areas related to human genetics and genomics. In the Special Features section of the journal, you will find articles by experts on the following topics: Genetic Control and Susceptibility to Osteoporosis (Stuart Ralston); Genetic Causes of Human Reproductive Disease (Larry Jameson); Protein-Tyrosine Phosphatases as Emerging Targets for Therapeutic Intervention in Type 2 Diabetes and Related States of Insulin Resistance (Barry Goldstein); Monogenic Disorders of Puberty (George Chrousos); Pharmacogenomics in Endocrinology (Richard Hockett); Molecular Pathogenesis of Hypophosphatemic Rickets (Suzanne Jan de Beur and Michael Levine); and The Genetics of Nonmedullary Thyroid Carcinoma (Carl Malchoff). In addition, the June issue of JCEM features original research that also has as its theme the focus of the meeting. We have designated the 39 articles that fit within this thematic context as special original articles. They are identified in the Table of Contents immediately following the Special Features Section and before the Endocrine Care Section. Covering virtually the entire spectra of subspecialties in endocrinology, these articles provide further insight into the relationship between genes and human disease. In many articles, abnormalities in single genes are identified as pathogenetic in syndromes associated with congenital adrenal hyperplasia, autosomal dominant hypocalcemia, Frasier syndrome, congenital diabetes insipidus, familial glucocorticoid resistance, vitamin D resistance, hyperthyrotropinemia, MODY-candidate genes in diabetes mellitus, multiple endocrine neoplasia type I, autoimmune polyendocrinopathy, Leydig cell hypoplasia, and Kallman syndrome. Two articles are Rapid Communications. Hinney et al. report on the Ghrelin gene in relationship to missense variants and a frameshift mutation. Arends et al. have studied the IGF-I gene with respect to its clinical relevance for short children born small for gestational age. This section of thematically related original research also include new insights into the role of certain genes in endometriosis, Graves&#146; disease, human preimplantation embryos, ovarian function, and in myometrial genes in labor and partuition. The original article by Chan et al. describing the differential expression of human myometrial genes in labor is accompanied by an editorial by Romero, Kuivaniemi, and Tromp on Functional Genomics and Proteomics in Parturition. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12050197_3714.121</DOCNO>
<TEXT>
    We hope that you will find this special issue of JCEM to be of special interest to you. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12050198_0.176</DOCNO>
<TEXT>
      Genetic Causes of Human Reproductive Disease          John C. Achermann,   Gokhan Ozisik,   Joshua J. Meeks and   J. Larry Jameson  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050198_179.343</DOCNO>
<TEXT>
    Division of Endocrinology, Metabolism and Molecular Medicine (G.O., J.J.M., J.L.J.), Northwestern University, The Feinberg School of Medicine, Chicago, Illinois 60611; and Centre for Human Growth &amp; Maturation (J.C.A.), Department of Medicine and Institute of Child Health, University College London, WC1N 1EH, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050198_525.556</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: J. Larry Jameson, M.D., Ph.D., Chairman, Department of Medicine, The Feinberg School of Medicine/Northwestern Memorial Hospital Galter Pavillon, Suite 3-150, 251 East Huron Street, Chicago, Illinois 60611-2908. E-mail: . ljameson{at}northwestern.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050199_0.153</DOCNO>
<TEXT>
      The Genetics of Hereditary Nonmedullary Thyroid Carcinoma          Carl D. Malchoff and   Diana M. Malchoff  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050199_156.90</DOCNO>
<TEXT>
    University of Connecticut Health Center, Farmington, Connecticut 06030-1850  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050199_249.494</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Carl D. Malchoff, M.D., Ph.D., Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030-1850. E-mail: . malchoff{at}nso2.uchc.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050201_0.152</DOCNO>
<TEXT>
      Molecular Pathogenesis of Hypophosphatemic Rickets          Suzanne M. Jan De Beur and   Michael A. Levine  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050201_155.317</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Medicine (S.M.J.), The Ilyssa Center for Molecular and Cellular Endocrinology (S.M.J., M.A.L.), and Division of Pediatric Endocrinology, Department of Pediatrics (M.A.L.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050201_475.457</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Suzanne M. Jan de Beur, M.D., Assistant Professor of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287. E-mail: . sjandebe{at}jhmi.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050202_0.210</DOCNO>
<TEXT>
      Protein-Tyrosine Phosphatases: Emerging Targets for Therapeutic Intervention in Type 2 Diabetes and Related States of Insulin Resistance          Barry J. Goldstein  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050202_213.231</DOCNO>
<TEXT>
    Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050202_447.598</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Barry J. Goldstein, M.D., Ph.D., Director, Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Jefferson Medical College, Jefferson Alumni Hall, Suite 349, 1020 Locust Street, Philadelphia, Pennsylvania 19107-6799. E-mail: . Barry.Goldstein{at}mail.tju.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050203_0.133</DOCNO>
<TEXT>
      Monogenic Disorders of Puberty          Sophia N. Kalantaridou and   George P. Chrousos  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050203_136.348</DOCNO>
<TEXT>
    Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology (S.N.K.), University of Ioannina, School of Medicine, 45500 Ioannina, Greece; and Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development (G.P.C.), National Institutes of Health, Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050203_487.747</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Sophia N. Kalantaridou, M.D., Department of Obstetrics and Gynecology, University Hospital of Ioannina, Panepistimiou Avenue, 45500 Ioannina, Greece. E-mail: kalantas@exchange.nih.gov; and George P. Chrousos, M.D., Chief, Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 9D42, Bethesda, Maryland 20892. E-mail: . chrousog{at}mail.nih.gov' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050204_0.170</DOCNO>
<TEXT>
      Pharmacogenomics in Endocrinology          Richard D. Hockett,   Sandra C. Kirkwood,   Bruce H. Mitlak and   Willard H. Dere  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050204_173.67</DOCNO>
<TEXT>
    Eli Lilly &amp; Company, Indianapolis, Indiana 46285  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050204_243.425</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Richard D. Hockett, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285. E-mail: . hockett{at}lilly.com' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050287_0.183</DOCNO>
<TEXT>
      Expression of Multiple Corticotropin-Releasing Hormone Receptors in the Human Heart          Edward W. Hillhouse and   Emmanouil Karteris  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050287_186.132</DOCNO>
<TEXT>
    Department of Biological Sciences, Medical Research Institute, University of Warwick Coventry CV4 7AL, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050287_321.437</DOCNO>
<TEXT>
     Address correspondence to: Prof. E. W. Hillhouse, Department of Biological Sciences, University of Warwick, Coventry, CV4 7AL, United Kingdom. E-mail: . ehillhouse{at}bio.warwick.ac.uk' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12050289_0.188</DOCNO>
<TEXT>
      Serum Cortisol and 17-Hydroxyprogesterone Concentrations in Children with Classic Congenital Adrenal Hyperplasia          Robert L. Rosenfield  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050289_191.125</DOCNO>
<TEXT>
    Section of Pediatric Endocrinology, The University of Chicago Children&#146;s Hospital Chicago, Illinois 60637  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050289_319.486</DOCNO>
<TEXT>
     Address correspondence to: Robert L. Rosenfield, M.D., University of Chicago, Department of Pediatric Endocrinology, Pritzker School of Medicine, 5841 South Maryland (M/C 5053), Chicago, Illinois 60637-1470. E-mail: . jmoore{at}peds.bsdjmoore@peds.bsd.'//--> uchicago.edu
</TEXT>
</DOC>

<DOC>
<DOCNO>12050291_0.147</DOCNO>
<TEXT>
      TSH Receptor Expression in Cardiac Muscle Tissue          Bridget E. Busuttil and   Albert G. Frauman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050291_150.142</DOCNO>
<TEXT>
    Clinical Pharmacology and Therapeutics Unit Department of Medicine University of Melbourne Heidelberg, Victoria 3084, Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>12050291_295.218</DOCNO>
<TEXT>
     Address correspondence to: Albert G. Frauman, M.D., Department of Medicine, Austin and Repatriation Medical Centre, University of Melbourne, Studley Road, Heidelberg, Victoria 3084, Australia.
</TEXT>
</DOC>

<DOC>
<DOCNO>12050292_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12050292_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12050292_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12050293_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12050293_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12050293_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12107191_0.139</DOCNO>
<TEXT>
      To Block Estrogen&#146;s Synthesis or Action: That Is the Question          Richard J. Santen  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107191_142.135</DOCNO>
<TEXT>
    Division of Endocrinology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia 22908  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107191_280.495</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Richard J. Santen, M.D., Division of Endocrinology, Department of Medicine, University of Virginia Health System, P.O. Box 800379, Charlottesville, Virginia 22908. E-mail: . rjs5y{at}virginia.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107192_0.105</DOCNO>
<TEXT>
      Somatostatin Analogs in Acromegaly          Pamela U. Freda  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107192_108.119</DOCNO>
<TEXT>
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107192_230.234</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Pamela U. Freda, M.D., Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.
</TEXT>
</DOC>

<DOC>
<DOCNO>12107193_0.155</DOCNO>
<TEXT>
      Hepatic Steatosis, Insulin Resistance, and Adipose Tissue Disorders          Abhimanyu Garg and   Anoop Misra  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107193_158.213</DOCNO>
<TEXT>
    Division of Nutrition and Metabolic Diseases Department of Internal Medicine and the Center for Human Nutrition The University of Texas Southwestern Medical Center at Dallas Dallas, Texas 75390-9052  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107193_374.500</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Abhimanyu Garg, M.D., The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9052. E-mail: . Abhimanyu.garg{at}utsouthwestern.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107195_0.170</DOCNO>
<TEXT>
      Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency          Phyllis W. Speiser  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107195_173.163</DOCNO>
<TEXT>
    Schneider Children&#146;s Hospital North Shore-Long Island Jewish Health System New York University School of Medicine New Hyde Park, New York 11042  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107195_339.526</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Phyllis W. Speiser, M.D., Schneider Children&#146;s Hospital, North Shore-Long Island Jewish Health System, New York University School of Medicine, 269-01 76th Avenue, New Hyde Park, New York 11042. E-mail: . pspeiser{at}LIJ.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107197_0.117</DOCNO>
<TEXT>
      Leptin and the Immunosuppression of Malnutrition          Carl Grunfeld  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107197_120.154</DOCNO>
<TEXT>
    University of California, San Francisco, Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, California 94121  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107197_277.493</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Carl Grunfeld, M.D., Ph.D., Metabolism Section (111F), Department of Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, California 94121. E-mail: . grunfld{at}itsa.ucsf.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107199_0.103</DOCNO>
<TEXT>
      The Skeleton, Race, and Ethnicity          Anne C. Looker  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107199_106.168</DOCNO>
<TEXT>
    Division of Health Examination Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland 20782  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107199_277.411</DOCNO>
<TEXT>
     Address all correspondence to: Anne Looker, Ph.D., Room 900, National Center for Health Statistics, 6525 Belcrest Road, Hyattsville, Maryland 20782. E-mail: . acl1{at}cdc.gov' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107270_0.344</DOCNO>
<TEXT>
      Identification and Characterization of a Putative Human Iodide Transporter Located at the Apical Membrane of Thyrocytes          Anne-Marie Rodriguez,   Barbara Perron,   Ludovic Lacroix,   Bernard Caillou,   G&eacute;rard Leblanc,   Martin Schlumberger,   Jean-Michel Bidart and   Thierry Pourcher  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107270_347.396</DOCNO>
<TEXT>
    Commissariat &agrave; l&#146;Energie Atomique LRC16V, University Nice  Sophia-Antipolis, CNRS UMR6078 (A.M.R., B.P., G.L., T.P.), F-06230  Villefranche-sur-Mer, France; and Departments of Clinical Biology  (L.L., J.M.B.), Pathology (B.C.), and Nuclear Medicine (M.S.),  Commissariat &agrave; l&#146;Energie Atomique LRC29V, Institut  Gustave-Roussy, F-94805 Villejuif Cedex, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107270_746.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12107271_0.264</DOCNO>
<TEXT>
      Vascular Endothelial Growth Factor Up-Regulates Cyclooxygenase-2 Expression in Human Endothelial Cells          Mitsutoshi Tamura,   Siby Sebastian,   Bilgin Gurates,   Sijun Yang,   Zongjuan Fang and   Serdar E. Bulun  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107271_267.147</DOCNO>
<TEXT>
    Departments of Ostetrics and Gynecology and Molecular Genetics, The  University of Illinois at Chicago, Chicago, Illinois 60612, USA  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107271_417.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12107273_0.117</DOCNO>
<TEXT>
      Soy Supplement: Why Is the Effect So Elusive?          Paola Albertazzi  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107273_120.100</DOCNO>
<TEXT>
    Centre for Metabolic Bone Disease, Hull Royal Infirmary Hull, HU3 2RW, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107273_223.470</DOCNO>
<TEXT>
     Address correspondence to: Paola Albertazzi, M.D., Centre for Metabolic Bone Disease, HS Brocklehurst Building, Hull Royal Infirmary, 220-236 Anlaby Road, Hull, HU3 2RW, United Kingdom. E-mail: . P.Albertazzi{at}Hull.ac.uk' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107275_0.207</DOCNO>
<TEXT>
      Excess Vascular Mortality in Hypopituitarism: Is it the Result of Estrogen or GH Deficiency?          Tarik A. Elhadd,   Tarig A.M. Abdu and   Richard N. Clayton  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107275_210.105</DOCNO>
<TEXT>
    Department of Medicine, Keele University Hartshill, Stoke-on-Trent, United Kingdom ST4 7QB  
</TEXT>
</DOC>


<DOC>
<DOCNO>12107275_318.434</DOCNO>
<TEXT>
     Address correspondence to: Dr. T. A. Elhadd, Department of Endocrinology, Wordsley Hospital, Stream Road, Stourbridge, West Midlands DY8 5QX, United Kingdom. E-mail: . tarikelhadd{at}aol.com' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12107276_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12107276_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12107276_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12107277_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12107277_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12107277_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12161467_0.141</DOCNO>
<TEXT>
      Diabetes on the Internet: Resources for Patients          Matthew I. Kim and   Paul W. Ladenson  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161467_144.160</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-0003  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161467_307.514</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Paul W. Ladenson, M.D., Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287-0003. E-mail: . ladenson{at}jhmi.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12161468_0.118</DOCNO>
<TEXT>
      Noonan Syndrome&#151;Certitude Replaces Conjecture          Paul Saenger  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161468_121.176</DOCNO>
<TEXT>
    Department of Pediatrics, Division of Pediatric Endocrinology, Albert Einstein College of Medicine, Children&#146;s Hospital at Montefiore, Bronx, New York 10467  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161468_300.472</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Paul Saenger, M.D., Division of Pediatric Endocrinology, Children&#146;s Hospital at Montefiore, 111 East 210th Street, Bronx, New York 10467. E-mail: . PHSAENGER{at}AOL.COM' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12161470_0.114</DOCNO>
<TEXT>
      Acromegaly&#151;Consensus, What Consensus?          Peter J. Trainer  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161470_117.97</DOCNO>
<TEXT>
    Department of Endocrinology, Christie Hospital, Manchester M20 4BX, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161470_217.470</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Peter J. Trainer, M.D., FRCP, Department of Endocrinology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, United Kingdom. E-mail: . peter.trainer{at}man.ac.uk' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12161550_0.223</DOCNO>
<TEXT>
      Insulin Regulates Plasma Ghrelin Concentration          Mohammed F. Saad,   Basem Bernaba,   Chii-Min Hwu,   Sujata Jinagouda,   Salwa Fahmi,   Ella Kogosov and   Rima Boyadjian  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161550_226.129</DOCNO>
<TEXT>
    Division of Clinical Epidemiology and Preventive Medicine, UCLA  School of Medicine, Los Angeles, California 90024  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161550_358.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12161551_0.197</DOCNO>
<TEXT>
      Activin A Promotes Human Endometrial Stromal Cell Decidualization in Vitro          Rebecca L. Jones,   Lois A. Salamonsen and   Jock K. Findlay  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161551_200.95</DOCNO>
<TEXT>
    Prince Henry&#146;s Institute of Medical Research, Clayton, VIC 3168,  Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161551_298.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12161552_0.342</DOCNO>
<TEXT>
      A Variation in the Ghrelin Gene Increases Weight and Decreases Insulin Secretion in Tall, Obese Children          M&aacute;rta Korbonits,   Maria Gueorguiev,   Eithne O&#146;Grady,   Cecile Lecoeur,   Daniel C. Swan,   Charles A. Mein,   Jacques Weill,   Ashley B. Grossman and   Philippe Froguel  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161552_345.389</DOCNO>
<TEXT>
    Department of Endocrinology (M.K., M.G., A.B.G.), St.  Bartholomew&#146;s Hospital, London EC1A 7BE, United Kingdom; The  Bart&#146;s &amp;  The London Genome Centre (M.G., C.L., D.C.S., C.A.M., P.F.), St.  Bartholomew&#146;s and the Royal London School of Medicine and Dentistry,  United Kingdom; and CNRS-Institute of Biology (J.W., P.F.) Pasteur  Institute, Lille, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161552_737.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12161553_0.213</DOCNO>
<TEXT>
      Author's Response: Effect of Estrogen Versus Testosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men          Sundeep Khosla  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161553_216.121</DOCNO>
<TEXT>
    Division of Endocrinology, Metabolism, and Nutrition Mayo Clinic and Foundation Rochester, Minnesota 55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161553_340.434</DOCNO>
<TEXT>
     Address correspondence to: Sundeep Khosla, M.D., Mayo Clinic, Endocrine Research Unit, 200 First Street SW, 5-194 Joseph, Rochester, Minnesota 55905. E-mail: . Khosla.Sundeep{at}Mayo.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12161554_0.230</DOCNO>
<TEXT>
      Dehydroepiandrosterone Supplementation in Elderly Men: The Role of Estrogens Versus Androgens on the Male Skeleton          Lorenz C. Hofbauer,   Bruno Allolio and   Wiebke Arlt  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161554_233.240</DOCNO>
<TEXT>
    Division of Gastroenterology and Endocrinology (L.C.H.), Philipps-University, D-35033 Marburg, Germany; and Department of Medicine (B.A., W.A.), Endocrine and Diabetes Unit, University of Wuerzburg, D-97080 Wuerzburg, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>12161554_476.504</DOCNO>
<TEXT>
     Address correspondence to: Lorenz C. Hofbauer, M.D., Division of Gastroenterology, Endocrinology and Metabolism, Department of Medicine, Philipps University, Baldingerstrasse, D-35033 Marburg, Germany. E-mail: . hofbauer{at}post.med.uni-marburg.de' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12161555_0.85</DOCNO>
<TEXT>
      The Endocrine Society Awards             
</TEXT>
</DOC>


<DOC>
<DOCNO>12161555_88.485</DOCNO>
<TEXT>
          RECIPIENTS of the Awards of The Endocrine Society are selected by the Awards Committee. The Endocrine Society Awards may be made to endocrinologists, members or non-members, from anywhere in the world. Nominations may be made by Society members only. A complete listing of all past Awardees is in The Endocrine Society Member Directory and within the Society&#146;s Web site, www.endo-society.org. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12161555_576.305</DOCNO>
<TEXT>
    Nominations must be submitted on the appropriate form by early April. The nomination form may be obtained by visiting the Society Web site or by writing to the Executive Office. It is important to document the nominee&#146;s contributions to endocrinology. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12161556_0.97</DOCNO>
<TEXT>
      THE ENDOCRINE SOCIETY 2002 ANNUAL AWARDS             
</TEXT>
</DOC>


<DOC>
<DOCNO>12161556_100.149</DOCNO>
<TEXT>
          Citation for the 2002 Fred Conrad Koch Award of The Endocrine Society to Dr. Jan-&Aring;ke Gustafsson
</TEXT>
</DOC>


<DOC>
<DOCNO>12161556_252.641</DOCNO>
<TEXT>
    Jan-&Aring;ke Gustafsson, the recipient of the 2002 Fred Conrad Koch Award, is Professor and Chairman of both the Departments of Medical Nutrition and of Bioscience at the Karolinska Institute in Sweden. Since the early 1980s, he has played a key role in the development of the new south campus in Huddinge, now the most rapidly expanding part of the Karolinska Institute, at the same time making the exciting scientific discoveries for which he is being honored. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12161557_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12161557_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12161557_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12161558_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12161558_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12161558_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12213840_0.222</DOCNO>
<TEXT>
      The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence          Mishaela R. Rubin and   John P. Bilezikian  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213840_225.164</DOCNO>
<TEXT>
    Departments of Medicine (M.R.R., J.P.B.) and Pharmacology (J.P.B.), College of Physicians and Surgeons, Columbia University, New York, New York 10032  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213840_392.2638</DOCNO>
<TEXT>
          One of the most important of the secondary causes of osteoporosis is chronic exposure to glucocorticoids, which are used for an extraordinarily large number of disorders. The adverse effects of hypercortisolism on bone metabolism were recognized more than half a century ago (1). Today, glucocorticoid exposure in the context of medicinal use has become far more common than excess endogenous exposure (Cushing&#146;s syndrome). Glucocorticoid-induced osteoporosis (GIO) is the third most common cause of osteoporosis, trailing only postmenopausal and age-related osteoporosis (2). As many as 50% of individuals on chronic glucocorticoid therapy will suffer an osteoporotic fracture (3). Recently, a large-scale retrospective cohort study by Van Staa et al. (4) in England clearly demonstrated that fracture risk is increased across virtually the entire dosage range of oral glucocorticoids. A large number of subjects with a history of glucocorticoid exposure (n = 244,235) were matched to the same number of control patients who had no history of glucocorticoid exposure. The average age of the subjects was 57 yr; respiratory diseases were the common indication for therapy, being prescribed in 40% of the patients (4). Referent to nonglucocorticoid users, subjects with a history of glucocorticoid therapy had significantly greater risk for fractures at the spine (rr = 2.6), the hip (rr = 1.6), and at any nonvertebral site (rr = 1.3). The magnitude of the fracture risk was directly related to dosage, with subjects receiving as little as 2.5 mg of prednisolone at significantly greater risk than control subjects (4). Bone loss from glucocorticoid use was also found to occur rapidly, within the first 3 months of treatment. A similarly precipitous loss of bone mass has also been observed prospectively when glucocorticoids are used in the setting of organ transplantation (5, 6), and in other clinical situations (7, 8, 9, 10). Even inhaled steroids have been implicated as a cause of bone loss (11, 12). 
</TEXT>
</DOC>

<DOC>
<DOCNO>12213841_0.97</DOCNO>
<TEXT>
      Postpartum Thyroiditis          Alex Stagnaro-Green  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213841_100.126</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, New York 10029  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213841_229.466</DOCNO>
<TEXT>
          Postpartum thyroiditis is a common thyroid disorder that presents during the first postpartum year. It is the occurrence of either transient hyperthyroidism, transient hypothyroidism, or transient hyperthyroidism followed by transient hypothyroidism (Fig. 1). Most, but not all, women are euthyroid 1 yr postpartum. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12213842_0.250</DOCNO>
<TEXT>
      Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology          Joint LWPES/ESPE CAH Working Group  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213842_253.469</DOCNO>
<TEXT>
    Writing Committee: Peter E. Clayton, Royal Manchester Children&#146;s Hospital, Manchester, United Kingdom; Walter L. Miller*, University of California, San Francisco, California; Sharon E. Oberfield, Columbia University, New York, New York; E. Martin Ritz&eacute;n, Karolinska Institute, Stockholm, Sweden; Wolfgang G. Sippell*, University Children&#146;s Hospital, Kiel, Germany; Phyllis W. Speiser, New York University, New York, New York (*co-chairs)  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213842_725.601</DOCNO>
<TEXT>
     Address requests for reprints to: Dr. Raymond L. Hintz, Secretary, Lawson Wilkins Pediatric Endocrine Society, 867 Allardice Way, Stanford, California 94305, E-mail:  or Dr. Martin O. Savage, Secretary, European Society for Pediatric Endocrinology, St. Bartholomew&#146;s Hospital, London EC1A 7BE, United Kingdom, E-mail: . m.o.savage{at}mds.qmw.ac.uk' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12213843_0.367</DOCNO>
<TEXT>
      Guidelines for Acromegaly Management          S. Melmed,   F. F. Casanueva,   F. Cavagnini,   P. Chanson,   L. Frohman,   A. Grossman,   K. Ho,   D. Kleinberg,   S. Lamberts,   E. Laws,   G. Lombardi,   M. L. Vance,   K. Von Werder,   J. Wass and   A. Giustina for the Acromegaly Treatment Consensus Workshop Participants  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213843_370.816</DOCNO>
<TEXT>
    Cedars-Sinai Research Institute-UCLA School of Medicine (S.M.), Los Angeles, California 90048; Santiago de Compostela University (F.F.C.), Santiago de Compostela, Spain; University of Milan (F.C.), Milan, Italy; Hospital Bicetre (P.C.), France; University of Illinois (L.F.), Chicago, Illinois; St. Bartholomew&#146;s Hospital (A.G.), London, United Kingdom; Garvan Institute of Medical Research (K.H.), Australia; New York University Medical Center (D.K.), New York, New York; University Hospital of Rotterdam (S.L.), Rotterdam, The Netherlands; University of Virginia (E.L., M.L.V.), Charlottesville, Virginia; School of Medicine (G.L.), Naples, Italy; Schlosspark Klinik (K.V.W.), Berlin, Germany; Radcliffe Infirmary (J.W.), Oxford, United Kingdom; and University of Brescia (A.G.), Brescia, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213843_1189.441</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Shlomo Melmed, M.D., Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room 2015, Los Angeles, California 90048. E-mail: . melmed{at}csmc.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12213844_0.164</DOCNO>
<TEXT>
      Optimizing the Outcomes of Adjuvant Radioiodine Therapy in Differentiated Thyroid Carcinoma          Steven I. Sherman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213844_167.89</DOCNO>
<TEXT>
    The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213844_259.476</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Steven I. Sherman, M.D., The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 435, Houston, Texas 77030. E-mail: . sisherma{at}mdanderson.org' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12213847_0.173</DOCNO>
<TEXT>
      The Etiology of Thyroid Dysgenesis&#151;Still an Enigma after All These Years          Rosalind S. Brown and   Laurie A. Demmer  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213847_176.115</DOCNO>
<TEXT>
    Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts 01655  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213847_294.498</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Rosalind S. Brown, M.D., Department of Pediatrics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655. E-mail: . Rosalind.Brown{at}umassmed.edu' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12213849_0.180</DOCNO>
<TEXT>
      Osteoprotegerin Gene Polymorphism and the Risk of Osteoporosis and Vascular Disease          Lorenz C. Hofbauer and   Michael Schoppet  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213849_183.194</DOCNO>
<TEXT>
    Departments of Internal Medicine and Gastroenterology, Endocrinology and Metabolism (L.C.H.) and Cardiology (M.S.), Philipps-University, Baldingerstrasse, D-35033 Marburg, Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213849_380.543</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Lorenz C. Hofbauer, M.D., Division of Gastroenterology, Endocrinology and Metabolism, Department of Internal Medicine, Philipps-University, Baldingerstrasse, D-35033 Marburg, Germany. E-mail: . hofbauer{at}post.med.uni-marburg.de' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12213851_0.158</DOCNO>
<TEXT>
      Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling          Ricardo Azziz  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213851_161.114</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California 90048  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213851_278.499</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Ricardo Azziz, M.D., M.P.H., M.B.A., Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Suite 160W, 8635 West Third Street, Los Angeles, California 90048. E-mail: . azzizr{at}cshs.org' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12213909_0.221</DOCNO>
<TEXT>
      Galectin-3 Is Not an Universal Marker of Malignancy in Thyroid Nodular Disease in Children and Adolescents          Marek Niedziela,   Jaroslaw Maceluch and   Eugeniusz Korman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213909_224.317</DOCNO>
<TEXT>
    Department of Pediatric Endocrinology and Diabetes, Institute of  Pediatrics, Karol Marcinkowski University of Medical Sciences in Poznan  (M.N., E.K.), and Department of Gene Expression, Institute of Molecular  Biology and Biotechnology, University of Adam Mickiewicz in Poznan  (J.M.), Poznan, Poland  
</TEXT>
</DOC>


<DOC>
<DOCNO>12213909_544.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12213910_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12213910_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12213910_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12213911_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12213911_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12213911_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12364411_0.157</DOCNO>
<TEXT>
      Adult Growth Hormone Replacement: Lessons Learned and Future Direction          R. D. Murray and   S. M. Shalet  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364411_160.97</DOCNO>
<TEXT>
    Department of Endocrinology, Christie Hospital, Manchester, United Kingdom M20 4BX  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364411_260.496</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Prof. S. M. Shalet, Department of Endocrinology, Christie Hospital, National Health Service Trust, Wilmslow Road, Manchester, United Kingdom M20 4BX. E-mail: stephen.m.shalet{at}man.ac.uk' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12364412_0.191</DOCNO>
<TEXT>
      Beyond Bone Mineral Density&#151;Navigating the Laboratory Assessment of Patients with Osteoporosis          Rachel B. Wagman and   Robert Marcus  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364412_194.65</DOCNO>
<TEXT>
    Eli Lilly and Company, Indianapolis, Indiana 46285  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364412_262.190</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Robert Marcus, M.D., Eli Lilly and Company, 1400 Raymond Street, Building 172, Indianapolis, Indiana 46285.
</TEXT>
</DOC>

<DOC>
<DOCNO>12364414_0.177</DOCNO>
<TEXT>
      Once and Again&#151;Issues Surrounding Replication in Genetic Association Studies          Joel N. Hirschhorn and   David Altshuler  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364414_180.443</DOCNO>
<TEXT>
    Divisions of Genetics and Endocrinology (J.N.H.), Children&#146;s Hospital, Boston, Massachusetts 02115; Departments of Genetics (J.N.H., D.A.) and Medicine (D.A.), Harvard Medical School, Boston, Massachusetts 02114; Whitehead/MIT Center for Genome Research (J.N.H., D.A.), Cambridge, Massachusetts 02139; and Department of Molecular Biology and Diabetes Unit (D.A.), Massachusetts General Hospital, Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364414_626.203</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Joel N. Hirschhorn, M.D., Ph.D., Children&#146;s Hospital, Enders 561, 300 Longwood Avenue, Boston, Massachusetts 02115.
</TEXT>
</DOC>

<DOC>
<DOCNO>12364480_0.309</DOCNO>
<TEXT>
      A Histone Deacetylase Inhibitor Enhances Killing of Undifferentiated Thyroid Carcinoma Cells by p53 Gene Therapy          Ryo Imanishi,   Akira Ohtsuru,   Miyoko Iwamatsu,   Takashi Iioka,   Hiroyuki Namba,   Shinji Seto,   Katsusuke Yano and   Shunichi Yamashita  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364480_312.307</DOCNO>
<TEXT>
    Department of Molecular Medicine, Atomic Bomb Disease Institute  (R.I., A.O., M.I., T.I., H.N., S.Y.), and Department of Cardiovascular  Medicine (R.I., S.S., K.Y.), Course of Medical and Dental Sciences,  Graduate School of Biomedical Sciences, Nagasaki University,  Nagasaki 852-8523, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364480_622.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12364481_0.277</DOCNO>
<TEXT>
      Receptor-Misrouting: An Unexpectedly Prevalent and Rescuable Etiology in Gonadotropin-Releasing Hormone Receptor-Mediated Hypogonadotropic Hypogonadism          Alfredo Lea&ntilde;os-Miranda,   Jo Ann Janovick and   P. Michael Conn  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364481_280.165</DOCNO>
<TEXT>
    Oregon National Primate Research Center and Department of  Physiology and Pharmacology, Oregon Health and Science University,  Beaverton, Oregon 97006  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364481_448.158</DOCNO>
<TEXT>
     Address correspondence to: P. Michael Conn, M.D., Oregon Health and Science University, 505 NW 18th Street, Beaverton, Oregon 97006.
</TEXT>
</DOC>

<DOC>
<DOCNO>12364482_0.375</DOCNO>
<TEXT>
      Ghrelin Secretion Is Inhibited by Either Somatostatin or Cortistatin in Humans          Fabio Broglio,   Peter van Koetsveld,   Andrea Benso,   Cristina Gottero,   Flavia Prodam,   Mauro Papotti,   Giampiero Muccioli,   Carlotta Gauna,   Leo Hofland,   Romano Deghenghi,   Emanuela Arvat,   Aart Jan van der Lely and   Ezio Ghigo  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364482_378.490</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Department of Internal  Medicine (F.B., A.B., C.G., F.P., C.G., E.A., E.G.), Department of  Biomedical Sciences and Oncology (M.P.), and Department of Anatomy,  Pharmacology and Forensic Medicine (G.M.), University of Turin, Turin,  Italy; Division of Endocrinology, Department of Internal Medicine  (P.V.K., L.H., A.J.V.D.L.), Erasmus University of Rotterdam, Rotterdam,  The Netherlands; and Europeptides (R.D.), Argenteuil, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364482_871.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12364483_0.116</DOCNO>
<TEXT>
      Macroprolactinemia Is Clinically Important          Adebayo O. Olukoga  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364483_119.64</DOCNO>
<TEXT>
    East Didsbury, Manchester M20 5QD, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364483_186.398</DOCNO>
<TEXT>
     Address correspondence to: Adebayo O. Olukoga, M.D., 9 Jayton Avenue, East Didsbury, Manchester M20 5QD, United Kingdom. E-mail: aolukoga{at}hotmail.com' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12364484_0.149</DOCNO>
<TEXT>
      Author&#146;s Response: Macroprolactinemia Revisited&#151;A Study on 106 Patients          Thierry Brue  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364484_152.98</DOCNO>
<TEXT>
    Department of Endocrinology, Hopital de la Timone, 13385 Marseille, Cedex 5, France  
</TEXT>
</DOC>


<DOC>
<DOCNO>12364484_253.419</DOCNO>
<TEXT>
     Address correspondence to: Thierry Brue, M.D., Department of Endocrinology, Hopital de la Timone, 264 rue Saint Pierre, 13385 Marseille, Cedex 5, France. E-mail: tbrue{at}ap-hm.fr' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12364485_0.207</DOCNO>
<TEXT>
      The Endocrine Society and Pharmacia Corporation Award for Published Clinical Research in The Journal of Clinical Endocrinology &amp; Metabolism             
</TEXT>
</DOC>


<DOC>
<DOCNO>12364485_210.198</DOCNO>
<TEXT>
          The Endocrine Society and Pharmacia Corporation Award for Published Clinical Research in The Journal of Clinical Endocrinology &amp; Metabolism
</TEXT>
</DOC>


<DOC>
<DOCNO>12364485_411.663</DOCNO>
<TEXT>
    In 1998, The Endocrine Society, through the generous support of the Pharmacia Corporation, established the annual award "The Pharmacia Corporation International Award for Excellence in Published Clinical Research in The Journal of Clinical Endocrinology &amp; Metabolism (JCE&amp;M)" for the best clinical research papers that appear in JCE&amp;M. The purpose of the award is to encourage, recognize, and reward excellence in clinical research in endocrinology. There are no restrictions with respect to professional affiliation or geographic location. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12364486_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12364486_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12364486_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12364487_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12364487_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12364487_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12414838_0.152</DOCNO>
<TEXT>
      Advances in Diagnosis and Treatment of Hyperinsulinism in Infants and Children          Charles A. Stanley  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414838_155.116</DOCNO>
<TEXT>
    Division of Endocrinology, Children&#146;s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414838_274.277</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Charles A. Stanley, M.D., Division of Endocrinology, Children&#146;s Hospital of Philadelphia, 409 G. Abramson Research Center, 3516 Civic Center Building, Philadelphia, Pennsylvania 19104-6205.
</TEXT>
</DOC>

<DOC>
<DOCNO>12414840_0.158</DOCNO>
<TEXT>
      Adrenal Incidentaloma&#151;A Modern Disease with Old Complications          Alberto Angeli and   Massimo Terzolo  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414840_161.138</DOCNO>
<TEXT>
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universit&agrave; di Torino, 10043 Orbassano (TO), Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414840_302.471</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Alberto Angeli, M.D., Dipartimento di Scienze Cliniche e Biologiche, A.S.O. San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy. E-mail: alberto.angeli{at}unito.it' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12414842_0.93</DOCNO>
<TEXT>
      Channel Surfing          Louis J. Pt&aacute;cek  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414842_96.139</DOCNO>
<TEXT>
    Howard Hughes Medical Institute, Departments of Neurology and Human Genetics, University of Utah, Salt Lake City, Utah 84112  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414842_238.538</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Louis J. Pt&aacute;cek, M.D., Associate Investigator, Howard Hughes Medical Institute, University of Utah, 4420 Eccles Institute of Human Genetics, 15 North 2030 East, Salt Lake City, Utah 84112. E-mail: ptacek{at}genetics.utah.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12414843_0.280</DOCNO>
<TEXT>
      A Mutation in the KCNE3 Potassium Channel Gene Is Associated with Susceptibility to Thyrotoxic Hypokalemic Periodic Paralysis          Magnus R. Dias Da Silva,   Janete M. Cerutti,   Liliane A. T. Arnaldi and   Rui M. B. Maciel  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414843_283.206</DOCNO>
<TEXT>
    Laboratory of Molecular Endocrinology, Division of Endocrinology,  Department of Medicine, Escola Paulista de Medicina, Universidade  Federal de S&atilde;o Paulo, S&atilde;o Paulo, SP, Brazil  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414843_492.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12414858_0.386</DOCNO>
<TEXT>
      Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia          Yuji Yamazaki,   Ryo Okazaki,   Minako Shibata,   Yukihiro Hasegawa,   Kohei Satoh,   Toshihiro Tajima,   Yasuhiro Takeuchi,   Toshiro Fujita,   Kazuhiko Nakahara,   Takeyoshi Yamashita and   Seiji Fukumoto  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414858_389.510</DOCNO>
<TEXT>
    Pharmaceutical Research Labs, KIRIN Brewery Co. Ltd. (Y.Y., T.Y.);  Third Department of Medicine, Teikyo University School of Medicine  (R.O., M.S.); Endocrinology, Metabolism and Genetics Unit, Tokyo  Metropolitan Kiyose Children&#146;s Hospital (Y.H.); Department of  Pediatrics, Hokkaido University School of Medicine (K.S., T.T.);  Department of Medicine, University of Tokyo School of Medicine (Y.T.,  T.F.); and Department of Laboratory Medicine, University of Tokyo  Hospital (K.N., S.F.)  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414858_902.52</DOCNO>
<TEXT>
      Abstract
</TEXT>
</DOC>

<DOC>
<DOCNO>12414911_0.470</DOCNO>
<TEXT>
      Transcriptional Expression of Genes Involved in Cell Invasion and Migration by Normal and Tumoral Trophoblast Cells          Jean-Louis Janneau,   Juan Maldonado-Estrada,   G&eacute;rard Tachdjian,   Isabelle Miran,   Nelly Mott&eacute;,   Patrick Saulnier,   Jean-Christophe Sabourin,   Jean-Fran&ccedil;ois Cot&eacute;,   B&eacute;n&eacute;dicte Simon,   Ren&eacute; Frydman,   G&eacute;rard Chaouat and   Dominique Bellet  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414911_473.722</DOCNO>
<TEXT>
    Laboratoire d&#146;Immunologie des Tumeurs ESA 8067 CNRS (J.L.J.,  D.B.), Facult&eacute; des Sciences Pharmaceutiques et Biologiques de  Paris, Universit&eacute; Ren&eacute; Descartes-Paris 5, Paris, Equipe  cytokines et r&eacute;gulation marterno-foetale, U131 INSERM (J.M.E.,  G.C.), Service de Biologie et G&eacute;n&eacute;tique de la Reproduction  (G.T.), Service de Gyn&eacute;cologie Obst&eacute;trique (B.S., R.F.),  H&ocirc;pital Antoine B&eacute;cl&egrave;re, Clamart, France; University  of Antioquia (J.M.E.), Medellin, Columbia; and Service de Biologie  Oncologique (I.M., N.M., P.S., D.B.) and Service d&#146;Anatomie  Pathologique (J.C.S., J.F.C.), Institut Gustave Roussy, Villejuif,  France  
</TEXT>
</DOC>


<DOC>
<DOCNO>12414911_1198.192</DOCNO>
<TEXT>
     Address correspondence to: Dominique Bellet, M.D., Service de Biologie Oncologique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France.
</TEXT>
</DOC>

<DOC>
<DOCNO>12414912_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12414912_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12414912_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12414913_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12414913_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12414913_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12466319_0.645</DOCNO>
<TEXT>
      Growth Hormone Treatment and Neoplasia&#151;Coincidence or Consequence?           Lawson Wilkins Pediatric Endocrine Society (LWPES) Writing Committee: Mark A. Sperling (University of Pittsburgh School of Medicine, Pittsburgh, PA), Paul H. Saenger (Albert Einstein College of Medicine, Bronx, NY), Ray Hintz (Stanford University School of Medicine, Stanford, CA), Tom Wilson (State University of New York, Stony Brook, NY), and Susan R. Rose (Cincinnati Children&#146;s Hospital Medical Center, Cincinnati, OH) on behalf of the LWPES Executive Committee and the LWPES Drug and Therapeutics Committee  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466319_648.480</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Mark A. Sperling, M.D., Department of Pediatrics/Endocrinology, Children&#146;s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, Pennsylvania 15213-2583. E-mail: masp{at}pitt.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>


<DOC>
<DOCNO>12466319_1131.1313</DOCNO>
<TEXT>
      The discovery that GH action in primates was species specific and the ability to extract GH from human pituitaries ushered in the era of GH therapy for humans in the 1950s. At the outset, these were investigational programs facilitated by a centralized and usually government-sponsored distribution program that also enabled monitoring of data on beneficial or adverse effects. Recombinant DNA-derived GH became available in 1985, shortly after human-derived GH was discontinued because of the occurrence of Creutzfeldt-Jakob disease in several recipients from different countries. With the introduction of recombinant DNA-derived GH, the indications for GH replacement therapy were broadened to include Turner&#146;s syndrome, chronic renal failure, Prader-Willi syndrome, and small-for-gestational-age, in addition to established GH deficiency in children. However, monitoring of potential adverse effects was meticulously continued, facilitated by scrupulously maintained, and continually enlarging, databases involving both government and pharmaceutical companies in concert with pediatric investigators. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12466320_0.371</DOCNO>
<TEXT>
      Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century          John P. Bilezikian,   John T. Potts, Jr.,   Ghada El-Hajj Fuleihan,   Michael Kleerekoper,   Robert Neer,   Munro Peacock,   Jonas Rastad,   Shonni J. Silverberg,   Robert Udelsman and   Samuel A. Wells  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466320_374.820</DOCNO>
<TEXT>
    Department of Medicine, Columbia University College of Physicians and Surgeons (J.P.B., S.J.S.), New York, New York 10032; Department of Medicine, Massachusetts General Hospital, Harvard Medical School (J.T.P., R.N.), Boston, Massachusetts 02114; American University of Beirut Medical Center (G.E.-H.F.), Beirut, Lebanon; Department of Medicine, Wayne State University School of Medicine (M.K.), Detroit, Michigan 48201; Department of Medicine, Indiana University School of Medicine (M.P.), Indianapolis, Indiana 46202; Department of Surgery, University Hospital (J.R.), Uppsala, Sweden; Department of Surgery, Yale-New Haven Hospital, Yale University School of Medicine (R.U.), New Haven, Connecticut 06520; and Department of Surgery, Duke University Medical Center (S.A.W.), Durham, North Carolina 27710  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466320_1197.463</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John P. Bilezikian, M.D., Department of Medicine, College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032. E-mail: jpb2{at}columbia.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466321_0.192</DOCNO>
<TEXT>
      Early Clinical Development of Pharmaceuticals for Type 2 Diabetes Mellitus: From Preclinical Models to Human Investigation          John A. Wagner  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466321_195.105</DOCNO>
<TEXT>
    Department of Clinical Pharmacology, Merck Research Laboratories, Rahway, New Jersey 07065  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466321_303.489</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. John A. Wagner, Department of Clinical Pharmacology, Merck Research Laboratories, P.O. Box 2000, RY34-A548, 126 East Lincoln Avenue, Rahway, New Jersey 07065. E-mail: wagner{at}merck.com' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466323_0.162</DOCNO>
<TEXT>
      The Genetics of Autoimmune Thyroid Disease          Bijayeswar Vaidya,   Pat Kendall-Taylor and   Simon H. S. Pearce  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466323_165.199</DOCNO>
<TEXT>
    School of Clinical Medical Sciences (B.V., P.K.-T., S.H.S.P.) and Institute of Human Genetics (S.H.S.P.), University of Newcastle upon Tyne, Newcastle upon Tyne NE1 3BZ, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466323_367.478</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Simon Pearce, Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, United Kingdom. E-mail: spearce{at}hgmp.mrc.ac.uk' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466324_0.113</DOCNO>
<TEXT>
      Local Biosynthesis of Sex Steroids in Bone          Juliet Compston  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466324_116.123</DOCNO>
<TEXT>
    Department of Medicine University of Cambridge School of Clinical Medicine Cambridge CB2 2QQ, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466324_242.445</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. J. E. Compston, Box 157, Department of Medicine, Addenbrooke&#146;s Hospital, Cambridge CB2 2QQ, United Kingdom. E-mail: jec1001{at}cam.ac.uk' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466326_0.100</DOCNO>
<TEXT>
      The Macroprolactin Problem          Janet A. Schlechte  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466326_103.87</DOCNO>
<TEXT>
    Department of Internal Medicine University of Iowa Iowa City, Iowa 52242  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466326_193.184</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Janet A. Schlechte, M.D., Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52242.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466328_0.142</DOCNO>
<TEXT>
      Intrahepatically Transplanted Islets&#151;Strangers in a Strange Land          R. Paul Robertson  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466328_145.104</DOCNO>
<TEXT>
    Pacific Northwest Research Institute and the University of Washington Seattle, Washington  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466328_252.213</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: R. Paul Robertson, M.D., Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington 98122.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466345_0.290</DOCNO>
<TEXT>
      Effects of Pioglitazone in Nondiabetic Patients with Arterial Hypertension: A Double-Blind, Placebo-Controlled Study          S. F&uuml;llert,   F. Schneider,   E. Haak,   H. Rau,   K. Badenhoop,   G. L&uuml;bben,   K.-H. Usadel and   T. Konrad  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466345_293.227</DOCNO>
<TEXT>
    Medical Department I, J. W. Goethe University (S.F., F.S., E.H.,  H.R., K.B., K.-H.U.), Frankfurt, Germany; Institute for Metabolic  Research (T.K.), Frankfurt, Germany; and Takeda Pharma (G.L.), Aachen,  Germany  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466345_523.194</DOCNO>
<TEXT>
     Address correspondence to: Thomas Konrad, M.D., Institut f&uuml;r Stoffwechselforschung, European RISC Study Centre, Heidelbergerstrasse 13, D-60327 Frankfurt, Germany.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466393_0.429</DOCNO>
<TEXT>
      Increased 25-Hydroxyvitamin D3 1-Hydroxylase and Reduced 25-Hydroxyvitamin D3 24-Hydroxylase Expression in Parathyroid Tumors: New Prospects for Treatment of Hyperparathyroidism with Vitamin D          Pamela Correa,   Ulrika Segersten,   Per Hellman,   G&ouml;ran &Aring;kerstr&ouml;m and   Gunnar Westin  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466393_432.119</DOCNO>
<TEXT>
    Department of Surgical Sciences, Endocrine Unit, Uppsala University  Hospital, SE-751 85 Uppsala, Sweden  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466393_554.226</DOCNO>
<TEXT>
     Address correspondence to: Gunnar Westin, M.D., Department of Surgical Sciences, Endocrine Unit, Uppsala University, Klinisk forskningsavdelning 2, ingang 70, plan 3, lab 9, SE-751 85 Uppsala, Sweden.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466394_0.290</DOCNO>
<TEXT>
      Fasting and Post-Glucose Ghrelin Levels in SGA Infants: Relationships with Size and Weight Gain at One Year of Age          Germ&aacute;n I&ntilde;iguez,   Ken Ong,   Veronica Pe&ntilde;a,   Alejandra Avila,   David Dunger and   Veronica Mericq  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466394_293.316</DOCNO>
<TEXT>
    Institute of Maternal and Child Research (G.I., A.A., V.M.) and  Department of Obstertrics and Gynecology, Faculty of Medicine (V.P.),  University of Chile, Santiago, Chile; and Department of Paediatrics  (K.O., D.D.), University of Cambridge, Addenbrookes Hospital, Cambridge  CB2 2QQ, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466394_612.182</DOCNO>
<TEXT>
     Address correspondence to: Germ&aacute;n I&ntilde;iguez Vila, Institute of Maternal and Child Research, University of Chile, Casilla 226-3, Santiago, Chile.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466395_0.304</DOCNO>
<TEXT>
      The Quantitative Insulin Sensitivity Check Index QUICKI Predicts the Onset of Type 2 Diabetes Better Than Fasting Plasma Insulin in Obese Subjects: A 5-Year Follow-Up Study          P. Vanhala,   M. Vanhala,   E. Kumpusalo and   S. Kein&auml;nen-Kiukaanniemi  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466395_307.308</DOCNO>
<TEXT>
    Imatra Health Centre (P.V.), Laukaa Health Centre (M.V.), Kuopio  University; Department of Public Health and General Practice (E.K.),  Kuopio University Hospital; General Practice (E.K.), Oulu University;  and Department of Public Health Science and General Practice (P.V.,  S.K.-K.), Finland  
</TEXT>
</DOC>


<DOC>
<DOCNO>12466395_618.169</DOCNO>
<TEXT>
     Address correspondence to: Pasi Vanhala, M.D., Department of Public Health and General Practice, Oulu University, PL-5000, 90020 Oulu, Finland.
</TEXT>
</DOC>

<DOC>
<DOCNO>12466396_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12466396_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12466396_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12466397_0.217</DOCNO>
<TEXT>
      National Hormone & Peptide Program - NIDDK: Recombinant Hormones, Hypothalamic Peptides & Other Hormones, Antisera, Reagents, & Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12466397_220.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12466397_245.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12519818_0.155</DOCNO>
<TEXT>
      The JCEM in 2003&#151;Looking Backwards and Forwards          John P. Bilezikian, M.D. Editor-in-Chief  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519818_158.363</DOCNO>
<TEXT>
          With this issue, the JCEM begins its fourth year in the New York-based editorial office at the College of Physicians and Surgeons, Columbia University. With hindsight and hopefully with some foresight, I would like to call your attention to points and perspectives as we begin the new year. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12519818_524.1480</DOCNO>
<TEXT>
    The Journal continues to attract original articles of exceptionally high quality. The distribution of endocrinological subcategories has been relatively constant over the past 3 years with Reproductive Endocrinology, Thyroid, Diabetes, Metabolism, Adrenal, Bone, Neuroendocrinology, Pediatric endocrinology, Molecular endocrinology, Oncology, Cardiovascular, and Obesity underscoring the premier position of JCEM as a repository of clinical endocrinology in its many different disciplinary configurations. I am relieved to report that during the past year, we finally saw a stabilization of what was an unprecedented period of growth. The number of papers submitted to JCEM did not change substantially over the past year. You will recall that in the previous 2-year period, the increase in submissions exceeded 20%. Papers continue to be received from all over the world with over 45 countries represented. The distribution of papers has not changed substantially with the United States heading the list (27%), followed by Italy (10%), Japan (9%), United Kingdom (8%), and Germany (7%). By region, papers from Europe constituted 49.3% of all manuscripts submitted, followed by North America (29.9%), Asia (13.9%) and "Other regions" (5.7%). 
</TEXT>
</DOC>

<DOC>
<DOCNO>12519819_0.165</DOCNO>
<TEXT>
      Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients          Michael Freemark  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519819_168.125</DOCNO>
<TEXT>
    Division of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, North Carolina 27710  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519819_296.454</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Michael Freemark, Box 3080, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710. E-mail: freem001{at}mc.duke.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12519820_0.175</DOCNO>
<TEXT>
      Reduced Metabolic Rate after Caloric Restriction&#151;Can We Agree on How to Normalize the Data?          &Eacute;ric T. Poehlman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519820_178.194</DOCNO>
<TEXT>
    D&eacute;partement de Nutrition, Unit&eacute; M&eacute;tabolique, Universit&eacute; de Montr&eacute;al, Pavillon Lilliane de Stewart Montr&eacute;al, Qu&eacute;bec H3T 1A8, Canada  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519820_375.607</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: &Eacute;ric T. Poehlman, Ph.D., D&eacute;partement de Nutrition, Unit&eacute; M&eacute;tabolique, Universit&eacute; de Montr&eacute;al, Pavillon Lilliane de Stewart, 2405 Chemin de la C&ocirc;te-Sainte Catherine, Montr&eacute;al, Qu&eacute;bec H3T 1A8, Canada. E-mail: Eric.Poehlman{at}UMONTREAL.CA' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12519822_0.130</DOCNO>
<TEXT>
      Time to Wake-Up to the Individual Variation in Sleep Needs          Scott A. Rivkees  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519822_133.95</DOCNO>
<TEXT>
    Yale Child Health Research Center, Yale University, New Haven, Connecticut 06520  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519822_231.188</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Scott A. Rivkees, M.D., Yale Child Health Research Center, Yale University, New Haven, Connecticut 06520.
</TEXT>
</DOC>

<DOC>
<DOCNO>12519824_0.138</DOCNO>
<TEXT>
      Cushing&#146;s Disease, 70 Years Later ... and the Beat Goes on          Thomas Moshang, Jr.  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519824_141.136</DOCNO>
<TEXT>
    University of Pennsylvania School of Medicine, Children&#146;s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519824_280.257</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Thomas Moshang, Jr., M.D., Professor of Pediatrics, University of Pennsylvania School of Medicine, Children&#146;s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104.
</TEXT>
</DOC>

<DOC>
<DOCNO>12519896_0.293</DOCNO>
<TEXT>
      Purification and Characterization of a Novel Intracellular 17&#223;-Estradiol Binding Protein in Estrogen-Resistant New World Primate Cells          Hong Chen,   Bing Hu,   Gang-Hua Huang,   Amanda G. Trainor,   David H. Abbott and   John S. Adams  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519896_296.396</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism (H.C., G.-H.H.,  J.S.A.), and Department of Pathology (B.H.), Cedars-Sinai Burns and  Allen Research Institute, UCLA School of Medicine, Los Angeles,  California; and Pathology Unit, Department of Obstetrics and Gynecology  (A.G.T., D.H.A.), Wisconsin Regional Primate Research Center,  University of Wisconsin, Madison, Wisconsin  
</TEXT>
</DOC>


<DOC>
<DOCNO>12519896_695.427</DOCNO>
<TEXT>
     Address correspondence to: Hong Chen, M.D., Division of Endocrinology, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room B-131, Los Angeles, California 90048. E-mail: chenh{at}cshs.orgchenh@cshs.org.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12519897_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12519897_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12519897_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12519898_0.232</DOCNO>
<TEXT>
      National Hormone &amp; Peptide Program&#151;NIDDK: Recombinant Hormones, Hypothalamic Peptides &amp; Other Hormones, Antisera, Reagents, &amp; Hormone Assay Services Available             
</TEXT>
</DOC>


<DOC>
<DOCNO>12519898_235.22</DOCNO>
<TEXT>
           
</TEXT>
</DOC>


<DOC>
<DOCNO>12519898_260.16</DOCNO>
<TEXT>
     
</TEXT>
</DOC>

<DOC>
<DOCNO>12574171_0.179</DOCNO>
<TEXT>
      New Special Feature Articles for the JCEM&#151;Cardiovascular Endocrinology          John P. Bilezikian, M.D., Editor-in-Chief  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574171_182.33</DOCNO>
<TEXT>
    New York, New York  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574171_218.1394</DOCNO>
<TEXT>
          With this issue of the JCEM, I am pleased to announce a new section devoted to cardiovascular endocrinology. John Baxter, President of The Endocrine Society, has made this subject the theme of the 2003 Annual Meeting in Philadelphia, Pennsylvania, this June. Traditionally, The Endocrine Society Journals support The Endocrine Society President by devoting part of the June issue to the theme of the meeting. In recognition of the importance of this topic and our hope to stimulate interest on a lasting basis, the JCEM is pleased to announce a new series of articles that will appear throughout the year. In the special features section, articles will appear under a separate heading, Cardiovascular Endocrinology. Authors of these special feature articles were invited by the Editors, and the papers were peer reviewed. In 2003, we expect to publish over 20 articles in this section. We also will be emphasizing original articles in cardiovascular endocrinology this year by devoting a special section to it in the June issue. By emphasizing this theme, we hope to rekindle interest in this important area of endocrinology and define it better for the field. 
</TEXT>
</DOC>

<DOC>
<DOCNO>12574172_0.181</DOCNO>
<TEXT>
      Aldosterone Function in Diabetes Mellitus: Effects on Cardiovascular and Renal Disease          Samy I. McFarlane and   James R. Sowers  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574172_184.277</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Hypertension, Departments of Medicine and Cell Biology at State University of New York, Health Science Center at Brooklyn, Kings County Hospital Center, and Veterans Affairs Medical Centers of Brooklyn, New York 11203-2098  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574172_464.589</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: James R. Sowers, M.D., FACP, Professor of Medicine and Cell Biology, Director of Endocrinology, Diabetes and Hypertension Division, State University of New York Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 1205, Brooklyn, New York 11203. E-mail: jsowers{at}downstate.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574173_0.107</DOCNO>
<TEXT>
      The Contributions of Frederick Hisaw          Adolph Friedman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574173_110.66</DOCNO>
<TEXT>
    The Endocrine Society Bethesda, Maryland 20814-4426  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574173_179.194</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Adolph Friedman, M.D., The Endocrine Society, 4350 East West Highway, Suite 500, Bethesda, Maryland 20814-4426.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574174_0.169</DOCNO>
<TEXT>
      Sulfonylureas Differ in Effects on Ischemic Preconditioning&#151;Is it Time to Retire Glyburide?          Matthew C. Riddle  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574174_172.159</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes, and Clinical Nutrition, Department of Medicine Oregon Health and Science, University Portland, Oregon 97201  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574174_334.227</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Matthew C. Riddle, M.D., Section of Diabetes L-345, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574176_0.119</DOCNO>
<TEXT>
      Greater Risk, Greater Benefit&#151;True or False?          Paul D. Miller  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574176_122.121</DOCNO>
<TEXT>
    University of Colorado Health Sciences Center, Colorado Center for Bone Research, Lakewood, Colorado 80227  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574176_246.262</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Paul D. Miller, M.D., Clinical Professor of Medicine, University of Colorado Health Sciences Center, Medical Director, Colorado Center for Bone Research, Lakewood, Colorado 80227.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574178_0.170</DOCNO>
<TEXT>
      Biochemical Diagnosis of Pheochromocytoma&#151;Is it Time to Switch to Plasma-Free Metanephrines?          Graeme Eisenhofer  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574178_173.160</DOCNO>
<TEXT>
    Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health Bethesda, Maryland 20892  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574178_336.455</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Graeme Eisenhofer, Ph.D., Building 10, Room 6N252, National Institutes of Health, Bethesda, Maryland 20892-1620. E-mail: graeme{at}catecholamine.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574180_0.159</DOCNO>
<TEXT>
      Hormonal Male Contraception&#151;Lessons from the East When the Western Market Fails          David J. Handelsman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574180_162.90</DOCNO>
<TEXT>
    ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574180_255.186</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: David J. Handelsman, M.D., ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574237_0.313</DOCNO>
<TEXT>
      Circulating Ghrelin Concentrations in the Polycystic Ovary Syndrome          Francesco Orio, Jr.,   Paola Lucidi,   Stefano Palomba,   Libuse Tauchmanova,   Teresa Cascella,   Tiziana Russo,   Fulvio Zullo,   Annamaria Colao,   Gaetano Lombardi and   Pierpaolo De Feo  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574237_316.386</DOCNO>
<TEXT>
    Departments of Molecular and Clinical Endocrinology and Oncology  (F.O., L.T., T.C., A.C., G.L.), University "Federico II," Naples;  Department of Internal Medicine, Section of Internal Medicine,  Endocrine and Metabolic Sciences (P.L., P.D.F.), University of Perugia;  and Chair of Obstetrics and Gynecology (S.P., T.R., F.Z.), University  of Catanzaro, Catanzaro, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574237_705.479</DOCNO>
<TEXT>
     Address correspondence to: Francesco Orio, Jr., M.D., Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universit&agrave; degli Studi di Napoli Federico II, Via Giovanni Santoro n.14, 84131 Salerno, Italy. E-mail: f.orio{at}tin.itf.orio@tin.it.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12574238_0.189</DOCNO>
<TEXT>
      Flutamide Counteracts the Antiproliferative Effects of Antiprogestins in the Primate Endometrium          Ov D. Slayden and   Robert M. Brenner  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574238_192.115</DOCNO>
<TEXT>
    Division of Reproductive Sciences, Oregon National Primate Research  Center, Beaverton, Oregon 97006  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574238_310.440</DOCNO>
<TEXT>
     Address correspondence to: Robert Brenner, M.D., Division of Reproductive Sciences, Oregon Regional Primate Research Center, 505 NW 185th Street, Beaverton, Oregon 97006. E-mail: brennerr{at}ohsu.edubrennerr@ohsu.edu.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12574239_0.312</DOCNO>
<TEXT>
      Authors&#146; Response: Methodological Considerations Regarding the Use of Galectin-3 Expression Analysis in Preoperative Evaluation of Thyroid Nodules          Marek Niedziela,   Eugeniusz Korman and   Jarosaw Maceluch  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574239_315.333</DOCNO>
<TEXT>
    Department of Pediatric Endocrinology and Diabetes, Institute of Pediatrics (M.N., E.K.), Karol Marcinkowski University of Medical Sciences in Poznan, 60-572 Poznan, Poland; and Department of Gene Expression, Institute of Molecular Biology and Biotechnology (J.M.), University of Adam Mickiewicz, 60-572 Poznan, Poland  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574239_651.254</DOCNO>
<TEXT>
     Address correspondence to: Marek Niedziela, Department of Pediatric Endocrinology and Diabetes, Institute of Pediatrics, Karol Marcinkowski University of Medical Sciences in Poznan, Szpitalna Street 27/33, 60-572 Poznan, Poland.
</TEXT>
</DOC>

<DOC>
<DOCNO>12574240_0.238</DOCNO>
<TEXT>
      Methodological Considerations Regarding the Use of Galectin-3 Expression Analysis in Preoperative Evaluation of Thyroid Nodules          Armando Bartolazzi,   Mauro Papotti and   Fabio Orlandi  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574240_241.219</DOCNO>
<TEXT>
    Department of Pathology, St. Andrea Hospital (A.B.), University La Sapienza, Rome, Italy; and Departments of Pathology (M.P.) and Clinical and Biological Sciences (F.O.), University of Turin, Turin, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12574240_463.467</DOCNO>
<TEXT>
     Address correspondence to: Armando Bartolazzi, M.D., Ph.D., Department of Pathology, St. Andrea Hospital, University La Sapienza, Via di Grottarossa 1035, 00189, Rome Italy. E-mail: Armando.Bartolazzi{at}cck.ki.se' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629068_0.174</DOCNO>
<TEXT>
      The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly          Anat Ben-Shlomo and   Shlomo Melmed  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629068_177.134</DOCNO>
<TEXT>
    Cedars-Sinai Research Institute, University of California Los Angeles School of Medicine, Los Angeles, California 90048  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629068_314.458</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Shlomo Melmed, M.D., Academic Affairs, Room 2015, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048. E-mail: melmed{at}csmc.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629069_0.168</DOCNO>
<TEXT>
      Pheochromocytoma in Von Hippel-Lindau Disease          Frederik J. Hes,   Jo W. M. H&ouml;ppener and   Cornelis J. M. Lips  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629069_171.316</DOCNO>
<TEXT>
    Center for Human and Clinical Genetics (F.J.H.), Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Endocrinology and Laboratory of Endocrinology (J.W.M.H.), and Department of Clinical Endocrinology (C.J.M.L.), University Medical Center Utrecht, Utrecht, The Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629069_490.480</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. C. J. M. Lips, University Medical Center Utrecht, Department of Clinical Endocrinology, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. E-mail: c.j.m.lips{at}digd.azu.nl' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629070_0.195</DOCNO>
<TEXT>
      How Should the Dose of Iodine-131 Be Determined in the Treatment of Graves&#146; Hyperthyroidism?          Judith E. Kalinyak and   I. Ross McDougall  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629070_198.111</DOCNO>
<TEXT>
    Division of Nuclear Medicine, Stanford University School of Medicine, Stanford, California 94305  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629070_312.231</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: I. Ross McDougall, M.D., Division of Nuclear Medicine, Stanford University School of Medicine, 300 Pasteur Route 8, Stanford, California 94305-5281.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629072_0.188</DOCNO>
<TEXT>
      Improvement of Bone in Patients with Osteogenesis Imperfecta Treated with Pamidronate&#151;Lessons from Biochemistry          Craig B. Langman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629072_191.180</DOCNO>
<TEXT>
    Division of Kidney Diseases, Department of Pediatrics, Children's Memorial Hospital and Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60614  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629072_374.558</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Craig B. Langman, M.D., Isaac A. Abt, M.D. Professor of Kidney Diseases, Northwestern University, Feinberg School of Medicine, Children's Memorial Hospital, 2300 Childrens Plaza, MS #37, Chicago, Illinois 60614. E-mail: c-langman{at}northwestern.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629135_0.232</DOCNO>
<TEXT>
      Resistin Is Expressed in the Human Placenta          Shigeo Yura,   Norimasa Sagawa,   Hiroaki Itoh,   Kazuyo Kakui,   Mercy A. Nuamah,   Daizo Korita,   Maki Takemura and   Shingo Fujii  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629135_235.124</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology, Kyoto University Graduate  School of Medicine, Kyoto 606-8507, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629135_362.486</DOCNO>
<TEXT>
     Address correspondence to: Norimasa Sagawa, M.D., Ph.D., Department of Obstetrics and Gynecology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: fetus{at}kuhp.kyoto-u.ac.jp' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12629136_0.262</DOCNO>
<TEXT>
      UROMODULIN Mutations Cause Familial Juvenile Hyperuricemic Nephropathy          J. J. O. Turner,   J. M. Stacey,   B. Harding,   P. Kotanko,   K. Lhotta,   J. G. Puig,   I. Roberts,   R. J. Torres and   R. V. Thakker  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629136_265.613</DOCNO>
<TEXT>
    Molecular Endocrinology Group (J.J.O.T., J.M.S., B.H., R.V.T.),  Nuffield Department of Medicine, Botnar Research Centre, University of  Oxford, Nuffield Orthopaedic Centre, Oxford, OX3 7LD, United  Kingdom; Department of Internal Medicine (P.K.), Krankenhaus der  Barmherzigen Brueder (Teaching Hospital KFU Graz), Graz, Austria;  Department of Clinical Nephrology (K.L.), Innsbruck University  Hospital, Austria; Servicio de Medicina Interna (J.G.P., R.J.T.),  Hospital General, Madrid, Spain; and Department of Cellular Pathology  (I.R.), John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629136_881.471</DOCNO>
<TEXT>
     Address correspodence to: Prof. R. V. Thakker, Nuffield Department  of Medicine, Botnar Centre, University of Oxford, Nuffield Orthopaedic  Centre, Oxford OX3 7LD, United Kingdom. E-mail:  rajesh.thakker{at}ndm.ox.ac.uk' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12629137_0.137</DOCNO>
<TEXT>
      Efficacy of Teriparatide and Alendronate on Nonvertebral Fractures          Nelson B. Watts  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629137_140.99</DOCNO>
<TEXT>
    Bone Health and Osteoporosis Center, University of Cincinnati Cincinnati, Ohio 45219  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629137_242.442</DOCNO>
<TEXT>
     Address correspondence to: Nelson Watts, M.D., University of Cincinnati, Bone Health and Osteoporosis Center, 222 Piedmont Avenue, Suite 4300, Cincinnati, Ohio 45219. E-mail: nelson.watts{at}uc.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629138_0.207</DOCNO>
<TEXT>
      Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes          Mehtap Cakir,   Hasan Altunbas and   Umit Karayalcin  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629138_210.117</DOCNO>
<TEXT>
    Akdeniz University, School of Medicine, Division of Endocrinology and Metabolism 07070 Antalya, Turkey  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629138_330.443</DOCNO>
<TEXT>
     Address correspondence to: Prof. Umit Karayalcin, M.D., Akdeniz University School of Medicine, Division of Endocrinology and Metabolism, 07070 Antalya, Turkey. E-mail: umit{at}med.akdeniz.edu.tr' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629139_0.229</DOCNO>
<TEXT>
      Authors&#146; Response: Hyperglycemia&#151;An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes          Guillermo E. Umpierrez and   Abbas E. Kitabchi  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629139_232.85</DOCNO>
<TEXT>
    University of Tennessee Health Science Center Memphis, Tennessee 38163  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629139_320.511</DOCNO>
<TEXT>
     Address correspondence to: Guillermo E. Umpierrez, M.D., Associate Professor of Medicine, Division of Endocrinology and Metabolism, University of Tennessee Health Science Center, 951 Court Avenue, Room 340M, Memphis, Tennessee 38163. E-mail: gumpierrez{at}utmem.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12629144_0.173</DOCNO>
<TEXT>
      Authors&#146; Response: Recommended Testing in Patients with Low Bone Density          Marjorie M. Luckey and   Cara Tannenbaum  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629144_176.143</DOCNO>
<TEXT>
    St. Barnabas Osteoporosis and Metabolic Bone Disease Center, Arthritis and Rheumatic Disease Center Livingston, New Jersey 07039  
</TEXT>
</DOC>


<DOC>
<DOCNO>12629144_322.477</DOCNO>
<TEXT>
     Address correspondence to: Marjorie Luckey, M.D., St. Barnabas Osteoporosis and Metabolic Bone Disease Center, Arthritis and Rheumatic Disease Center, 200 South Orange Avenue, Livingston, New Jersey 07039. E-mail: mluckey{at}sbhcs.com' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12641111_0.123</DOCNO>
<TEXT>
      Endocrine-Related Resources from the National Institutes of Health             
</TEXT>
</DOC>


<DOC>
<DOCNO>12641111_126.337</DOCNO>
<TEXT>
          Resources currently available to the scientific community that may be of interest for endocrinology research are described briefly here. More information is available through The Endocrine Society Home Page (http://www.endo-society.org) or the information provided below. 
</TEXT>
</DOC>


<DOC>
<DOCNO>12641111_466.64</DOCNO>
<TEXT>
    HUMAN TISSUE RESOURCES
</TEXT>
</DOC>

<DOC>
<DOCNO>12679417_0.133</DOCNO>
<TEXT>
      Classification of Thyroid Diseases: Suggestions for a Revision          Fabrizio Monaco  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679417_136.94</DOCNO>
<TEXT>
    Department of Endocrinology, University G. D&#146;Annunzio, 66100 Chieti, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679417_233.424</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Fabrizio Monaco, M.D., Department of Endocrinology, University G. D&#146;Annunzio, 66100 Chieti, Italy. E-mail: hmonac{at}tin.it' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679419_0.190</DOCNO>
<TEXT>
      Autoimmunity to Gastrointestinal Endocrine Cells in Autoimmune Polyendocrine Syndrome Type I          Roberto Gianani and   George S. Eisenbarth  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679419_193.129</DOCNO>
<TEXT>
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679419_325.533</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: George S. Eisenbarth, M.D., Ph.D., Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Box B140, Denver, Colorado 80262. E-mail: George.Eisenbarth{at}uchsc.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679421_0.160</DOCNO>
<TEXT>
      Growth Hormone Replacement Therapy and Insulin Sensitivity          Johan Svensson and   Bengt-&Aring;ke Bengtsson  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679421_163.119</DOCNO>
<TEXT>
    Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, G&ouml;teborg, Sweden  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679421_285.519</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Johan Svensson, M.D., Ph.D., Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, Gr&ouml;na Str&aring;ket 8, SE-413 45 G&ouml;teborg, Sweden. E-mail: Johan.Svensson{at}medic.gu.se' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679425_0.178</DOCNO>
<TEXT>
      Calcification of the Basal Ganglia in Chronic Hypoparathyroidism          Rita Rastogi,   Norman J. Beauchamp and   Paul W. Ladenson  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679425_181.176</DOCNO>
<TEXT>
    Division of Endocrinology and Metabolism, Departments of Medicine (R.R., P.W.L.) and Radiology (N.J.B.), Johns Hopkins University, Baltimore, Maryland 21287-0003  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679425_360.272</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Paul W. Ladenson, M.D., Department of Medicine, Division of Endocrinology and Metabolism, The Johns Hopkins University, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287-0003.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679456_0.313</DOCNO>
<TEXT>
      Loss of Meal-Induced Decrease in Plasma Ghrelin Levels in Patients with Anorexia Nervosa          Jara Nedv&iacute;dkov&aacute;,   Ivana Krykorkov&aacute;,   Vladim&iacute;r Bart&aacute;k,   Hana Papezov&aacute;,   Philip W. Gold,   Salvatore Alesci and   Karel Pacak  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679456_316.505</DOCNO>
<TEXT>
    Institute of Endocrinology (J.N., I.K., V.B.), Faculty of Natural  Sciences (I.K., V.B.), and Department of Psychiatry (H.P.), Charles  University, Prague, Czech Republic; Pediatric and Reproductive  Endocrinology Branch (S.A., K.P.), NICHD, NIH, Bethesda, Maryland;  Clinical Neuroendocrinology Branch (S.A., P.W.G.), NIMH, NIH, Bethesda,  Maryland; and Sezione di Endocrinologia, Dipartimento Clinico  Sperimentale di Medicina e Farmacologia (S.A.), University of Messina,  Messina, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679456_824.543</DOCNO>
<TEXT>
     Address correspondence to: Karel Pacak, M.D., Ph.D., D.Sc., Chief, Unit on Clinical Neuroendocrinology, Pediatric and Reproductive Endocrine Branch Building 10, Room 9D42, 10 Center Drive, MSC 1583, NICHD, NIH, Bethesda, Maryland 20892-1583. Tel: 301-402-4594, Fax: 301-402-4712 karel{at}mail.nih.gov' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12679490_0.234</DOCNO>
<TEXT>
      Mitochondria of Human Adrenal Cortex Have Tubular Cristae with Bulbous Tips          Alessandro Riva,   Felice Loffredo,   Alessandro Uccheddu,   Francesca Testa Riva and   Bernard Tandler  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679490_237.243</DOCNO>
<TEXT>
    Departments of Cytomorphology (A.R., F.L., F.T.R.) and Surgery  (A.U.), University of Cagliari, Italy; and Department of Veterans  Affairs Medical Center, Geriatric Research Education and Clinical  Center (B.T.), Cleveland, Ohio  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679490_483.456</DOCNO>
<TEXT>
     Address correspondence to: Alessandro Riva, M.D., Professor of Human Anatomy, Department of Cytomorphology, Cittadella Universitaria, I-09042 Monserrato (Cagliari), Italy. Fax: +39 070 6754003, e-mail: riva{at}unica.it' + u + '@' + d + ''//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12679491_0.412</DOCNO>
<TEXT>
      Circulating Concentration of Adiponectin and Its Expression in Subcutaneous Adipose Tissue in Patients with Highly Active Antiretroviral Therapy-Associated Lipodystrophy          Jussi Sutinen1,   Elena Korsheninnikova1,   Tohru Funahashi,   Yuji Matsuzawa,   Tuulikki Nyman and   Hannele Yki-J&auml;rvinen  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679491_415.361</DOCNO>
<TEXT>
    Department of Medicine, Divisions of Diabetes (J.S., H.Y.-J.) and  Infectious Diseases (J.S.), Helsinki University Central Hospital,  Helsinki, Finland; Minerva Research Institute (E.K., T.N.), Helsinki,  Finland; and Department of Internal Medicine and Molecular Science  (T.F., Y.M.), Osaka University Graduate School of Medicine, Osaka,  Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679491_779.164</DOCNO>
<TEXT>
     Address correspondence to: Jussi Sutinen, M.D., Department of Medicine, University of Helsinki, P.O. Box 348, FIN-00029 Helsinki, Finland.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679492_0.212</DOCNO>
<TEXT>
      Authors&#146; Response: Pituitary Magnetic Resonance Imaging in Idiopathic and Genetic Growth Hormone Deficiency          Ivo J. P. Arnhold and   Berenice B. Mendonca  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679492_215.180</DOCNO>
<TEXT>
    Hospital das Clinicas da Faculdade de Medicina da Universidade de S&atilde;o Paulo, Laboratorio de Hormonios e Genetica Molecular, S&atilde;o Paulo 05403-900, Brazil  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679492_398.542</DOCNO>
<TEXT>
     Address correspondence to: Ivo J. P. Arnhold, M.D., Hospital das Clinicas da Universidade de S&atilde;o Paulo, Laboratorio de Hormonios e Genetica Molecular, Avenida Eneas de Carvalho Aguiar 155, Predio dos Ambulatorios, 2 andar Bloco 6, S&atilde;o Paulo, 05403-900, Brazil. E-mail: iarnhold{at}usp.br' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679493_0.193</DOCNO>
<TEXT>
      Pituitary Magnetic Resonance Imaging in Idiopathic and Genetic Growth Hormone Deficiency          Mohamad Maghnie,   Sandro Loche and   Marco Cappa  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679493_196.390</DOCNO>
<TEXT>
    Department of Pediatrics (M.M.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy; Servizio di Endocrinologia Pediatrica (S.L.), Ospedale Regionale per le Microcitemie, 09121 Cagliari, Italy; Unit&agrave; Operativa di Auxologia (M.C.), Ospedale Bambino Ges&ugrave;, IRCCS, Palidoro, 00050 Rome, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679493_589.426</DOCNO>
<TEXT>
     Address correspondence to: Mohamad Maghnie, M.D., Ph.D., Department of Pediatrics, IRCCS Policlinico S. Matteo, Viale Golgi 2, 27100 Pavia, Italy. E-mail: maghnie{at}smatteo.pv.it' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679494_0.184</DOCNO>
<TEXT>
      Insulin-Like Growth Factor (IGF)-II/IGF-Binding Proteins in Constitutionally Tall Children          Sundeep Khosla and   Cheryl A. Conover  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679494_187.79</DOCNO>
<TEXT>
    Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679494_269.179</DOCNO>
<TEXT>
     Address all correspondence to: Sundeep Khosla, M.D., Endocrine Research Unit, Mayo Clinic, 200 First Street SW, 5-194 Joseph, Rochester, Minnesota 55905.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679495_0.127</DOCNO>
<TEXT>
      Acromegaly Consensus: The Next Steps          Andrea Giustina and   Shlomo Melmed  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679495_130.231</DOCNO>
<TEXT>
    Endocrine Section, Department of Internal Medicine, University of Brescia, 25125 Brescia, Italy; and Cedars Sinai Medical Center, University of California Los Angeles School of Medicine, Los Angeles, California 90048  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679495_364.400</DOCNO>
<TEXT>
     Address correspondence to: Prof. Andrea Giustina, Endocrine Section c/o 2a Medicina, Spedali Civili, 25125 Brescia, Italy. E-mail: a.giustina{at}libero.it' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12679496_0.186</DOCNO>
<TEXT>
      Author&#146;s Response: Insulin-Like Growth Factor (IGF)-II/IGF-Binding Proteins in Constitutionally Tall Children          Antonina Barreca  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679496_189.93</DOCNO>
<TEXT>
    Cattedra di Endocrinologia, DiSEM, University of Genova, I-16132 Genova, Italy  
</TEXT>
</DOC>


<DOC>
<DOCNO>12679496_285.437</DOCNO>
<TEXT>
     Address all correspondence to: Antonina Barreca, M.D., Ph.D., Cattedra di Endocrinologia, DiSEM, University of Genova, Viale Benedetto XV, no 6, I-16132 Genova, Italy. E-mail: barreca{at}unige.it' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727935_0.280</DOCNO>
<TEXT>
      A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills          Evanthia Diamanti-Kandarakis,   Jean-Patrice Baillargeon,   Maria J. Iuorno,   Daniela J. Jakubowicz and   John E. Nestler  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727935_283.400</DOCNO>
<TEXT>
    First Department of Medicine (E.D.-K.), University of Athens, GR-17548 Athens, Greece; Department of Medicine (J.-P.B.), Universitaire de Sherbrooke, Sherbrooke, Canada J1H 5N4; Departments of Medicine (M.J.I., J.E.N.) and Obstetrics and Gynecology (J.E.N.), Virginia Commonwealth University, Richmond, Virginia 23298; and Hospital de Clinicas Caracas (D.J.J.), 1040 Caracas, Venezuela  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727935_686.432</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John E. Nestler, M.D., Medical College of Virginia, P.O. Box 980111, Richmond, Virginia 23298-0111. E-mail: nestler{at}hsc.vcu.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727936_0.155</DOCNO>
<TEXT>
      Recombinant Human Thyrotropin and Thyroid Cancer Management          Richard J. Robbins and   Anne K. Robbins  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727936_158.196</DOCNO>
<TEXT>
    Endocrine Service, Division of General Medicine, Department of Medicine, and Medical Library-Nathan Cummings Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727936_357.480</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Richard J. Robbins, M.D., Endocrinology Service, Box 296, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021. E-mail address: robbinsr{at}mskcc.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727937_0.139</DOCNO>
<TEXT>
      Pathophysiology of Graves&#146; Ophthalmopathy: The Cycle of Disease          Rebecca S. Bahn  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727937_142.108</DOCNO>
<TEXT>
    Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727937_253.449</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Rebecca Bahn, Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905. E-mail: bahn.rebecca{at}mayo.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727939_0.268</DOCNO>
<TEXT>
      Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies          M. K. S. Leow,   C. L. Addy and   C. S. Mantzoros  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727939_271.405</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism (M.K.S.L., C.L.A., C.S.M.), Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215; and Division of Endocrinology, Diabetes, and Hypertension (C.L.A.), Department of Internal Medicine, Brigham and Women&#146;s Hospital, Harvard Medical School, Boston, Massachusetts 02115  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727939_679.607</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Christos S. Mantzoros, M.D., D.Sc., Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, 99 Brookline Avenue, Research North 325, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215. E-mail: cmantzor{at}caregroup.harvard.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727940_0.106</DOCNO>
<TEXT>
      The Future Endocrinology Workforce          Harry R. Kimball  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727940_109.99</DOCNO>
<TEXT>
    President, American Board of Internal Medicine Philadelphia, Pennsylvania 19106-3699  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727940_211.176</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Harry R. Kimball, M.D., 510 Walnut Street, Suite 1700, Philadelphia, Pennsylvania 19106-3699.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727995_0.332</DOCNO>
<TEXT>
      Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia          Kaori Koga,   Yutaka Osuga,   Osamu Yoshino,   Yasushi Hirota,   Xie Ruimeng,   Tetsuya Hirata,   Satoru Takeda,   Tetsu Yano,   Osamu Tsutsumi and   Yuji Taketani  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727995_335.361</DOCNO>
<TEXT>
    Department of Obstetrics and Gynecology (K.K., Y.O., O.Y., Y.H.,  X.R., T.H., T.Y., O.T., Y.T.), Faculty of Medicine, University of  Tokyo, Tokyo 113-8655; Department of Obstetrics and Gynecology (S.T.),  Saitama Medical Center, Saitama Medical School, Saitama 350-8550; and  CREST (O.T.), Japan Science and Technology, Kawaguchi 332-0012,  Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727995_699.157</DOCNO>
<TEXT>
     Address correspondence to: Yutaka Osuga, M.D., Department of Obstetrics and Gynecology, University of Tokyo, Tokyo 113-8655, Japan.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727996_0.169</DOCNO>
<TEXT>
      Authors&#146; Response: Androgens, Estrogens, and Bone Turnover in Men          Benjamin Z. Leder and   Joel S. Finkelstein  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727996_172.90</DOCNO>
<TEXT>
    Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727996_265.433</DOCNO>
<TEXT>
     Address correspondence to: Benjamin Z. Leder, M.D., Massachusetts General Hospital, Endocrine Unit, Bulfinch 327 Fruit Street, Boston, Massachusetts 02114. E-mail: bzleder{at}partners.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12727997_0.134</DOCNO>
<TEXT>
      Androgens, Estrogens, and Bone Turnover in Men          Sundeep Khosla and   B. L. Riggs  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727997_137.79</DOCNO>
<TEXT>
    Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>12727997_219.433</DOCNO>
<TEXT>
     Address correspondence to: Sundeep Khosla, M.D., Mayo Clinic, Endocrine Research Unit, 200 First Street SW, 5-194 Joseph, Rochester, Minnesota 55905. E-mail: khosla.sundeep{at}mayo.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788828_0.119</DOCNO>
<TEXT>
      A Focus on Cardiovascular Endocrinology          John P. Bilezikian, M.D.  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788828_122.30</DOCNO>
<TEXT>
    Editor-in-Chief  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788828_155.3216</DOCNO>
<TEXT>
          A few months ago, I announced that the JCEM had begun a series on Cardiovascular Endocrinology, in keeping with the theme of this month&#146;s Annual Meeting of The Endocrine Society. Recognizing that this important area of endocrinology has not received the attention it deserves, our President, John Baxter, asked each of The Endocrine Society Journals to highlight this theme for June. In 2003, the JCEM has already published two special feature articles in cardiovascular endocrinology: McFarlane S. I., and Sowers J. R.: Aldosterone function in diabetes mellitus&#151;effects on cardiovascular and renal disease 88:516&#150;523, 2003; and Goran M. I., Ball G. D. C., and Cruz M. L.: Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents 88:1417&#150;1428, 2003. In the following pages, the special June section features 15 more articles on cardiovascular endocrinology. We are pleased to have received the cooperation of the most prominent investigators and thought leaders in this field to provide for you a compendium of information you should find refreshingly new and timely. Jonathan S. Williams and Gordon Williams&#146; historical perspective on the 50th anniversary of aldosterone is followed by an editorial by John Funder, in which he comments on the Ephesus Trial. Hypertension and cardiac function is a focus of the next three articles: Aldosterone in the heart (Perrin White); the cortisol-cortisone shuttle (Paul Stewart and Marcus Quinkler); and pregnancy (Ellen Seely and Caren G. Solomon). The metabolic syndrome is covered in three articles by Gerald Reaven (Insulin resistance, hypertension, and coronary artery disease), Monica Carr and John Brunzell (The emergence of the metabolic syndrome with menopause), and V. Krishna Chatterjee, Steve O&#146;Rahilly, Mark Gurnell, and David B. Savage (Insulin resistance and dyslipidemia). The need for metabolic control in type 2 diabetes is reviewed by Paresh Dandona, Ahmad Alijada, Ajay Chaudhuri, and Arindam Bandyopadhyay, and by Irl Hirsch, Dace L. Trence, and Janet Kelly in the next two articles. Paul Ladenson and Anne R. Cappola write about hypothyroidism as a risk factor for atherosclerosis. Robert Kreisberg and Albert Oberman discuss the medical management of hyperlipidemia. David Weigle addresses issues related to the medical therapy of obesity. The last two articles in this series are new views related to markers of cardiovascular disease risk in women (Sonia Davison and Susan R. Davis) and how adult-onset growth hormone deficiency may be related to atherosclerosis (T. B. Twickler, M. J. M. Cramer, G. M. Dallinga-Thie, M. J. Chapman, D. W. Erkelens, and H. P. F. Koppeschaar). 
</TEXT>
</DOC>

<DOC>
<DOCNO>12788829_0.132</DOCNO>
<TEXT>
      50th Anniversary of Aldosterone          Jonathan S. Williams and   Gordon H. Williams  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788829_135.179</DOCNO>
<TEXT>
    Endocrinology, Hypertension and Diabetes Division, Department of Medicine, Brigham and Women&#146;s Hospital and Harvard Medical School, Boston, Massachusetts 02115  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788829_317.500</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Gordon H. Williams, M.D., Endocrinology, Hypertension and Diabetes Division, Brigham and Women&#146;s Hospital, 221 Longwood Avenue, Boston, Massachusetts 02115. E-mail: gwilliams{at}partners.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788830_0.116</DOCNO>
<TEXT>
      Aldosterone Resurgens&#151;Letter from EPHESUS          John W. Funder  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788830_119.98</DOCNO>
<TEXT>
    Prince Henry&#146;s Institute of Medical Research Clayton, Victoria, Australia 3168  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788830_220.464</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John W. Funder, M.D., Ph.D., Prince Henry&#146;s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria, Australia 3168. Email: John.Funder{at}medJohn.Funder@med.'//--> monash.edu.au.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788831_0.129</DOCNO>
<TEXT>
      Aldosterone: Direct Effects on and Production by the Heart          Perrin C. White  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788831_132.114</DOCNO>
<TEXT>
    Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9063  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788831_249.506</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Perrin C. White, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9063. E-mail: perrin.white{at}utsouthwestern.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788834_0.172</DOCNO>
<TEXT>
      Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease          Gerald M. Reaven  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788834_175.118</DOCNO>
<TEXT>
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788834_296.476</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Gerald Reaven, M.D., Falk Cardiovascular Research Center, Stanford Medical Center, 300 Pasteur Drive, Stanford, California 94305. E-mail: greaven{at}cvmed.stanford.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788837_0.288</DOCNO>
<TEXT>
      The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes          Paresh Dandona,   Ahmad Aljada,   Ajay Chaudhuri and   Arindam Bandyopadhyay  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788837_291.150</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, Buffalo, New York 14209  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788837_444.467</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Paresh Dandona, M.D., Ph.D., Diabetes-Endocrinology Center of Western New York, 3 Gates Circle, Buffalo, New York 14209. E-mail: pdandona{at}kaleidahealth.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788839_0.128</DOCNO>
<TEXT>
      Hypothyroidism and Atherosclerosis          Anne R. Cappola and   Paul W. Ladenson  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788839_131.413</DOCNO>
<TEXT>
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and Division of Epidemiology, Center for Clinical Epidemiology and Biostatistics (A.R.C.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; and Division of Endocrinology and Metabolism, Department of Medicine (P.W.L.), Johns Hopkins University School of Medicine, Baltimore, Maryland 21287  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788839_547.608</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Anne R. Cappola, M.D., Sc.M., Division of Endocrinology, Diabetes, and Metabolism, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 932 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104-6021. E-mail: acappola{at}cceb.med.upenn.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788840_0.145</DOCNO>
<TEXT>
      Medical Management of Hyperlipidemia/Dyslipidemia          Robert A. Kreisberg and   Albert Oberman  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788840_148.155</DOCNO>
<TEXT>
    University of South Alabama (R.A.K.), Mobile, Alabama 36688; and University of Alabama (A.O.), School of Medicine, Birmingham, Alabama 35205  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788840_306.466</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Robert A. Kreisberg, M.D., University of South Alabama, 307 North University Boulevard, CSAB 170, Mobile, Alabama 36688-0002. E-mail: rkreisberg{at}usouthal.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788841_0.132</DOCNO>
<TEXT>
      Pharmacological Therapy of Obesity: Past, Present, and Future          David S. Weigle  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788841_135.115</DOCNO>
<TEXT>
    University of Washington School of Medicine and Harborview Medical Center, Seattle, Washington 98104  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788841_253.462</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: David S. Weigle, M.D., Endocrinology, Box 359757, Harborview Medical Center, 325 Ninth Avenue, Seattle, Washington 98104. E-mail: weigle{at}u.washington.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788843_0.279</DOCNO>
<TEXT>
      Adult-Onset Growth Hormone Deficiency: Relation of Postprandial Dyslipidemia to Premature Atherosclerosis          T. B. Twickler,   M. J. M. Cramer,   G. M. Dallinga-Thie,   M. J. Chapman,   D. W. Erkelens and   H. P. F. Koppeschaar  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788843_282.390</DOCNO>
<TEXT>
    INSERM, Unit&eacute; 551 Dyslipoproteinemia and Atherosclerosis, H&ocirc;pital Piti&eacute;-Salpetri&egrave;re (T.B.T., M.J.C.), 75651 Paris, France; and Department of Internal Medicine (T.B.T., G.M.D.-T., D.W.E.), Department of Cardiology, Heart Lung Institute (M.J.M.C.), and Department of Clinical Endocrinology, University Medical Center, Utrecht G02.228, The Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788843_675.423</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: T. B. Twickler, M.D., Department of Internal Medicine, Utrecht G02.228, The Netherlands. E-mail: th.b.twickler{at}azu.nl' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788901_0.421</DOCNO>
<TEXT>
      Genetic Variation at the Scavenger Receptor Class B Type I Gene Locus Determines Plasma Lipoprotein Concentrations and Particle Size and Interacts with Type 2 Diabetes: The Framingham Study          Doreen Osgood,   Dolores Corella,   Serkalem Demissie,   L. Adrienne Cupples,   Peter W. F. Wilson,   James B. Meigs,   Ernst J. Schaefer,   Oscar Coltell and   Jose M. Ordovas  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788901_424.573</DOCNO>
<TEXT>
    Nutrition and Genomics Laboratory (D.O., D.C., O.C., J.M.O.) and Lipid Metabolism Laboratory (E.J.S.), Jean Mayer&#150;U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111; Boston University School of Public Health (S.D., L.A.C.) and Boston University School of Medicine (P.W.F.W.), Boston, Massachusetts 02118; Framingham Heart Study (P.W.F.W.), Framingham, Massachusetts 01702; and General Internal Medicine Department (J.B.M.), Massachusetts General Hospital, Boston, Massachusetts 02114  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788901_1000.553</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. J. M. Ordovas, Nutrition and Genomics Laboratory, Jean Mayer&#150;U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, Massachusetts 02111. E-mail: jose.ordovas{at}tufts.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788909_0.267</DOCNO>
<TEXT>
      Cerebrospinal Fluid Ghrelin Is Negatively Associated with Body Mass Index          Nicholas A. Tritos,   Alexander Kokkinos,   Ekaterini Lampadariou,   Eleni Alexiou,   Nicholas Katsilambros and   Eleftheria Maratos-Flier  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788909_270.253</DOCNO>
<TEXT>
    Joslin Diabetes Center and Harvard Medical School (N.A.T., E.M.F.),  Boston, Massachusetts; and Laikon General Hospital and Department of  Internal Medicine, University of Athens Medical \E  School (A.K., E.L., E.A., N.K.), Athens, Greece  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788909_526.186</DOCNO>
<TEXT>
     Address correspondence to: Nicholas A. Tritos, M.D., Department of Endocrinology, Joslin Diabetes Center, 1 Joslin Place&#151;#653, Boston, Massachusetts 02215.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788910_0.271</DOCNO>
<TEXT>
      A Locus for Autosomal Recessive Idiopathic Hypogonadotropic Hypogonadism on Chromosome 19p13.3          James S. Acierno Jr.,   Jenna K. Shagoury,   Y&oslash;usef Bo-Abbas,   William F. Crowley Jr. and   Stephanie B. Seminara  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788910_274.191</DOCNO>
<TEXT>
    Reproductive Endocrine Unit (S.B.S., J.S.A., J.K.S., W.F.C.),  Massachusetts General Hospital, Boston, Massachusetts; and Faculty of  Medicine (Y.B.), Kuwait University, Kuwait  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788910_468.221</DOCNO>
<TEXT>
     Address correspondence to: Stephanie B. Seminara, M.D., Reproductive Endocrinology Unit, Massachusetts General Hospital, Bartlett Hall Extension 505, 55 Fruit Street, Boston, Massachusetts 02114.
</TEXT>
</DOC>

<DOC>
<DOCNO>12788912_0.145</DOCNO>
<TEXT>
      Cortisol Metabolism and Glucose Intolerance          Michiel N. Kerstens and   Robin P. F. Dullaart  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788912_148.99</DOCNO>
<TEXT>
    Department of Endocrinology University Hospital Groningen Groningen, The Netherlands  
</TEXT>
</DOC>


<DOC>
<DOCNO>12788912_250.192</DOCNO>
<TEXT>
     Address correspondence to: Michiel N. Kerstens, M.D., Department of Endocrinology, University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843129_0.220</DOCNO>
<TEXT>
      Is the Achilles&#146; Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?          Ivan V. Litvinov,   Angelo M. De Marzo and   John T. Isaacs  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843129_223.341</DOCNO>
<TEXT>
    The Sidney Kimmel Comprehensive Cancer Center (I.V.L., A.M.D., J.T.I.), the Department of Pathology (A.M.D.), the Cellular and Molecular Graduate Program (I.V.L., J.T.I.), and the Brady Urological Institute, The Department of Urology (A.M.D., J.T.I.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843129_567.457</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: John T. Isaacs, Ph.D., Johns Hopkins Oncology, 1650 Orleans Street, Cancer Research Building 1M44, Baltimore, Maryland 21231-1000. E-mail: isaacjo{at}jhmi.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843132_0.183</DOCNO>
<TEXT>
      Ghrelin and Gastric Bypass: Is There a Hormonal Contribution to Surgical Weight Loss?          David E. Cummings and   Michael H. Shannon  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843132_186.189</DOCNO>
<TEXT>
    Department of Medicine, Division of Metabolism, Endocrinology and Nutrition University of Washington Veterans Affairs Puget Sound Health Care System Seattle, Washington 98108  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843132_378.493</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: David E. Cummings, M.D., University of Washington, VA Puget Sound Health Care System, 1660 South Columbian Way, S-111-Endo, Seattle, Washington 98108. E-mail: davidec{at}u.washington.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843133_0.116</DOCNO>
<TEXT>
      Cytokine Regulation of Lipolysis in Humans?          Michael D. Jensen  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843133_119.92</DOCNO>
<TEXT>
    Endocrine Research Unit Mayo Clinic and Foundation Rochester, Minnesota 55905  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843133_214.466</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael D. Jensen, M.D., Endocrine Research Unit, Joseph 5-194, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail: jensen.michael{at}mayo.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843135_0.133</DOCNO>
<TEXT>
      How Should Patients with Primary Hyperparathyroidism Be Treated?          Orlo H. Clark  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843135_136.104</DOCNO>
<TEXT>
    Department of Surgery UCSF/Mount Zion Medical Center San Francisco, California 94143-1674  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843135_243.232</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Orlo H. Clark, M.D., Department of Surgery, UCSF/Mount Zion Medical Center, 1600, Divisadero Street, Room C347, San Francisco, California 94143-1674.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843137_0.124</DOCNO>
<TEXT>
      Statins Sentence Thyroid Cancer Cells to Death Rho          Richard J. Robbins  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843137_127.152</DOCNO>
<TEXT>
    Endocrine Service, Division of General Medicine, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843137_282.468</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Richard J. Robbins, M.D., Endocrine Service, Box 296, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021. E-mail: robbinsr{at}mskcc.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843202_0.264</DOCNO>
<TEXT>
      Ghrelin Main Action on the Regulation of Growth Hormone Release Is Exerted at Hypothalamic Level          V. Popovic,   D. Miljic,   D. Micic,   S. Damjanovic,   E. Arvat,   E. Ghigo,   C. Dieguez and   F. F. Casanueva  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843202_267.323</DOCNO>
<TEXT>
    Institute of Endocrinology, University Clinical Centre Belgrade  Yugoslavia (V.P., D.Mil., D.Mic., S.D.); Division of Endocrinology  (E.A., E.G.), University of Turin, Italy; Departments of Medicine  (F.F.C.) and Physiology (C.D.), Complejo Hospitalario de Santiago,  Santiago de Compostela University, Spain  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843202_593.208</DOCNO>
<TEXT>
     Address correspondence to: F. F. Casanueva, M.D., Department of Medicine, Complejo Hospitalario de Santiago, Santiago de Compostela University, Santiago de Compostela, E-15780 Spain.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843203_0.328</DOCNO>
<TEXT>
      Authors&#146; Response: Dubious Assumptions Underlying the Adjustment of Metabolic Rates for Changes in Fat-Free Mass          St&eacute;phane Blanc,   Dale Schoeller,   Joseph Kemnitz,   Richard Weindruch,   Ricki Colman,   Wendy Newton,   Kelly Wink,   Scott Baum and   Jon Ramsey  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843203_331.514</DOCNO>
<TEXT>
    Department of Nutritional Sciences (S.B., D.S.), National Primate Research Center (J.K., R.C., W.N., K.W., S.B.), Department of Physiology (J.K.), and Department of Medicine (R.W.), University of Wisconsin&#150;Madison, Madison, Wisconsin 53706;Veterans Administration Hospital (R.W.), Geriatric Research, Education and Clinical Center, Madison, Wisconsin 53705; and Department of Molecular Sciences (J.R.), School of Veterinary Medicine, University of California&#150;Davis, Davis, California 95616  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843203_848.549</DOCNO>
<TEXT>
     Address correspondence to: St&eacute;phane Blanc, Ph.D., Centre d&#146;Ecologie et Physiologie Energetiques, Centre National de la Recherche Scientifique&#150;Unit&eacute; Propre de Recherche 9010, 23 Rue Becquerel, Strasbourg Cedex 02, 67087, France. E-mail: stephane.blanc{at}c-strasbourg.fr' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843204_0.210</DOCNO>
<TEXT>
      Dubious Assumptions Underlying the Adjustment of Metabolic Rates for Changes in Fat-Free Mass          Dympna Gallagher,   Stanley Heshka and   Steven B. Heymsfield  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843204_213.154</DOCNO>
<TEXT>
    Obesity Research Center, St. Luke&#146;s-Roosevelt Hospital, and Columbia University Institute of Human Nutrition New York, New York, 10025  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843204_370.468</DOCNO>
<TEXT>
     Address correspondence to: Dympna Gallagher, Ed.D., St. Luke&#146;s Roosevelt Hospital, Obesity Research Center, Columbia University, 1090 Amsterdam Avenue, 14th Floor, New York, New York 10025. E-mail: dg108{at}columbia.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843205_0.561</DOCNO>
<TEXT>
      Regarding the Consensus Statement on 21-Hydroxylase Deficiency from the Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology          Sarah Creighton,   Philip Ransley,   Patrick Duffy,   Duncan Wilcox,   Imran Mushtaq,   Peter Cuckow,   Christopher Woodhouse,   Catherine Minto,   Naomi Crouch,   Richard Stanhope,   Ieuan Hughes,   Mehul Dattani,   Peter Hindmarsh,   Caroline Brain,   John Achermann,   Gerard Conway,   Lih Mei Liao,   Angela Barnicoat and   Les Perry  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843205_564.164</DOCNO>
<TEXT>
    Clinicians from the Multidisciplinary Intersex Clinic at Great Ormond Street Hospital and University College London Hospitals, London, United Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843205_731.227</DOCNO>
<TEXT>
     Address correspondence to: Sarah Creighton, M.D., FRCOG, University College London Hospitals, Gynaecology Services, Elizabeth Garrett Anderson Hospital, Huntley Street, London WC1E 6DH, United Kingdom.
</TEXT>
</DOC>

<DOC>
<DOCNO>12843206_0.416</DOCNO>
<TEXT>
      Authors&#146; Response: Regarding the Consensus Statement on 21-Hydroxylase Deficiency from the Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology          Walter L. Miller,   Sharon E. Oberfield,   Phyllis W. Speiser,   Laurence S. Baskin,   Patricia K. Donahoe,   Claire N-Fekete,   John M. Hutson and   Dix Phillip Poppas  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843206_419.544</DOCNO>
<TEXT>
    University of California (W.L.M., L.S.B.), San Francisco, California; Columbia University, College of Physicians and Surgeons (S.E.O.), New York, New York; Long Island Jewish Hospital (P.W.S.), New York, New York; Massachusetts General Hospital (P.K.D.), Boston, Massachusetts; H&ocirc;pital des Enfants Malades (C.N.-F.), Paris, France; Royal Children&#146;s Hospital (J.M.H.), Parkville, Australia; and Children&#146;s Hospital of New York Presbyterian (D.P.P.), Weill Medical College of Cornell University, New York, New York.  
</TEXT>
</DOC>


<DOC>
<DOCNO>12843206_966.207</DOCNO>
<TEXT>
     Address correspondence to: Walter L. Miller, M.D., Department of Pediatrics, University of California, San Francisco, Building MR-IV, Room 205, San Francisco, California 94143-0978.
</TEXT>
</DOC>

<DOC>
<DOCNO>12915620_0.201</DOCNO>
<TEXT>
      Antithyroid Drugs in the Management of Patients with Graves&#146; Disease: An Evidence-Based Approach to Therapeutic Controversies          David S. Cooper  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915620_204.145</DOCNO>
<TEXT>
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915620_352.560</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: David S. Cooper, M.D., Johns Hopkins University School of Medicine, Division of Endocrinology, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215. E-mail: dcooper{at}lifebridgehealth.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12915624_0.103</DOCNO>
<TEXT>
      The Parathyroid Hormone D-Lema          Michael F. Holick  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915624_106.200</DOCNO>
<TEXT>
    Vitamin D, Skin, and Bone Research Laboratory, Section of Endocrinology, Diabetes, and Nutrition, Department of Medicine Boston University School of Medicine Boston, Massachusetts 02118  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915624_309.303</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Michael F. Holick, M.D., Ph.D., Vitamin D, Skin, and Bone Research Laboratory, Section of Endocrinology, Diabetes, and Nutrition, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
</TEXT>
</DOC>

<DOC>
<DOCNO>12915626_0.143</DOCNO>
<TEXT>
      Obesity and Pregnancy&#151;The Propagation of a Viscous Cycle?          Patrick M. Catalano, M.D.  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915626_146.131</DOCNO>
<TEXT>
    MetroHealth Medical Center, Department of Reproductive Biology Case Western Reserve University Cleveland, Ohio 44109  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915626_280.496</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Patrick M. Catalano, M.D., MetroHealth Medical Center, Department of Obstetrics/Gynecology, 2500 MetroHealth Drive, Suite A-219, Cleveland, Ohio 44109. E-mail: pcatalano{at}Metrohealth.org' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12915628_0.153</DOCNO>
<TEXT>
      Reproductive Hormones in Infant Girls&#151;a Harbinger of Adult Reproductive Function?          Mary M. Lee  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915628_156.103</DOCNO>
<TEXT>
    Pediatric Endocrine Division Duke University Medical Center Durham, North Carolina 27710  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915628_262.472</DOCNO>
<TEXT>
     Address all correspondence and requests for reprints to: Dr. Mary M. Lee, Duke University Medical Center, Pediatric Endocrine Division, 308 Bell Building, Box 3080, Durham, North Carolina 27710. E-mail: Lee00140{at}mc.duke.edu' + u + '@' + d + ''//-->.
</TEXT>
</DOC>

<DOC>
<DOCNO>12915697_0.262</DOCNO>
<TEXT>
      Pancreatic Polypeptide Reduces Appetite and Food Intake in Humans          R. L. Batterham,   C. W. Le Roux,   M. A. Cohen,   A. J. Park,   S. M. Ellis,   M. Patterson,   G. S. Frost,   M. A. Ghatei and   S. R. Bloom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915697_265.155</DOCNO>
<TEXT>
    Department of Metabolic Medicine, Imperial College Faculty of  Medicine at Hammersmith Campus, Du Cane Road, London W12 0NN, United  Kingdom  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915697_423.472</DOCNO>
<TEXT>
     Address correspondence to: Stephen R. Bloom, M.D., Imperial College at Hammersmith Campus, Division of Investigative Science, 6th Floor, Commonwealth Building, Du Cane Road, London W12 0NN, United Kingdom. E-mail: s.bloom{at}ic.ac.uks.bloom@ic.ac.uk.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12915698_0.180</DOCNO>
<TEXT>
      Plasma BNP Levels in the Treatment of Type 2 Diabetes with Pioglitazone          Susumu Ogawa,   Kazuhisa Takeuchi and   Sadayoshi Ito  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915698_183.145</DOCNO>
<TEXT>
    Division of Nephrology, Endocrinology and Vascular Biology, Tohoku  University Graduate School of Medicine, Sendai 980-8574, Japan  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915698_331.486</DOCNO>
<TEXT>
     Address correspondence to: Kazuhisa Takeuchi, M.D., Tohoku University School of Medicine, The Second Department of Internal Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. E-mail:  hek293{at}mail.cc.tohoku.ac.jphek293@mail.cc.tohoku.ac.jp.'//-->
</TEXT>
</DOC>

<DOC>
<DOCNO>12915699_0.311</DOCNO>
<TEXT>
      Effects of Dehydroepiandrosterone-sulfate on the Apo E Genotype Influence on Plasma Lipid Levels in Prepubertal Children          Carmen Garc&eacute;s,   Mercedes Benavente,   Beatriz Cano,   Enrique Viturro,   Henar Ortega,   Cristina Horcajada and   Manuel De Oya  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915699_314.195</DOCNO>
<TEXT>
    Unidad de L&iacute;pidos (C.G., M.B., B.C., E.V. M.D.O.), Servicio  de Bioqu&iacute;mica (C.H.), Fundaci&oacute;n Jim&eacute;nez D&iacute;az,  Universidad Aut&oacute;noma de Madrid  
</TEXT>
</DOC>


<DOC>
<DOCNO>12915699_512.398</DOCNO>
<TEXT>
     Address correspondence to: Carmen Garces, M.D., Unidad de Lpidos, Fundacion Jimenez Diaz, Avida Reyes Catolicos, 2, Madrid, 28040, Spain. E-mail: cgarces{at}fjd.escgarces@fjd.es.'//-->
</TEXT>
</DOC>

